<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Lithium for acute mania - McKnight, RF - 2019 | Cochrane Library</title> <meta content="Lithium for acute mania - McKnight, RF - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004048.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Lithium for acute mania - McKnight, RF - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004048.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004048.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Lithium for acute mania" name="citation_title"/> <meta content="Rebecca F McKnight" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Saïk J.G.N. de La Motte de Broöns de Vauvert" name="citation_author"/> <meta content="Oxford University Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Edward Chesney" name="citation_author"/> <meta content="Institute of Psychiatry, Psychology and Neuroscience, King's College London" name="citation_author_institution"/> <meta content="Ben H Amit" name="citation_author"/> <meta content="Tel Aviv University" name="citation_author_institution"/> <meta content="John Geddes" name="citation_author"/> <meta content="Andrea Cipriani" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="andrea.cipriani@psych.ox.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD004048.pub4" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/06/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004048.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004048.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004048.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Antipsychotic Agents [therapeutic use]; *Bipolar Disorder [drug therapy]; *Lithium Compounds [therapeutic use]; Acute Disease; Randomized Controlled Trials as Topic; Valproic Acid [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004048.pub4&amp;doi=10.1002/14651858.CD004048.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="1ljSZou6";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004048\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004048\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa","fr","zh_HANT","ru","ms","pt","ja","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004048.pub4",title:"Lithium for acute mania",firstPublishedDate:"Jun 1, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Common Mental Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1ljSZou6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004048.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004048.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004048.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004048.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004048.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004048.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004048.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004048.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004048.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004048.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9447 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004048.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-sec-0289"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-sec-0084"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-sec-0272"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/appendices#CD004048-sec-0294"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/table_n/CD004048StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/table_n/CD004048StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Lithium for acute mania</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#CD004048-cr-0002">Rebecca F McKnight</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#CD004048-cr-0003">Saïk J.G.N. de La Motte de Broöns de Vauvert</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#CD004048-cr-0004">Edward Chesney</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#CD004048-cr-0005">Ben H Amit</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#CD004048-cr-0006">John Geddes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information#CD004048-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Andrea Cipriani</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information/en#CD004048-sec-0300">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 June 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004048.pub4">https://doi.org/10.1002/14651858.CD004048.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004048-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004048-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004048-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004048-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004048-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004048-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004048-abs-0001" lang="en"> <section id="CD004048-sec-0001"> <h3 class="title" id="CD004048-sec-0001">Background</h3> <p>Bipolar disorder is a common condition associated with high morbidity; developing efficacious, safe treatments is therefore essential. Lithium is an effective maintenance treatment for bipolar disorder. It acts as mood stabiliser and reduces the risk of suicide. However, evidence assessing the efficacy of lithium in the treatment of acute mania is less robust. Current evidence‐based guidelines cite multiple anti‐dopaminergic and mood‐stabilising agents as initial treatments: more definite evidence is needed to decide if lithium should be the first‐line therapy. </p> </section> <section id="CD004048-sec-0002"> <h3 class="title" id="CD004048-sec-0002">Objectives</h3> <p>1. To assess the effects of lithium in comparison with placebo or other active treatment in alleviating the acute symptoms of a manic or mixed episode in people with bipolar disorder.<br/> 2. To review the acceptability and tolerability of treatment with lithium in comparison with placebo or other active treatments in alleviating the acute symptoms of a manic or mixed episode in people with bipolar disorder. </p> </section> <section id="CD004048-sec-0003"> <h3 class="title" id="CD004048-sec-0003">Search methods</h3> <p>We searched the Cochrane Common Mental Disorders Controlled Trials Register, CENTRAL, MEDLINE, Embase, and PsycINFO. We also searched the World Health Organization trials portal (ICTRP) and ClinicalTrials.gov. We checked the reference lists of all included studies and relevant systematic reviews. We have incorporated studies from searches to 18 May 2018 into the current analyses. </p> </section> <section id="CD004048-sec-0004"> <h3 class="title" id="CD004048-sec-0004">Selection criteria</h3> <p>Prospective randomised controlled studies comparing lithium with placebo or alternative drug treatment in treatment of acute mania. We included anyone with bipolar disorder, male and female, of any age. </p> </section> <section id="CD004048-sec-0005"> <h3 class="title" id="CD004048-sec-0005">Data collection and analysis</h3> <p>At least two review authors independently extracted data and assessed methodological quality. We used odds ratios (ORs) to analyse binary efficacy outcomes, and mean differences (MDs) or standardised mean differences (SMDs) for continuously distributed outcomes. We used a fixed‐effect model unless heterogeneity was moderate or substantial, in which case we used a random‐effects model. We used Review Manager 5 to analyse data. We assessed the certainty of evidence for individual outcomes using the GRADE approach. </p> </section> <section id="CD004048-sec-0006"> <h3 class="title" id="CD004048-sec-0006">Main results</h3> <p>We found 36 randomised controlled studies comparing lithium with placebo, one of 12 drugs, or electroconvulsive therapy for treatment of acute mania. Studies included male and female participants (n = 4220), of all ages, who all fitted criteria for a manic episode within the context of a diagnosis of bipolar disorder. </p> <p>Risk of bias was variable; 12 studies had a high risk of bias in one domain and 27 gave inadequate information on randomisation leading to an 'unclear' rating for selection bias. </p> <p><b>Lithium versus placebo</b> </p> <p>High‐certainty evidence found that lithium was an effective treatment for acute mania and was more effective than placebo at inducing a response (OR 2.13, 95% confidence interval (CI) 1.73 to 2.63; participants = 1707; studies = 6; I<sup>2</sup> = 16%; high‐certainty evidence), or remission (OR 2.16, 95% CI 1.73 to 2.69; participants = 1597; studies = 5; I<sup>2</sup> = 21%; high‐certainty evidence). </p> <p>Lithium was more likely than placebo to cause tremor (OR 3.25, 95% CI 2.10 to 5.04; participants = 1241; studies = 6; I<sup>2</sup> = 0%; high‐certainty evidence), and somnolence (OR 2.28, 95% CI 1.46 to 3.58; participants = 1351; studies = 7; I<sup>2</sup> = 0%; high‐certainty evidence). </p> <p>There was insufficient evidence to determine the effect of lithium for all‐cause dropouts (OR 0.76; 95% CI 0.46 to 1.25; participants = 1353; studies = 7; I<sup>2</sup> = 75%; moderate‐certainty evidence), and weight gain (OR 1.48, 95% CI 0.56 to 3.92; participants = 735, studies = 3; I<sup>2</sup>= 51%; moderate‐certainty evidence). </p> <p><b>Lithium versus antipsychotics or mood stabilisers</b> </p> <p>For the outcome of inducing a response, there was only very low‐certainty evidence regarding lithium compared to haloperidol (MD −2.40, 95% CI −6.31 to 1.50; participants = 80; studies = 3; I<sup>2</sup> = 95%), quetiapine (OR 0.66, 95% CI 0.28 to 1.55; participants = 335; studies = 2; I<sup>2</sup> = 71%), and carbamazepine (SMD 0.21, 95% CI −0.18 to 0.60; participants = 102; studies = 3; I<sup>2</sup> = 0%). </p> <p>Lithium was probably less likely to induce a response than olanzapine (OR 0.44, 95% CI 0.20 to 0.94; participants = 180; studies = 2; I<sup>2</sup> = 0%; moderate‐certainty evidence). </p> <p>Lithium may be less likely to induce a response than risperidone (MD 7.28, 95% CI 5.22 to 9.34; participants = 241; studies = 3; I<sup>2</sup> = 49%; low‐certainty evidence). </p> <p>There was no evidence of a difference between lithium and valproate (OR 1.22, 95% CI 0.87 to 1.70; participants = 607; studies = 5; I<sup>2</sup> = 22%; moderate‐certainty evidence). </p> <p>There was moderate‐certainty evidence that lithium was more effective than topiramate at treating acute mania (OR 2.28, 95% CI 1.63 to 3.20; participants = 660; studies = 1). </p> <p>Data on adverse events for these comparisons contained too few studies to provide high‐certainty evidence. </p> </section> <section id="CD004048-sec-0007"> <h3 class="title" id="CD004048-sec-0007">Authors' conclusions</h3> <p>This systematic review indicates that lithium is more effective than placebo as a treatment for acute mania but increases the risk for somnolence and tremor. Limited evidence suggests little or no difference between lithium and other mood stabilisers (valproate, carbamazepine) or antipsychotics (risperidone, quetiapine, haloperidol). Olanzapine may be an exception, as it is probably slightly more effective than lithium. There is uncertain evidence that risperidone may also be more effective than lithium. Lithium is probably more effective at treating acute mania than topiramate. When compared to placebo, lithium was more likely to cause adverse events. However, when compared to other drugs, too few studies provided data on adverse effects to provide high‐certainty evidence. More, rigorously designed, large‐scale studies are needed to definitively conclude if lithium is superior to other interventions in treating acute mania. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004048-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004048-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004048-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004048-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004048-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004048-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004048-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004048-abs-0010">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD004048-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004048-abs-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD004048-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004048-abs-0004" lang="en"> <h3>Lithium for the treatment of acute mania</h3> <p><b>Review question</b> </p> <p>Is lithium (a mood‐stabilising medication) as effective at treating an episode of mania (high mood) as other available drug treatments or electroconvulsive therapy (ECT)? </p> <p><b>Background</b> </p> <p>Bipolar disorder is a common condition in which people experience episodes of low mood (depression) and high mood (mania). The symptoms of bipolar disorder may lower quality of life. Traditionally a range of medications have been used to treat mania, including medications that try to lessen changes in mood (e.g. lithium, valproate, lamotrigine, carbamazepine, divalproex, topiramate), and those that reduce distressing experiences, such as hearing voices or having unusual ideas (e.g. olanzapine, risperidone, quetiapine, aripiprazole, haloperidol, chlorpromazine). ECT (delivering an electric shock to the brain whilst the patient is under a general anaesthetic) is also a treatment for mania. We already know that lithium is the most effective of all these treatments for keeping people with bipolar disorder well in the long term, but we do not know if it is as effective for treating mania. </p> <p><b>Method</b> </p> <p>The review authors searched for studies comparing lithium to other treatments for mania published up to May 2018. We identified 36 randomised studies, including 4220 participants who attended hospitals in at least 30 different countries. Randomisation means that each participant has the same chance of being assigned to each of the study groups, and reduces the chance that unknown but important factors could influence the study accidentally. Three studies included children and adolescents aged under 18 years. The studies compared lithium to placebo (inactive substance), ECT and 12 other medications for between three and 12 weeks. </p> <p><b>Results</b> </p> <p>Lithium is an effective treatment for acute mania. Lithium was more effective than a placebo or the anti‐epileptic drug topiramate. There was some evidence that lithium may be less effective than the antipsychotic drug olanzapine, but this needs further investigation. There was no evidence that lithium was better or worse at treating mania than any of the other drugs, and not enough evidence to draw a conclusion for ECT. </p> <p>There was not enough evidence to provide a definite answer as to which treatment for mania has the fewest side effects. It is probable that more people will develop a mild tremor when treated with lithium than other treatments. Participants were not more likely to withdraw from a study if they were treated with lithium compared to another treatment. </p> <p>Unanswered questions remain, and these would be best resolved by further large, well‐designed studies comparing lithium to other treatments for acute mania. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004048-sec-0289" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004048-sec-0289"></div> <h3 class="title" id="CD004048-sec-0290">Implications for practice</h3> <section id="CD004048-sec-0290"> <p>Within the limitations of this review, there is consistent evidence from randomised studies that lithium is an effective treatment for acute mania. There is clear and at least moderate‐certainty evidence that lithium is more effective than a placebo or topiramate at treating acute mania and is at least as well tolerated. It may be that olanzapine is slightly more effective than lithium, but the certainty of evidence is not high. The wide range of adverse events experienced by the placebo group compared to those on lithium could provide a useful perspective for counselling patients regarding the risks and benefits of taking lithium. There is not enough evidence at present to clearly guide clinicians on the best dosing strategy for lithium ‐ the recommendation would be as per the National Institute for Health and Care Excellence (NICE) or British Association of Pharmacology Guidelines of aiming for plasma level 0.6 mmol/L to 0.8 mmol/L (<a href="./references#CD004048-bbs2-0096" title="GoodwinGM , HaddadPM , FerrierIN , AronsonJK , BarnesT , CiprianiA , et al. Evidence‐based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology2016;30(6):495‐553. ">Goodwin 2016</a>; <a href="./references#CD004048-bbs2-0119" title="National Institute for Health and Care Excellence (NICE). Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. Clinical Guideline 185. www.nice.org.uk/guidance/cg185 (accessed before 14 February 2019). ">NICE 2014</a>), or on the timescale over which lithium could be expected to work compared to other drugs. </p> <p>The results are consistent with current guidelines for treatment mania, that antipsychotics such as olanzapine, quetiapine, risperidone or haloperidol are reasonable first‐line choices for patients not already on a long‐term antimanic (<a href="./references#CD004048-bbs2-0096" title="GoodwinGM , HaddadPM , FerrierIN , AronsonJK , BarnesT , CiprianiA , et al. Evidence‐based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology2016;30(6):495‐553. ">Goodwin 2016</a>; <a href="./references#CD004048-bbs2-0119" title="National Institute for Health and Care Excellence (NICE). Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. Clinical Guideline 185. www.nice.org.uk/guidance/cg185 (accessed before 14 February 2019). ">NICE 2014</a>). This study suggests that lithium is not inferior to the antipsychotics (perhaps to olanzapine, but the evidence is of low certainty), but is a second‐line choice in published guidelines. The probable reason for that is the clinical experience that lithium is slower to act than antipsychotics, and as mania is associated with high clinical risk, a faster working medication ‐ and one that does not required blood level monitoring in agitated patients‐ may be preferred. This is a reasonable strategy given the current evidence, especially for olanzapine. If patients are already taking an antipsychotic, the addition of lithium does seem a logical next step, especially given the recent guidance issued regarding valproate use in women of reproductive age (<a href="./references#CD004048-bbs2-0114" title="The Medicines and Healthcare products Regulatory Agency (MHRA). Valproate use by women and girls. Drug Safety Update2018;11(9):1. ">MHRA 2018</a>). </p> <p>We found no evidence that lamotrigine is less effective than lithium, as would be suggested by the current NICE or Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines, but the evidence was not of high certainty (<a href="./references#CD004048-bbs2-0080" title="YathamLN , KennedySH , ParikhSV , SchafferA , BondDJ , FreyBN , et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders2018;20(2):97‐170. ">CANMAT 2018</a>; <a href="./references#CD004048-bbs2-0119" title="National Institute for Health and Care Excellence (NICE). Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. Clinical Guideline 185. www.nice.org.uk/guidance/cg185 (accessed before 14 February 2019). ">NICE 2014</a>). The time (and therefore cost) needed to safely titrate lamotrigine make other antimanic agents a more practical choice. There is insufficient high‐certainty evidence to guide clinical practice on the use of carbamazepine or benzodiazepines in acute mania compared to lithium. Similarly, the relative efficacy and tolerability of lithium to ECT in acute mania remains unclear. </p> <p>It should be noted that the paucity of evidence relating to children and adolescents mean that the results here apply only to adults. </p> </section> <h3 class="title" id="CD004048-sec-0291">Implications for research</h3> <section id="CD004048-sec-0291"> <p>More well‐designed, randomised controlled studies investigating the relative efficacy and acceptability of lithium in the treatment of acute mania are required. This is especially the case in children and adolescents. Future researchers should learn from existing studies and aim to include a power calculation to ensure detecting moderate but worthwhile benefits and include as wide a clinical range of people with bipolar disorder as practicable. Outcome measures of relevance to both patients and clinicians, such as length of hospital stay, occupational and social assessments and reports of patient satisfaction should be included. In view of the practical and ethical difficulties of the inclusion of a placebo group, especially for severely ill patients, future studies should focus on the comparison of lithium with other medications. Considering the cost implications of large studies, and the multiple available treatments for acute mania, network meta‐analysis may prove a useful tool to investigate direct and indirect treatments in future. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004048-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004048-sec-0029"></div> <div class="table" id="CD004048-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lithium compared to placebo for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to placebo for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients and a specialist paediatric psychiatry outpatient clinic<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS/MRS decrease by ≥ 50% at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.13<br/> (1.73 to 2.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1707<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>347 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>531 per 1000<br/> (479 to 583) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>YMRS change from baseline at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) measured as YMRS change from baseline to end of study in the placebo group ranged between −20.1 and −6.71 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) measured as YMRS change from baseline to end of study in the lithium group ranged between −22.8 and −12 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>935<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS &lt; 12 at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.16<br/> (1.73 to 2.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1597<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>301 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>482 per 1000<br/> (427 to 536) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.76<br/> (0.46 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1353<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>427 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>362 per 1000<br/> (255 to 482) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> tremor </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 3.25<br/> (2.10 to 5.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1241<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>48 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000<br/> (96 to 203) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> somnolence </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.28<br/> (1.46 to 3.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1351<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>99 per 1000<br/> (66 to 147) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> weight gain </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.48<br/> (0.56 to 3.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>735<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (11 to 70) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MRS:</b> Mania Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to imprecision: wide confidence interval for most of the studies.<br/> <sup>2</sup>Seven studies of variable size, all of which give imprecise results individually, and six cross line of no difference. Overall result is precise but likely over‐exaggeration of true effect.<br/> <sup>3</sup>Downgraded as all three studies cross line of no difference with wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Lithium compared to valproate for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to valproate for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients and outpatients attending mood disorders clinics<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> valproate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with valproate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>YMRS/SADS‐C decrease ≥ 50% by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.22<br/> (0.87 to 1.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>607<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>438 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>487 per 1000<br/> (404 to 569) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>Change in YMRS (ITT‐LOCF) from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in YMRS (ITT‐LOCF) from baseline to end of study in the valproate group ranged from −23.8 to −7.4 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in YMRS (ITT‐LOCF) from baseline to end of study in the lithium group ranged from −23.55 to −6.1 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>398<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 and no increase in MADRS at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.78<br/> (0.46 to 1.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>257<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>713 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>660 per 1000<br/> (533 to 766) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability</b>: total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.20<br/> (0.86 to 1.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>629<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>330 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>372 per 1000<br/> (298 to 455) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> tremor </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 10.51<br/> (1.96 to 56.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>449<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High<sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1000<br/> (9 to 200) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> somnolence </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.47<br/> (0.29 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>575<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>221 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>118 per 1000<br/> (76 to 177) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> nausea </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.53<br/> (0.97 to 2.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>583<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>158 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>222 per 1000<br/> (154 to 310) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>ITT:</b> intention‐to‐treat; <b>LOCF:</b> last observation carried forward; <b>MADRS:</b> Montgomery‐Åsberg Depression Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>SADS‐C:</b> Schedule for Affective Disorders and Schizophrenia‐change; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to imprecision: two small studies with very wide confidence intervals; overall result is precise which is probably an overestimate of true precision.<br/> <sup>2</sup>Downgarded two levels due to imprecision and inconsistency. Six studies, three missing standard deviation, which could not be imputed. Three studies giving highly variable results. Overall estimate is therefore much more consistent than heterogeneity of studies should suggest.<br/> <sup>3</sup>Downgraded for imprecision. Three studies all with differing, imprecise results.<br/> <sup>4</sup>Downgraded one level due to suspicion of reporting bias. Single study reported this outcome when multiple other larger studies will have had this data available; strongly suggests few participants met remission criteria by end of study.<br/> <sup>5</sup>Both studies have very wide confidence intervals.<br/> <sup>6</sup>Likely publication bias, but not downgraded as the included studies are of high quality. Four large studies examined this question but did not report this common adverse event with lithium.<br/> <sup>7</sup>Downgraded one level due to imprecision. All values fairly imprecise, especially <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>, may be overestimating true effect. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Lithium compared to lamotrigine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to lamotrigine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients (GlaxoSmithKline studies did not state if the participants were inpatients or outpatients)<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> lamotrigine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lamotrigine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>YMRS/SADS‐C decrease ≥ 50% by end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous</b>) </p> <p>Change in BPRS from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in BPRS from baseline to end of study in lamotrigine group ranged between −3.6 and −2.9 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in BPRS from baseline to end of study in lithium group ranged between −5.1 and −4.9 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>301<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 and no increase in MADRS at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.80<br/> (0.50 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>303<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>408 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>355 per 1000<br/> (256 to 471) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> tremor </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.28<br/> (0.48 to 3.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>272<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000<br/> (28 to 171) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> somnolence </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.14<br/> (0.34 to 3.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>272<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>3,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/> (16 to 151) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MADRS:</b> Montgomery‐Åsberg Depression Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>SADS‐C:</b> Schedule for Affective Disorders and Schizophrenia‐change; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for imprecision.<br/> <sup>2</sup>Downgraded two levels for inconsistency. Heterogeneity was 82%. Two studies by GlaxoSmithKline have similar methodology and inclusion criteria but had very different dropout rates. The study authors do not provide any insight into the cause of this.<br/> <sup>3</sup>Downgraded one level for imprecision: wide confidence interval.<br/> <sup>4</sup>Downgraded one level for imprecision.<br/> <sup>5</sup><a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> would have been expected to have reported somnolence as it is a common adverse effect, however, as we have no objective measure of reporting bias we decided not to downgrade on the basis of a suspicion only. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Lithium compared to carbamazepine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to carbamazepine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> carbamazepine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with carbamazepine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS/SADS‐C decrease ≥ 50% by end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>YMRS/BPRS change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS/BPRS endpoint score in the carbamazepine group ranged between 9 and 24 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS/BPRS endpoint score in the lithium group ranged between 9.46 and 30.9 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>CGI change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) CGI endpoint score ranged between 4.1 and 5.6 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) CGI endpoint score ranged between 5.3 and 5.7 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 and no increase in MADRS at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.20<br/> (0.02 to 1.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>34<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000<br/> (7 to 409) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> sedation </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.16<br/> (0.01 to 3.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>27<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>154 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (2 to 398) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CGI:</b> Clinical Global Impression; <b>CI:</b> confidence interval; <b>MADRS:</b> Montgomery‐Åsberg Depression Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>SADS‐C:</b> Schedule for Affective Disorders and Schizophrenia‐change; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for risk of bias, and two levels for imprecision.<br/> <sup>2</sup>Downgraded for risk of bias. <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> blinding strategy unclear, very poor completion rate to the study and not all outcomes reported. <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a> selective reporting. Other studies low risk of bias.<br/> <sup>3</sup>Pooled estimate has wide confidence interval, reflective of imprecision of all studies. Sample size is very small, would not meet optimal information size (OIS). Downgraded two levels for this.<br/> <sup>4</sup>Downgraded two levels for risk of bias. Studies included participants aged older than 25 years; methodology poorly reported compared to modern studies.<br/> <sup>5</sup>Downgraded for risk of bias (methodology) and imprecision. Single study with wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Lithium compared to quetiapine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to quetiapine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> quetiapine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with quetiapine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS decrease by ≥ 50% by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.66<br/> (0.28 to 1.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>335<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>644 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>544 per 1000<br/> (336 to 737) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous</b>) </p> <p>YMRS change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS change from baseline to end of study in the quetiapine group ranged from −20.28 to −18.2 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS change from baseline to end of study in the lithium group ranged from −20.76 to −15.9 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>359<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission (categorical)</b> </p> <p>Decrease in YMRS ≤ 12 by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.64<br/> (0.26 to 1.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>359<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>538 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>427 per 1000<br/> (232 to 646) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.38<br/> (0.83 to 2.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>359<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>212 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>271 per 1000<br/> (182 to 380) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for inconsistency. High heterogeneity from two similar studies.<br/> <sup>2</sup>Downgraded one level for imprecision: wide confidence intervals.<br/> <sup>3</sup>Outcome 1 downgraded for publication bias. Only two studies found for this outcome, which makes it likely that there are unpublished data not found by our search.<br/> <sup>4</sup>Downgraded one level for imprecision. Large study with tight confidence interval, small study with wide confidence interval. This is to be expected, but it means the precision is highly dependent upon one study. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Lithium compared to olanzapine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to olanzapine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> olanzapine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with olanzapine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response (categorical)</b> </p> <p>MSRS/YMRS ≥ 50% decrease in score by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.44<br/> (0.20 to 0.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>180<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>730 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>544 per 1000<br/> (351 to 718) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>CGI severity score at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) CGI severity endpoint score in the olanzapine group ranged between 2.26 and 3.69 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) CGI severity endpoint score in the lithium group ranged between 2.83 and 3.41 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>210<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.00<br/> (0.89 to 4.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>826 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>905 per 1000<br/> (809 to 955) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.60<br/> (1.13 to 5.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>210<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>198 per 1000<br/> (97 to 362) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse even</b>ts </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CGI:</b> Clinical Global Impression; <b>CI:</b> confidence interval; <b>MSRS:</b> Manic‐State Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for publication bias. Olanzapine is used widely to treat acute mania; why so few studies? The lack of studies precluded the use of funnel plots.<br/> <sup>2</sup><a href="./references#CD004048-bbs2-0004" title="BerkM , IchimL , BrookS . Olanzapine compared to lithium in mania: a double‐blind randomized controlled trial. International Clinical Psychopharmacology1999;14:339‐43. ">Berk 1999</a> rated as high risk of bias for selective reporting. Downgraded one level for risk of bias. Downgraded one level for suspected publication bias as described above.<br/> <sup>3</sup>Downgraded one level for imprecision. Wide confidence interval on single small study. Downgraded one level for suspected publication bias as described above.<br/> <sup>4</sup>All studies have wide confidence intervals; strongly suspect result to be an overestimate of favouring olanzapine. Downgraded one level for imprecision. Downgraded one level for suspected publication bias as described above. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Lithium compared to chlorpromazine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to chlorpromazine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> chlorpromazine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with chlorpromazine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response (categorical)</b> </p> <p>MSRS/YMRS ≥ 50% decrease in score by end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>BPRS score change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) BPRS score change from baseline to end of study in the chlorpromazine group ranged from 1.21 to 2.23 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) BPRS score change from baseline to end of study in the lithium group ranged from 0.99 to 1.16 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>284<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.75<br/> (0.92 to 3.31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>262<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>223 per 1000<br/> (131 to 351) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BPRS:</b> Brief Psychiatric Rating Scale; <b>CI:</b> confidence interval; <b>MSRS:</b> Manic‐State Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for risk of bias and publication bias. We identified only two studies comparing lithium and chlorpromazine that we could pool (a third, <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> did not provide any outcomes that were comparable): these were both conducted &gt; 30 years ago. It is possible that the trend to using atypical antipsychotics means research using chlorpromazine has reduced, but we would have expected more publications. Also note that the methodology used in the 1970s/80s was not as rigorous as today, but these studies do give relatively clear accounts of systematic study procedures.<br/> <sup>2</sup>Downgraded for inconsistency. Heterogeneity 90%. Methodology of studies might well be the explanation but this is hard to investigate with minimal information.<br/> <sup>3</sup>Downgraded for publication bias. Chlorpromazine was a mainstay of psychiatry in mid 20th century. We would have expected more publications on this topic. Part of the issue is the lack of combinable outcomes.<br/> <sup>4</sup>Downgraded for risk of bias as <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> was quasi‐randomised. Removing <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> does not change the result. <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a> does not give a detailed enough methodology to feel confident about risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Lithium compared to haloperidol for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to haloperidol for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients (one study did not specify a setting)<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> haloperidol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with haloperidol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>MSRS/YMRS ≥ 50% decrease in score by end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>change in BPRS (total) from baseline to end of study ‐all data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in BPRS (total) from baseline to end of study in the haloperidol group ranged from 1.24 to 12 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in BPRS (total) from baseline to end of study in the lithium group ranged from 0.99 to 1 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.29<br/> (0.03 to 3.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>30<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68 per 1000<br/> (7 to 438) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BPRS:</b> Brief Psychiatric Rating Scale; <b>CI:</b> confidence interval; <b>MSRS:</b> Manic‐State Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded two levels for potential risk of bias. Includes studies from 1980 and 1975 with sparse published methodology. Downgraded for inconsistency. Heterogeneity very high (88%); even with removal of outlier in <a href="./references#CD004048-fig-0142" title="">Analysis 8.1</a> (95%).<br/> <sup>2</sup>Downgraded for imprecision. Single study with wide confidence interval. Downgraded for publication bias. Similar to other categories, haloperidol versus lithium is a question we would have expected to see more literature on. It is not possible to do funnel plots with such a limited number of studies. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Lithium compared to zuclopenthixol for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to zuclopenthixol for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> zuclopenthixol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with zuclopenthixol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>BMRS change ≥ 50% from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.33<br/> (0.30 to 5.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>462 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>533 per 1000<br/> (205 to 835) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>change in BPRS (total) from baseline to end of study ‐all data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.78<br/> (0.17 to 3.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>462 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>401 per 1000<br/> (127 to 749) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BPRS:</b> Brief Psychiatric Rating Scale; <b>BRMS:</b> Bech‐Rafaelsen Mania Scale; <b>CI:</b> confidence interval; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level: single study with high risk of bias for blinding and selective reporting.<br/> <sup>2</sup>Downgraded one level for imprecision. Single small study with wide confidence interval.<br/> <sup>3</sup>Downgraded one level for publication bias. Only a single study found in the literature fitting our inclusion criteria. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0010"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Lithium compared to risperidone for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to risperidone for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients and specialist mood disorders clinic (one study did not describe the setting)<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> risperidone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with risperidone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>BMRS change ≥ 50% from baseline to end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>YMRS/MRS change at the end of the study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous): YMRS/MRS change at the end of the study was 0 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 7.28 more<br/> (5.22 to 9.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>241<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12/absence of DSM‐IV mania by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.30<br/> (0.11 to 14.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>211<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>590 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>652 per 1000<br/> (137 to 956) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.85<br/> (1.02 to 3.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>255<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>181 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000<br/> (184 to 425) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events:</b> drowsiness/ somnolence </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.43<br/> (0.24 to 0.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>219<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>455 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>264 per 1000<br/> (167 to 385) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BRMS:</b> Bech‐Rafaelsen Mania Scale; <b>CI:</b> confidence interval; <b>DSM‐IV:</b> Diagnostic and Statistical Manual of Mental Disorders, fourth edition; <b>OR:</b> odds ratio; <b>MRS:</b> Mania Rating Scale; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for imprecision. All studies have wide confidence intervals.<br/> <sup>2</sup>Downgraded one level for publication bias. Very few studies found for this important clinical question using widely used medications.<br/> <sup>3</sup>Downgraded one level for imprecision. Two studies each with wide confidence interval.<br/> <sup>4</sup>Downgraded one level for high probability of publication bias. This is an important clinical question using widely used medications. Seems probable few studies were long enough to show remission and so this outcome has not been reported. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0011"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Lithium compared to aripiprazole for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to aripiprazole for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> aripiprazole </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with aripiprazole</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>BMRS change ≥ 50% from baseline to end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>YMRS change by ≥ 50% at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.96<br/> (0.62 to 1.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>309<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>468 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>457 per 1000<br/> (352 to 570) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.99<br/> (0.63 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>309<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>403 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>400 per 1000<br/> (298 to 513) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.94<br/> (0.60 to 1.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>315<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>529 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>514 per 1000<br/> (403 to 621) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events:</b> tremor </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.45<br/> (0.65 to 3.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>313<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000<br/> (48 to 200) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events:</b> somnolence/sedation </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.56<br/> (0.26 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>313<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000<br/> (33 to 140) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events:</b> clinically relevant (&gt; 7%) weight gain </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.07<br/> (0.18 to 23.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>184<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (2 to 201) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BRMS:</b> Bech‐Rafaelsen Mania Scale; <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for publication bias. Despite a full repeated database search and handsearching of grey literature, we found only <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> lithium verus aripiprazole. We found no ongoing studies for this category. This strongly suggests that data are missing.<br/> <sup>2</sup>Downgraded one level for imprecision. Single study with wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0012"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Lithium compared to topiramate for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to topiramate for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> topiramate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with topiramate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>YMRS change ≥ 50% from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.28<br/> (1.63 to 3.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>660<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>270 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>458 per 1000<br/> (376 to 542) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>YMRS change by ≥ 50% at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.24<br/> (1.58 to 3.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>660<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>415 per 1000<br/> (333 to 499) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.28<br/> (0.66 to 2.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1352<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000<br/> (50 to 166) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD004048-tbl-0013"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">Lithium compared to clonazepam for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to clonazepam for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> clonazepam </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with clonazepam</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS change ≥ 50% from baseline to end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>change in CGI score from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) mean CGI endpoint score in the clonazepam group ranged from 2.71 to 4 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) mean CGI endpoint score in the lithium group ranged from 2.07 to 4.4 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy : remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CGI:</b> Clinical Global Impression; <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of bias; includes a single blinded study. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0014"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">Lithium compared to electroconvulsive therapy (ECT) for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to electroconvulsive therapy</b> (<b>ECT) for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> ECT </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with ECT</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS change ≥ 50% from baseline to end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>MRS mean change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) MRS mean change from baseline to end of study in the ECT group was −18.5 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) MRS mean change from baseline to end of study in the ECT group was −16.4 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Acceptability:</b> total withdrawa<b>ls</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>ECT:</b> electroconvulsive therapy; <b>MRS:</b> Mania Rating Scale; <b>OR:</b> odds ratio; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for imprecision. Downgraded one level for suspected publication bias. We only found this one study looking at electroconvulsive therapy in mania. It is not possible to do a funnel plot in this situation. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004048-tbl-0015"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">Lithium compared to all antimanic agents for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to all antimanic agents for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients and specialised outpatient clinics<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> all antimanic agents </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with all antimanic agents</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>YMRS/MRS/BPRS change by ≥ 50% at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.36<br/> (1.01 to 1.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3666<br/> (14 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>395 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>476 per 1000<br/> (407 to 545) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>YMRS/BPRS: change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS/BPRS change from baseline to end of study was 0 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.30 lower<br/> (−1.45 to lower 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2410<br/> (19 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.16<br/> (0.89 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4201<br/> (24 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>308 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>341 per 1000<br/> (284 to 404) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BPRS:</b> Brief Psychiatric Rating Scale; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MRS:</b> Mania Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded two levels for inconsistency. The overall result of this meta‐analysis is precise, but the individual results are highly heterogeneous. This is probably explainable by small sample sizes in early studies and missing standard deviations that could not be imputed, however, with such a high I<sup>2</sup> value (99%) the results could not be said to be consistent. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004048-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004048-sec-0030"></div> <section id="CD004048-sec-0031"> <h3 class="title" id="CD004048-sec-0031">Description of the condition</h3> <p>Bipolar disorder is a chronic, severe mental disorder characterised by episodes of elevated mood (mania), depression or mixed states. The estimated prevalence worldwide is 1%, but there is a wider group (1.5% to 2% total), who have clinically relevant milder symptoms that do not quite meet diagnostic criteria (<a href="./references#CD004048-bbs2-0117" title="MontgomerySA , KeckPE . First international exchange on bipolar disorder. Journal of Affective Disorders2000;59(Suppl 1):81‐88. ">Montgomery 2000</a>; <a href="./references#CD004048-bbs2-0123" title="PhillipsML , KupferDJ . Bipolar disorder diagnosis: challenges and future directions. Lancet2013;381(9878):1663‐71. ">Philips 2013</a>). Both genders and all nationalities, ethnicities and cultures appear to be equally affected (<a href="./references#CD004048-bbs2-0123" title="PhillipsML , KupferDJ . Bipolar disorder diagnosis: challenges and future directions. Lancet2013;381(9878):1663‐71. ">Philips 2013</a>). Average age of onset is 15 to 19 years, although the mean delay in diagnosis between onset of symptoms and formal diagnosis is seven years (<a href="./references#CD004048-bbs2-0073" title="BerkM , DoddS , CallalyP , BerkL , FitzgeraldP , DeCastellaAR , et al. History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. Journal of Affective Disorders2007;103:181‐6. ">Berk 2007</a>). The impact of bipolar disorder is considerable: globally it accounts for 0.3% of disability‐adjusted life years, impacts upon the sufferer's ability to carry out normal daily activities and is associated with a high suicide rate (<a href="./references#CD004048-bbs2-0067" title="AlonsoJ , PetukhovaM , VilagutG , ChatterjiS , HeeringaS , ÜstünTB , et al. Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Molecular Psychiatry2011;16(12):1234‐46. ">Alsonso 2011</a>; <a href="./references#CD004048-bbs2-0081" title="ChenY , DilsaverS . Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other axis I disorders. Biological Psychiatry1996;39(10):896‐9. ">Chen 1996</a>). Bipolar disorder also reduces life expectancy ‐ this is due to a combination of a greater risk of physical health conditions and the high suicide rate (<a href="./references#CD004048-bbs2-0094" title="GoldsteinBI , CarnethonMR , MatthewsKA , McIntyreRS , RaghuveerG , StoneyCM , et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease a scientific statement from the American Heart Association. Circulation2015;132(10):965‐86. ">Goldstein 2015</a>; <a href="./references#CD004048-bbs2-0107" title="LaursenTM . Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophrenia Research2011;131(1‐3):101‐4. ">Laursen 2011</a>). </p> <p>A diagnosis of bipolar disorder is usually made using one of the two major diagnostic classification systems, the Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV; <a href="./references#CD004048-bbs2-0068" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV). 5th Edition. Washington, DC: American Psychiatric Association, 2013. ">APA 2013</a>) or the International Classification of Diseases 10th revision (ICD‐10; <a href="./references#CD004048-bbs2-0141" title="World Health Organization (WHO). The Tenth Revision of the International Classification of Diseases and Related Jealth Problems. 10th Edition. Geneva: World Health Organization, 1992. ">WHO 1992</a>). Two main subtypes are recognised: bipolar 1, which requires at least one manic or mixed episode with or without a history of depressive episode(s) and bipolar 2, which requires at least one hypomanic episode and a depressive episode. People who present with bipolar spectrum symptoms but do not fit criteria for bipolar 1 or 2 may be diagnosed with bipolar disorder not‐otherwise‐specified (bipolar‐NOS). Bipolar disorder is a chronic condition, at least 80% of people who have an episode of mania will have recurrent episodes (<a href="./references#CD004048-bbs2-0120" title="NIMH‐NIH Consensus Group. Mood disorders: pharmacologic prevention of recurrences. American Journal of Psychiatry1985;142(4):469‐72. ">NIMH‐NIH 1985</a>). </p> <p>A manic episode is characterised by elevated or irritable mood, excess energy, racing thoughts, pressured speech, grandiosity, decreased need for sleep, poor attention and an increase in goal‐directed activities. Symptoms must last at least seven days (unless hospitalisation occurs before that time). It is often associated with an increase in risk‐taking behaviours (e.g. over‐spending, promiscuity, dangerous driving), which may be the precipitant for hospitalisation. Many people with bipolar disorder develop mood‐congruent psychotic symptoms, usually along grandiose or paranoid themes, and may show pronounced psychomotor agitation or aggression. Hypomania differs from mania in the degree of severity: mood must be elevated for four days and four additional typical manic symptoms must be present (<a href="./references#CD004048-bbs2-0128" title="SamaraMT , GoldbergY , LevineSZ , FurukawaTA , GeddesJR , CiprianiA , et al. Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta‐analysis of individual participant data from five placebo‐controlled studies. Lancet Psychiatry2017;4(11):859‐67. [DOI: 10.1016/S2215‐0366(17)30331‐0] ">Samara 2017</a>). A mixed episode is diagnosed when people with bipolar disorder experience manic and depressive symptoms (low mood, loss of energy, lack of interest in life) at the same time. Manic episodes may also occur in people who have symptoms of both schizophrenia and mood disorder (schizoaffective disorder). </p> <p>The costs of bipolar disorder are high for both the patient and health services. Admissions to hospital for a manic disorder typically last at least several weeks, and as treatment within a psychiatric intensive care unit is often necessary it can be very costly (<a href="./references#CD004048-bbs2-0085" title="deZelicourtM , DardennesR , VerdouxH . Frequency of hospitalisations and inpatient care costs of manic episodes. Pharmacoeconomics2003;21(15):1081‐90. ">de Zelicourt 2003</a>). During a manic episode, patients are typically at high risk of accidental injury due to reckless behaviour, of not eating and drinking sufficiently or of interfering with family or members of the general public and putting themselves at risk. There is a particularly high risk of harm to self during mixed episodes (<a href="./references#CD004048-bbs2-0070" title="BalazsJ , BenazziF , RihmerZ , RihmerA , AkiskalKK , AkiskalHS . The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. Journal of Affective Disorders2006;91(2‐3):133‐8. ">Balazs 2006</a>). For the individual, as well as the period of acute illness, manic episodes often leave an aftermath of psychological, social and financial problems. Overall, 1/3 of people with bipolar disorder attempt suicide during their lifetime, with 10% to 12% eventually completing suicide (<a href="./references#CD004048-bbs2-0122" title="PallaskorpiS , SuominenK , KetokiviM , ValtonenH , ArvilommiP , MantereO , et al. Incidence and predictors of suicide attempts in bipolar I and II disorders: a 5‐year follow‐up study. Bipolar Disorders2017;19(1):13‐22. ">Pallaskorpi 2017</a>). </p> <p>Management of bipolar disorder has two main aspects: treatment of an acute mood episode and maintenance treatment. The latter is designed to prevent or reduce the either the frequency or the intensity of episodes of illness, or both. The pharmacological agent with the strongest evidence base for maintenance treatment in bipolar disorder is lithium (<a href="./references#CD004048-bbs2-0079" title="BurgessSS , GeddesJ , HawtonKK , TaylorMJ , TownsendE , JamisonK , et al. Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003013] ">Burgess 2001</a>; <a href="./references#CD004048-bbs2-0101" title="HayesJF , MarstonL , WaltersK , GeddesJR , KingM , OsbornDP . Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population‐based UK cohort study using electronic health records. World Psychiatry2016;15(1):53‐8. ">Hayes 2016</a>; <a href="./references#CD004048-bbs2-0131" title="SeverusE , TaylorMJ , SauerC , PfennigA , RitterP , BauerM , et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta‐analysis. International Journal of Bipolar Disorders2014;20(2):15. ">Severus 2014</a>). Systematic review evidence has consistently shown that lithium reduces the risk of a mood episode by about one‐third (<a href="./references#CD004048-bbs2-0131" title="SeverusE , TaylorMJ , SauerC , PfennigA , RitterP , BauerM , et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta‐analysis. International Journal of Bipolar Disorders2014;20(2):15. ">Severus 2014</a>). In addition lithium independently reduces the risk of completed suicide in bipolar disorder and unipolar depression (<a href="./references#CD004048-bbs2-0083" title="CiprianiA , HawtonK , StocktonS , GeddesJR . Lithium in the prevention of suicide in mood disorders: updated systematic review and meta‐analysis. BMJ2013;346:f3646. ">Cipriani 2013</a>; <a href="./references#CD004048-bbs2-0127" title="RibletNB , ShinerB , Young‐XuY , WattsBV . Strategies to prevent death by suicide: meta‐analysis of randomised controlled trials. British Journal of Psychiatry2017;210(6):396‐402. ">Riblet 2017</a>; <a href="./references#CD004048-bbs2-0135" title="SmithKA , CiprianiA . Lithium and suicide in mood disorders: updated meta‐review of the scientific literature. Bipolar Disorder2017;19(7):575‐86. [DOI: 10.1111/bdi.12543] ">Smith 2017</a>). Other options for long‐term mood stabilisation include anticonvulsive agents (e.g. sodium valproate, lamotrigine, carbamazepine), or atypical antipsychotics, such as quetiapine or olanzapine (<a href="./references#CD004048-bbs2-0101" title="HayesJF , MarstonL , WaltersK , GeddesJR , KingM , OsbornDP . Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population‐based UK cohort study using electronic health records. World Psychiatry2016;15(1):53‐8. ">Hayes 2016</a>). </p> <p>Options for treatment of acute episodes of mood disorder depend upon the pole of illness; depressive, mania or a mixed state. The evidence base for treatment of bipolar depression is growing, but still in its infancy. Present guidelines recommend either fluoxetine combined with olanzapine/quetiapine, or quetiapine/ olanzapine alone as the first‐line option (<a href="./references#CD004048-bbs2-0096" title="GoodwinGM , HaddadPM , FerrierIN , AronsonJK , BarnesT , CiprianiA , et al. Evidence‐based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology2016;30(6):495‐553. ">Goodwin 2016</a>; <a href="./references#CD004048-bbs2-0119" title="National Institute for Health and Care Excellence (NICE). Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. Clinical Guideline 185. www.nice.org.uk/guidance/cg185 (accessed before 14 February 2019). ">NICE 2014</a>). Other options include lithium plus an antidepressant (first line for those in whom lithium has been previously effective), lamotrigine, an atypical antipsychotic alone, sodium valproate or antidepressants alone (<a href="./references#CD004048-bbs2-0138" title="TaylorDM . Comparative efficacy and acceptability of drug treatments for bipolar depression: a multi‐treatments meta‐analysis. Acta Psychiatrica Scandinavia2014;130:452‐69. ">Taylor 2014</a>). The latter is frequently avoided due to the small risk of precipitating a manic episode. Mixed states are typically treated along the same guidelines as a manic episode. Treatment of acute mania has traditionally been with antipsychotics or mood stabilisers, with the addition of sedatives or anxiolytic drugs used as needed. There has been randomised controlled trial (RCT)‐level evidence that typical and atypical antipsychotics are effective in treating mania; meta‐analysis has suggested that olanzapine, risperidone, quetiapine and haloperidol are the most efficacious (<a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a>; <a href="./references#CD004048-bbs2-0134" title="SmithLA . Acute bipolar mania: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavia2007;115:12‐20. ">Smith 2007</a>; <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a>). </p> <p>For severe mania, or if drug treatments fail, electroconvulsive therapy (ECT) is an effective alternative. ECT has been used since the 1950s and involves passing an electric current through the brain to intentionally trigger a brief seizure. ECT is done under a general anaesthetic and the patient is given muscle relaxant, so the majority only experience mild twitching of their limbs during the few minutes of the procedure. It is not understood how ECT works, but it is known to cause sudden release of neurotransmitters and neurohormones, and effectively relieves symptoms of depression, mania and psychosis more quickly than other interventions. ECT is usually given twice weekly, and patients usually need between six to 12 sessions in total. The main side effects are those related to the general anaesthetic and short‐term memory loss, which for most patients does not persist long term. </p> </section> <section id="CD004048-sec-0032"> <h3 class="title" id="CD004048-sec-0032">Description of the intervention</h3> <p>Lithium (Li, from the Greek 'lithos', meaning stone), is a chemical element with the atomic number 3. It is a member of the alkali family that also includes sodium and potassium. These latter elements, in ionic form, are essential for physiological functioning in humans. The uses of lithium are numerous; it is widely used across the manufacturing and energy sectors, as well as in medicine for the treatment of mood disorders. Medical uses of lithium account for about 2% of global consumption per year, with the majority being used within the energy industry to produce lithium‐ion batteries (<a href="./references#CD004048-bbs2-0110" title="MalhiG , MassonM , BellivierF . The Science and Practice of Lithium Therapy. 1st Edition. Springer, 2017. ">Malhi 2017</a>). </p> <p>Lithium was first used therapeutically by John Cade in 1949, to treat what he termed 'psychotic excitement'. Over the intervening 60 plus years, lithium has been widely shown to be an effective mood stabiliser and protect against completed suicide (<a href="./references#CD004048-bbs2-0079" title="BurgessSS , GeddesJ , HawtonKK , TaylorMJ , TownsendE , JamisonK , et al. Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003013] ">Burgess 2001</a>; <a href="./references#CD004048-bbs2-0083" title="CiprianiA , HawtonK , StocktonS , GeddesJR . Lithium in the prevention of suicide in mood disorders: updated systematic review and meta‐analysis. BMJ2013;346:f3646. ">Cipriani 2013</a>; <a href="./references#CD004048-bbs2-0092" title="GeddesJR , GoodwinGM , RendellJ . Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. ">Geddes 2010</a>). It is now the first‐line drug for maintenance treatment of bipolar disorder, and an adjunctive treatment for unipolar depression. </p> <p>Lithium is prescribed as one of its salts ‐ citrate or carbonate ‐ and due to being a simple natural element is an inexpensive drug. Lithium is an oral medication and is well absorbed in the small intestine, with a bioavailability of 80% to 100% (<a href="./references#CD004048-bbs2-0110" title="MalhiG , MassonM , BellivierF . The Science and Practice of Lithium Therapy. 1st Edition. Springer, 2017. ">Malhi 2017</a>). It distributes equally across intracellular and extracellular spaces. Lithium does not undergo any form of metabolism. Lithium is handled very similarly to sodium by the kidney. It is freely filtered by the glomerulus and reabsorbed (˜80%) in the proximal tubule. Lithium renal excretion is in proportion to its plasma level; half‐life is 16 to 30 hours (<a href="./references#CD004048-bbs2-0071" title="BauerM , GrofP , MullerB . Lithium in neuropsychiatry: the comprehensive guide. Abingdon, UK: Informa Healthcare, 2006. ">Bauer 2006</a>). Lithium is excreted as a free ion. Clearance is influenced by intrinsic renal disease, age, body weight, low sodium intake, dehydration, cardiac failure and drugs that affect renal function (e.g. diuretics, non‐steroidal anti‐inflammatory drugs, angiotensin‐converting enzyme (ACE)‐inhibitors). Care is therefore needed if these situations should arise whilst a patient is taking lithium. </p> <p>Lithium therapy requires regular monitoring of plasma levels. This is because lithium has a narrow therapeutic index, meaning that the dose range that is therapeutic is very close to levels that can become toxic. Lithium is started at a low dose and gradually titrated over a few weeks, taking weekly blood levels 12 hours after a dose until the plasma level is within the therapeutic range, typically 0.5 to 0.8 mmol/L (<a href="./references#CD004048-bbs2-0076" title="Joint Formulary Committee. British National Formulary. 70. BMJ Group and Pharmaceutical press, 2015. ">BNF 2017</a>; <a href="./references#CD004048-bbs2-0119" title="National Institute for Health and Care Excellence (NICE). Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. Clinical Guideline 185. www.nice.org.uk/guidance/cg185 (accessed before 14 February 2019). ">NICE 2014</a>). The usual maintenance dose varies from 400 mg to 1500 mg daily. Once the dose is stable, blood samples need only be taken every three months. Lithium toxicity is dangerous; coarse tremor, diarrhoea and nausea, muscle weakness, confusion and eventually seizures may occur. The main risk factors for toxicity are changes in sodium levels, for example, due to the drugs previously mentioned, dehydration or a low‐salt diet. </p> <p>Most side effects of lithium are dose‐related. Common minor symptoms include mild gastrointestinal upset (this usually resolves), fine tremor, polyuria and polydipsia. Longer term, there is a risk of thyroid dysfunction, especially hypothyroidism in women, and hyperparathyroidism (<a href="./references#CD004048-bbs2-0133" title="ShineB , McKnightR , LeaverL , GeddesJ . Long‐term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet2015;386:461‐8. ">Shine 2015</a>). Thyroid function and calcium levels should be regularly monitored. Lithium is strongly associated with reduced urinary concentrating ability; this is due to a (mostly) reversible nephrogenic diabetes insipidus. In the great majority of patients, the risk of a clinically significant decline in renal function is very low, even in the long term (<a href="./references#CD004048-bbs2-0112" title="McKnightRF , AdidaM , BudgeK , StocktonS , GoodwinGM , GeddesJR . Lithium toxicity profile: a systematic review and meta‐analysis. Lancet2012;379(9817):721‐8. ">McKnight 2012</a>; <a href="./references#CD004048-bbs2-0133" title="ShineB , McKnightR , LeaverL , GeddesJ . Long‐term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet2015;386:461‐8. ">Shine 2015</a>). The risk of developing end‐stage renal function is extremely low, but renal function should be monitored in all people taking lithium (<a href="./references#CD004048-bbs2-0112" title="McKnightRF , AdidaM , BudgeK , StocktonS , GoodwinGM , GeddesJR . Lithium toxicity profile: a systematic review and meta‐analysis. Lancet2012;379(9817):721‐8. ">McKnight 2012</a>). Lithium is associated with a congenital cardiac malformation called Ebstein's anomaly, but the risk to the foetus if exposed to lithium is low, approximately 1:1000. Women of childbearing age can take lithium during pregnancy but the risks to the mothers' mood destabilising need to be carefully balanced against potential risks to the developing foetus (<a href="./references#CD004048-bbs2-0112" title="McKnightRF , AdidaM , BudgeK , StocktonS , GoodwinGM , GeddesJR . Lithium toxicity profile: a systematic review and meta‐analysis. Lancet2012;379(9817):721‐8. ">McKnight 2012</a>). </p> </section> <section id="CD004048-sec-0033"> <h3 class="title" id="CD004048-sec-0033">How the intervention might work</h3> <p>Lithium has been the mainstay of treatment of manic episodes since John Cade's serendipitous discovery of the antimanic effects of lithium and has repeatedly been shown to be effective (<a href="./references#CD004048-bbs2-0079" title="BurgessSS , GeddesJ , HawtonKK , TaylorMJ , TownsendE , JamisonK , et al. Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003013] ">Burgess 2001</a>; <a href="./references#CD004048-bbs2-0083" title="CiprianiA , HawtonK , StocktonS , GeddesJR . Lithium in the prevention of suicide in mood disorders: updated systematic review and meta‐analysis. BMJ2013;346:f3646. ">Cipriani 2013</a>; <a href="./references#CD004048-bbs2-0092" title="GeddesJR , GoodwinGM , RendellJ . Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open‐label trial. Lancet2010;375(9712):385‐95. ">Geddes 2010</a>). Lithium is handled by the body in a very similar way to sodium, which is essential for physiological homeostasis. Sodium (and therefore lithium) is present in all parts of the body and is involved in virtually all biological processes. Narrowing down the process by which lithium exerts its mood stabilising effect has therefore proved extremely challenging. </p> <p>Current evidence points towards lithium acting as a neuroprotective agent in the brain: reducing cell death (apoptosis) and enhancing new neuronal growth (neuroproliferation). On a macroscopic level, functional imaging has shown that people treated with lithium have a global increase in grey matter across the cerebrum, but especially concentrated in the prefrontal cortex, amygdala and hippocampus (<a href="./references#CD004048-bbs2-0109" title="MalhiGS , TaniousM , DasP , CoulstonC , BerkM . Potential mechanisms of action of lithium in bipolar disorder. CNS Drugs2013;27:135‐53. ">Malhi 2013</a>). Compared to controls or non‐treated bipolar patients, lithium‐treated patients have greater grey matter volume. This is important because evidence has shown that bipolar disorder may well be a neurodegenerative condition (<a href="./references#CD004048-bbs2-0074" title="BerkM . Neuroprogression: pathways to progressive brain changes in bipolar disorder. International Journal of Neuropsychopharmacology2009;12(4):441‐5. ">Berk 2009</a>). How these changes relate to mood stabilisation is not understood. </p> <p>At a neuronal level, lithium acts to modulate neurotransmission, probably by 'dampening down' the system (<a href="./references#CD004048-bbs2-0109" title="MalhiGS , TaniousM , DasP , CoulstonC , BerkM . Potential mechanisms of action of lithium in bipolar disorder. CNS Drugs2013;27:135‐53. ">Malhi 2013</a>). Lithium appears to have an effect on both excitatory (glutamate/dopamine) and inhibitory (gamma‐aminobutyric acid (GABA)) transmission. There is strong evidence that in mania there is an excess of dopamine, with dopamine agonists inducing mania in healthy people, and elevated dopamine levels found in manic people (<a href="./references#CD004048-bbs2-0124" title="PostRM , JimersonDC , BunneyWE . Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology1980;67(3):297‐305. ">Post 1980</a>). It appears that lithium reduces dopamine‐induced excitatory neurotransmission by interacting with the G‐protein‐coupled post‐synaptic dopamine receptors (<a href="./references#CD004048-bbs2-0111" title="ManjiHK , LenoxRH . Signaling: cellular insights into the pathophysiology of bipolar disorder. Biological Psychiatry2000;48(6):518‐30. ">Manji 2000</a>). It is not clear how this is mediated at present. Similarly, increased levels of glutamate are seen during mania. Glutamate acts via the N‐methyl‐D‐aspartate (NMDA)‐receptor which, when glutamate and its cofactor glycine are absent, has magnesium bound to it. Lithium competes with magnesium to bind, and when bound, unlike magnesium, stimulates the receptor. Chronic lithium stimulation (such as during regular therapy) leads to downregulation of the NMDA‐receptors, and an overall reduction in glutamate transmission (<a href="./references#CD004048-bbs2-0139" title="TsapakisEM , TravisMJ . Glutamate and psychiatric disorders. Advances in Psychiatric Treatment2002;8:189‐97. ">Tsapakis 2002</a>). People with bipolar disorder are known to have lower levels of GABA‐neurotransmission than controls: this reduction in inhibition leads to excess excitation via glutamate/dopamine and eventually apoptosis and cell loss (<a href="./references#CD004048-bbs2-0118" title="NgWX , LauIY , GrahamS , SimK . Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Neuroscience and Biobehavioral Reviews2009;33(3):336‐54. ">Ng 2009</a>). Lithium counteracts this by facilitating inhibition via GABA. Lithium directly enhances GABA release and increases upregulation of the GABA‐B receptor (<a href="./references#CD004048-bbs2-0066" title="AhluwaliaP , GrewaalDS , SinghalRL . Brain gabaergic and dopaminergic systems following lithium treatment and withdrawal. Progress in Neuropsychopharmacology1981;5(5‐6):527‐30. ">Ahluwalia 1982</a>). Lithium also increases brain‐derived neurotrophic factor (BDNF) and B‐cell lymphoma 2 (Bcl‐2), which are neuroprotective factors, via activation of G<sub>s</sub>‐protein‐coupled receptors (<a href="./references#CD004048-bbs2-0125" title="QuirozJA , Machado‐VieiraR , ZarateJC . Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology2010;62(1):50‐60. ">Quiroz 2010</a>). It appears that these complex actions of lithium occur through multiple second messenger signalling cascades (cyclic adenosine monophosphate (cAMP), inositol phosphate (IP3), protein kinase C (PKC), myristoylated alanine‐rich C‐kinase substrate (MARCKS) and glycogen synthase kinase 3 (GSK‐3)). In some way, not clear as yet, lithium moderates the actions of these cascades, which leads to changes in gene transcription and, ultimately, mood stabilisation. </p> </section> <section id="CD004048-sec-0034"> <h3 class="title" id="CD004048-sec-0034">Why it is important to do this review</h3> <p>Bipolar disorder is a common, chronic condition that represents a high burden of disability for the individual and society. Effective treatments are needed, both for acute mood episodes and maintenance. Unlike maintenance therapy, for which the evidence strongly supports the use of lithium as a first‐line treatment, it remains unclear which psychotropic drugs are the most effective for the treatment of mania (<a href="./references#CD004048-bbs2-0079" title="BurgessSS , GeddesJ , HawtonKK , TaylorMJ , TownsendE , JamisonK , et al. Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003013] ">Burgess 2001</a>; <a href="./references#CD004048-bbs2-0083" title="CiprianiA , HawtonK , StocktonS , GeddesJR . Lithium in the prevention of suicide in mood disorders: updated systematic review and meta‐analysis. BMJ2013;346:f3646. ">Cipriani 2013</a>). Systematic reviews and network analysis have suggested that multiple antipsychotics (especially haloperidol, olanzapine, risperidone and quetiapine) and mood stabilisers (lithium, valproate, carbamazepine) can all treat mania (<a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a>; <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a>). Current clinical guidelines recommend that if a person with bipolar disorder is not on medication, starting one of the antidopamine agents above should be first line. Other options include valproate, lithium, aripiprazole or carbamazepine (<a href="./references#CD004048-bbs2-0096" title="GoodwinGM , HaddadPM , FerrierIN , AronsonJK , BarnesT , CiprianiA , et al. Evidence‐based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology2016;30(6):495‐553. ">Goodwin 2016</a>; <a href="./references#CD004048-bbs2-0119" title="National Institute for Health and Care Excellence (NICE). Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. Clinical Guideline 185. www.nice.org.uk/guidance/cg185 (accessed before 14 February 2019). ">NICE 2014</a>). As lithium is the most efficacious treatment for maintenance, and there is evidence that it is effective in mania, it is a strong contender for being a first‐line agent (<a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a>; <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a>). Lithium has the advantage that it can be used for both acute treatment and maintenance, which is attractive to many patients. Similarly, whilst lithium carries its own set of potential adverse events, it can be used in patients who have not tolerated anti‐dopaminergic agents (e.g. had extra‐pyramidal symptoms or raised prolactin) and has much less risk of teratogenicity than valproate. The previous network meta‐analyses that have been done using studies dating up to January 2014, had fairly narrow criteria (no children/adolescents, one main outcome measure), and therefore the knowledge base remains incomplete (<a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a>; <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a>). This review aims to assess the available evidence to date (up to January 2017) comparing the effectiveness of lithium to other antimanic agents in treating acute mania in all ages and settings. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004048-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004048-sec-0035"></div> <p> <ol id="CD004048-list-0001"> <li> <p>To assess the effects of lithium in comparison with placebo or other active treatment in alleviating the acute symptoms of a manic or mixed episode in people with bipolar affective disorder. </p> </li> <li> <p>To review the acceptability and tolerability of treatment with lithium in comparison with placebo or other active treatments in alleviating the acute symptoms of a manic or mixed episode in people with bipolar affective disorder. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004048-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004048-sec-0036"></div> <section id="CD004048-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004048-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included prospective double‐ or single‐blinded randomised controlled trials (RCTs) where lithium was used in the treatment of acute manic episodes in comparison with other antimanic treatments or placebo. For the comparison between lithium and ECT we also considered single‐blind studies, due to the nature of the comparator (see also <a href="#CD004048-sec-0304">Differences between protocol and review</a>). For studies that had a cross‐over design, we only considered results from the first period prior to the cross‐over. We included cluster‐randomised studies, if the effect of clustering could be accounted for in the statistical analysis. </p> </section> <section id="CD004048-sec-0039"> <h4 class="title">Types of participants</h4> <section id="CD004048-sec-0040"> <h5 class="title">Subset data</h5> <p>We considered for inclusion, people of both sexes of any age with a primary diagnosis of bipolar affective disorder and experiencing a manic episode, according to any of the following standard operational criteria: Feighner criteria, Research Diagnostic Criteria, DSM‐III , DSM‐III‐R , DSM‐IV, DSM‐IV‐TR, DSM‐5 (<a href="./references#CD004048-bbs2-0068" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV). 5th Edition. Washington, DC: American Psychiatric Association, 2013. ">APA 2013</a>), or ICD‐10 (<a href="./references#CD004048-bbs2-0141" title="World Health Organization (WHO). The Tenth Revision of the International Classification of Diseases and Related Jealth Problems. 10th Edition. Geneva: World Health Organization, 1992. ">WHO 1992</a>). We included studies using operational diagnostic criteria essentially similar to the above. We excluded studies using ICD‐9, as it has only disease names and no diagnostic criteria. We also excluded studies that defined mania as scoring above a certain cut‐off on a screening questionnaire. Finally, we included studies recruiting participants with treatment‐resistant mania and, if any, we planned to examine these in a sensitivity analysis. We did not include studies of acute treatment with lithium, which recruited people with diagnoses other than bipolar disorder or schizoaffective disorder and did not stratify randomisation according to diagnosis in this review. </p> <section id="CD004048-sec-0041"> <h6 class="title">Comorbidities</h6> <p>We did not consider concurrent secondary diagnosis of another psychiatric disorder an exclusion criterion. However, we excluded studies in which all participants had a concurrent primary diagnosis of another Axis I or II disorder. We also excluded participants with a serious concomitant medical illness or with postpartum depression. </p> </section> <section id="CD004048-sec-0042"> <h6 class="title">Setting</h6> <p>We did not apply restrictions on setting.</p> </section> </section> </section> <section id="CD004048-sec-0043"> <h4 class="title">Types of interventions</h4> <section id="CD004048-sec-0044"> <h5 class="title">Experimental intervention</h5> <p>Lithium: at any dose within the therapeutic range and pattern of administration.</p> </section> <section id="CD004048-sec-0045"> <h5 class="title">Comparator interventions</h5> <p> <ol id="CD004048-list-0002"> <li> <p>Placebo</p> </li> <li> <p>All other antimanic drugs (mood stabilisers, antipsychotics, anticonvulsants or sedatives)</p> </li> <li> <p>ECT</p> </li> </ol> </p> <p>All comparator interventions were used either as monotherapy or combined with other treatments. </p> <p>We included studies that allowed rescue medications (as required, short‐term, infrequent use of medications aimed at emergent symptom relief only, for example, short‐term use of hypnotics) as long as these medications were equally distributed among the randomised arms. </p> </section> </section> <section id="CD004048-sec-0046"> <h4 class="title">Types of outcome measures</h4> <p>We included studies that met the above inclusion criteria regardless of whether they reported on the following outcomes. </p> <section id="CD004048-sec-0047"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004048-list-0003"> <li> <p>Efficacy outcomes: response (categorical). Number of participants who responded to treatment, where treatment response was defined as a decrease in score on the Young Mania Rating Scale (YMRS), or any other equivalent standardised rating scale, of at least 50% from baseline to the end of the study. </p> </li> <li> <p>Efficacy outcomes: response (continuous). Mean endpoint scores or mean change scores in manic symptoms (YMRS or other equivalent standardised rating scale) from baseline to the end of the study. </p> </li> <li> <p>Efficacy outcomes: remission (categorical). Number of participants who achieved remission by the end of the study out of the total number of randomised participants. We defined remission as a YMRS score of 12 or less (or equivalent on other validated mania rating scales). </p> </li> <li> <p>Acceptability (categorical): overall number of participants who dropped out during the study as a proportion of the total number of randomised participants. </p> </li> <li> <p>Acceptability: adverse events (categorical). We evaluated adverse events using the following outcome measures. </p> <ol id="CD004048-list-0004"> <li> <p>Total number of participants who experienced at least one side effect between first treatment dose and end of study. </p> </li> <li> <p>Total number of participants who experienced the following specific side effects between the first treatment dose and the end of the study (<a href="./references#CD004048-bbs2-0075" title="Joint Formulary Committee. British National Formulary. Vol. 73, London: BMJ Group and Pharmaceutical Press, 2017. ">BNF 2016</a>). </p> <ol id="CD004048-list-0005"> <li> <p>Depression</p> </li> <li> <p>Mania</p> </li> <li> <p>Weight gain</p> </li> <li> <p>Akathisia</p> </li> <li> <p>Headache</p> </li> <li> <p>Somnolence</p> </li> <li> <p>Dizziness</p> </li> <li> <p>Insomnia</p> </li> <li> <p>Diarrhoea</p> </li> <li> <p>Nausea</p> </li> <li> <p>Vomiting</p> </li> <li> <p>Dry mouth</p> </li> <li> <p>Pain</p> </li> <li> <p>Extra‐pyramidal side effects</p> </li> <li> <p>Tremor</p> </li> <li> <p>Constipation</p> </li> <li> <p>Fever</p> </li> <li> <p>Rash</p> </li> <li> <p>Attempted suicide</p> </li> <li> <p>Anorexia</p> </li> <li> <p>Infection</p> </li> <li> <p>Weight loss</p> </li> <li> <p>Agitation</p> </li> <li> <p>Convulsions or seizures</p> </li> <li> <p>Dyspepsia</p> </li> <li> <p>Psychosis</p> </li> <li> <p>Suicidal ideation</p> </li> <li> <p>Blood disorders</p> </li> <li> <p>Hyperprolactinaemia</p> </li> <li> <p>Thyroid disorders</p> </li> <li> <p>Arthralgia</p> </li> <li> <p>Rhinitis</p> </li> <li> <p>Pruritis</p> </li> <li> <p>Renal impairment</p> </li> <li> <p>Sexual dysfunction</p> </li> </ol> </li> </ol> </li> </ol> </p> <p>In order to avoid missing any relatively rare or unexpected, yet important side effects in the data extraction phase we collected information on all side effects data reported in the studies and discussed ways to summarise them post hoc. We extracted descriptive data regarding adverse effect profiles from all available studies. In a specific number of cases, we combined terms describing similar side effects: for example, we combined ’dry mouth’ and ’reduced salivation’ into ’dry mouth’. </p> <p>We included a higher number of primary outcomes than is standard in a Cochrane Review in order to capture the full breadth of the available evidence. Included studies were published from 1970 onwards, and earlier studies did not necessarily use the standardised outcome measures of recent times. Excluding those data would reduce the value of the analysis results. </p> </section> <section id="CD004048-sec-0048"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004048-list-0006"> <li> <p>Efficacy outcome (continuous): mean endpoint scores or mean change scores in depressive symptoms (Montgomery and Asberg Depression Rating Scale (MADRS), Hamilton Rating Scale for Depression (HAMD) or other equivalent standardised rating scale) from baseline to the end of the study </p> </li> <li> <p>Efficacy outcome (continuous): mean endpoint scores or mean change scores in psychotic symptoms (Positive and Negative Syndrome Scale (PANSS) or other equivalent standardised rating scale) from baseline to the end of the study </p> </li> <li> <p>Efficacy outcome (continuous): mean endpoint scores or mean change scores in general wellness and social functioning (Clinical Global Impressions‐Bipolar (CGI‐BP), Goal Attainment Scale (GAS) or other equivalent standardised rating scale) from baseline to the end of the study </p> </li> <li> <p>Efficacy outcome (categorical): response. Number of participants who responded to treatment, where treatment response was defined as a decrease in score between baseline and end of study as defined by the study authors on standardised rating scales not within the primary outcomes (e.g. CGI‐BP). </p> </li> <li> <p>Use of rescue medications (categorical or continuous): either number of participants who required treatment with rescue medications as a proportion of the total number of randomised participants or mean/total dosage use of rescue medications from baseline to the end of the study. </p> </li> <li> <p>Acceptability (categorical), evaluated using the following outcome measures.</p> <ol id="CD004048-list-0007"> <li> <p>Number of participants who dropped out due to lack of efficacy during the study as a proportion of the total number of randomised participants </p> </li> <li> <p>Number of participants who dropped out due to side effects during the study as a proportion of the total number of randomised participants </p> </li> </ol> </li> </ol> </p> <section id="CD004048-sec-0049"> <h6 class="title">Timing of outcome assessment</h6> <p>Outcomes were measured at three weeks (21 days) and 12 weeks (84 days).</p> </section> </section> </section> </section> <section id="CD004048-sec-0050"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004048-sec-0051"> <h4 class="title">Cochrane Common Mental Disorders' Controlled Trials Register (CCMD‐CTR)</h4> <p>Cochrane Common Mental Disorders maintains a specialised register of RCTs, the CCMD‐CTR. This register contains over 40,000 reference records (reports of RCTs) for anxiety disorders, depression, bipolar disorder, eating disorders, self‐harm and other mental disorders within the scope of this Group. The CCMD‐CTR is a partially studies‐based register with more than 50% of reference records tagged to around 12,500 individually PICO‐coded study records. Reports of studies for inclusion in the register are collated from (weekly) generic searches of MEDLINE (1950 onwards), Embase (1974 onwards) and PsycINFO (1967 onwards), quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL) and review‐specific searches of additional databases. Reports of studies are also sourced from international trials registries, drug companies, the handsearching of key journals, conference proceedings and other (non‐Cochrane) systematic reviews and meta‐analyses. Details of <a href="http://cmd.cochrane.org/search-strategies-identification-studies" target="_blank">CCMD's core search strategies</a> (used to identify RCTs) can be found on the Group's website, with an example of the core MEDLINE search displayed in <a href="./appendices#CD004048-sec-0295">Appendix 1</a>. </p> <p>In 2016 the Group’s Specialised Register (CCMD‐CTR) became out of date with the Editorial Group’s move from Bristol to York. </p> </section> <section id="CD004048-sec-0052"> <h4 class="title">Electronic searches</h4> <section id="CD004048-sec-0053"> <h5 class="title">Cochrane Common Mental Disorders' Specialised Register (CCMD‐CTR)</h5> <p>The Cochrane Common Mental Disorders' Information Specialist (IS) searched the CCMD‐CTR using the following terms. </p> <p> <ol id="CD004048-list-0008"> <li> <p><b>CCMD‐CTR Studies Register:</b> condition = (mania or hypomania) and Intervention = lithium </p> </li> <li> <p><b>CCMD‐CTR‐References Register:</b> (lithium and (mania* or manic* or hypomani* or ((bipolar or schizoaffective) NEAR (acute or psychos* or psychotic or "mixed episode*" or “mixed state*” or "rapid cycl*")))) </p> </li> </ol> </p> <p>The IS applied no date, language or publication restrictions to the searches. The CCMD‐CTR was up to date as of June 2016 (<a href="./appendices#CD004048-sec-0295">Appendix 1</a>). </p> </section> <section id="CD004048-sec-0054"> <h5 class="title">Additional bibliographic database searches</h5> <p>The IS performed additional searches on the following databases, in February 2017 and April/May 2018. The search strategies are displayed in <a href="./appendices#CD004048-sec-0296">Appendix 2</a>: </p> <p> <ol id="CD004048-list-0009"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 4) in the Cochrane Library; </p> </li> <li> <p>Ovid MEDLINE (2014 to 17 May 2018);</p> </li> <li> <p>Ovid Embase (2014 to 17 May 2018);</p> </li> <li> <p>Ovid PsycINFO (2014 to 17 May 2018);</p> </li> <li> <p>World Health Organization (WHO) trials portal (ICTRP) (17 May 2018);</p> </li> <li> <p>ClinicalTrials.gov (17 May 2018).</p> </li> </ol> </p> <p>We applied no restriction on date, language or publication status to the searches.</p> </section> </section> <section id="CD004048-sec-0055"> <h4 class="title">Searching other resources</h4> <section id="CD004048-sec-0056"> <h5 class="title">Reference checking</h5> <p>We handsearched any major textbooks of affective disorder, journals or conference proceedings specifically relating to lithium therapy in mania (up to May 2018). </p> </section> <section id="CD004048-sec-0057"> <h5 class="title">Personal communication</h5> <p>We identified the authors of significant papers over the last five years from authorship lists. We contacted them and other experts in the field to ask if they knew of any other published or unpublished studies relevant to the review article. We requested relevant published and unpublished data from pharmaceutical companies marketing lithium. </p> </section> <section id="CD004048-sec-0058"> <h5 class="title">Grey literature</h5> <p>We searched the following drug regulatory authorities for additional unpublished data: the US Food and Drug Administration, the Medicines and Healthcare products Regulatory Agency in the UK, the European Medicines Agency in the EU, the Pharmaceuticals and Medical Devices Agency in Japan, and the Therapeutic Goods Administration in Australia. </p> </section> <section id="CD004048-sec-0059"> <h5 class="title">Handsearching</h5> <p>We handsearched and incorporated into the CCMD‐CTR appropriate journals and conference proceedings relating to the treatment of mania with lithium (up to May 2018). </p> </section> <section id="CD004048-sec-0060"> <h5 class="title">Reference lists</h5> <p>We checked the reference lists of all included studies and relevant systematic reviews to identify additional studies missed from the original electronic searches (for example unpublished or in‐press citations). We also conducted a cited reference search on Web of Science (up to May 2018). </p> </section> </section> </section> <section id="CD004048-sec-0061"> <h3 class="title" id="CD004048-sec-0061">Data collection and analysis</h3> <section id="CD004048-sec-0062"> <h4 class="title">Selection of studies</h4> <p>Two out of three review authors (SdLM, BA, RMK) independently screened titles and abstracts for inclusion of all the references retrieved by the search strategy. Subsequently, we retrieved full‐text study reports/publications, which two out of three review authors (SdLM, BA, RMK) independently screened for inclusion. At this stage, we recorded the reasons for excluding the ineligible studies. </p> <p>We resolved any disagreement through discussion or, if required, by consulting a third review author (AC). We identified and removed duplicate records and collated multiple reports that related to the same study so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA (<a href="./references#CD004048-bbs2-0115" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG . Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. Annals of Internal Medicine2009;151(4):264‐9. ">Moher 2009</a>), flow diagram and the characteristics of excluded studies table. </p> </section> <section id="CD004048-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form to extract study characteristics and outcome data that we piloted on at least one study in the review. Three review authors (SdLM, EC and RMK) independently extracted study characteristics and outcome data from each included study and compared their results. We resolved any disagreement through discussion with a third member of the team (AC). We contacted the study authors when necessary, to obtain supplemental information. We extracted the following study characteristics. </p> <p> <ol id="CD004048-list-0010"> <li> <p>Participant characteristics (age, sex, depression diagnosis, comorbidity, depression severity, antidepressant treatment history for the index episode, study setting) </p> </li> <li> <p>Intervention details (intended dosage range, mean daily dosage actually prescribed, co‐intervention if any, lithium as investigational drug or as comparator drug, sponsorship) </p> </li> <li> <p>Outcome measures of interest from the included studies. We noted in the <a href="./references#CD004048-sec-0306" title="">Characteristics of included studies</a> if outcome data were not reported in a usable way. We resolved disagreements by consensus or by involving a third person (AC). Two review authors (SdLM and RMK) entered data into the Review Manager 5 (RevMan 5) software (<a href="./references#CD004048-bbs2-0126" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </li> <li> <p>We double‐checked that we had entered data correctly by comparing the data presented in the systematic review with the study reports. </p> </li> </ol> </p> <section id="CD004048-sec-0064"> <h5 class="title">Main comparisons</h5> <p> <ol id="CD004048-list-0011"> <li> <p>Lithium versus placebo</p> </li> <li> <p>Lithium versus all other antimanic drugs (mood stabilisers, antipsychotics, anticonvulsants or sedatives) </p> </li> <li> <p>Lithium versus ECT</p> </li> </ol> </p> </section> </section> <section id="CD004048-sec-0065"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two out of four review authors (SdLM, RMK, EC and BA) independently assessed the risks of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004048-bbs2-0105" title="HigginsJP , AltmanDG , Sterne JA(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). We resolved any disagreements by discussion or by involving another review author (AC). We assessed the risk of bias according to the following domains. </p> <p> <ol id="CD004048-list-0012"> <li> <p>Random sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants and personnel</p> </li> <li> <p>Blinding of outcome assessment</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective outcome reporting</p> </li> <li> <p>Other bias</p> </li> </ol> </p> <p>We judged each potential source of bias as high, low, or unclear and provided a supporting quotation from the study report together with a justification for our judgement in the ’Risk of bias’ table. We summarised the risk of bias judgements across different studies for each of the domains listed. We considered blinding separately for different key outcomes where necessary. Where information on risk of bias relates to unpublished data or correspondence with a study author, we noted this in the ’Risk of bias’ table. When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome. </p> </section> <section id="CD004048-sec-0066"> <h4 class="title">Measures of treatment effect</h4> <section id="CD004048-sec-0067"> <h5 class="title">Categorical data</h5> <p>We calculated the odds ratio (OR) with corresponding 95% confidence interval (CI) for categorical or event‐like outcomes. We calculated response rates out of the total number of randomised participants. </p> </section> <section id="CD004048-sec-0068"> <h5 class="title">Continuous data</h5> <p>We calculated the mean difference (MD) or standardised mean difference (SMD) along with corresponding 95% CI for continuous outcomes. We used the MD where studies used the same scale to measure an outcome. We employed the SMD where studies used different scales to measure the same underlying construct. For both continuous and categorical data, we undertook meta‐analyses only where this was meaningful, that is if the treatments, participants, and the underlying clinical question were similar enough for pooling to make sense. We narratively described skewed data reported as medians and interquartile ranges. Where a single study reported multiple study arms, we planned to include only the relevant arms. </p> </section> </section> <section id="CD004048-sec-0069"> <h4 class="title">Unit of analysis issues</h4> <section id="CD004048-sec-0070"> <h5 class="title">Cluster‐randomised studies</h5> <p>We included cluster‐randomised studies if either of the two methods below were possible.</p> <p> <ol id="CD004048-list-0013"> <li> <p>When the original report had correctly analysed the cluster‐randomised study, we entered the effect estimate and standard error using the generic inverse variance method in RevMan 5 (<a href="./references#CD004048-bbs2-0126" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </li> <li> <p>If the original report failed to adjust for cluster effects, we included such a study in the meta‐analysis if we could extract the following information. </p> <ol id="CD004048-list-0014"> <li> <p>Number of clusters randomised to each intervention or the average size of each cluster.</p> </li> <li> <p>Outcome data ignoring the cluster design for the total number of participants.</p> </li> <li> <p>Estimate of the intra‐cluster correlation coefficient (ICC). The ICC was borrowed from similarly designed studies when such were available. We then conducted the approximately correct analysis following the procedures described in section 16.3.4 of the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD004048-bbs2-0103" title="HigginsJP , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). </p> </li> </ol> </li> </ol> </p> </section> <section id="CD004048-sec-0071"> <h5 class="title">Cross‐over trials</h5> <p>A major concern of cross‐over studies was the potential of carry‐over effects, which occur if an effect (for example, pharmacological, physiological, or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase, the participants could differ systematically from their initial state, despite a washout phase. For the same reason, cross‐over studies are not appropriate if the condition of interest is unstable (<a href="./references#CD004048-bbs2-0088" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). As both effects are very likely in bipolar affective disorder, we only used data from the first phase of cross‐over studies. However, we are aware that cross‐over studies for which only first period data are available, should be considered to be at risk of bias (<a href="./references#CD004048-bbs2-0105" title="HigginsJP , AltmanDG , Sterne JA(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). </p> </section> <section id="CD004048-sec-0072"> <h5 class="title">Studies with multiple treatment groups</h5> <p>Where a study involved more than two treatment arms, we included all relevant treatment arms in comparisons. If data were binary, we combined them into one group or divided the comparison arm into two (or more) groups as appropriate. If data were continuous, we combined data following the formula in section 7.7.3.8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004048-bbs2-0104" title="HigginsJP , Deeks JJ(editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). </p> </section> </section> <section id="CD004048-sec-0073"> <h4 class="title">Dealing with missing data</h4> <section id="CD004048-sec-0074"> <h5 class="title">Categorical data</h5> <p>We calculated responders to treatment and remitters on a strict intention‐to‐treat (ITT) basis: we included dropouts in this analysis. Where participants had been excluded from a study before the endpoint, we assumed that they had experienced a negative outcome by the end of the study (e.g. failure to respond to treatment). We examined the validity of this decision in sensitivity analyses by applying worst‐ and best‐case scenarios (that is, we assumed missing participants to be either a responder or non‐responder in the corresponding sensitivity analysis). </p> </section> <section id="CD004048-sec-0075"> <h5 class="title">Continuous data</h5> <p>When there were missing data and the study had used the 'last observation carried forward' (LOCF) method to perform an ITT analysis, we used the LOCF data. We contacted the original study authors for missing data. </p> <p>When only the standard error (SE) or t‐test or P values were reported, we calculated SDs according to <a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011170/full#CD011170-bbs2-0001" target="_blank">Altman 1996</a>. Where studies did not report SDs, we contacted study authors and asked them to supply the data but, in the absence of data from the study authors, we borrowed SDs from other studies in the review (<a href="./references#CD004048-bbs2-0091" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7‐10. ">Furukawa 2006</a>). We examined the validity of this imputation in the sensitivity analyses. </p> </section> <section id="CD004048-sec-0076"> <h5 class="title">Missing data</h5> <p>We contacted the original study authors for missing data.</p> </section> <section id="CD004048-sec-0077"> <h5 class="title">Missing statistics</h5> <p>When only the SE or t‐test or P values were reported, we calculated SDs as suggested by <a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011170/full#CD011170-bbs2-0001" target="_blank">Altman 1996</a>. Where studies did not report SDs, we contacted study authors and asked them to supply the data. In the absence of a response from the study authors, we borrowed SDs from other studies in the review (<a href="./references#CD004048-bbs2-0091" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7‐10. ">Furukawa 2006</a>). We examined the validity of this imputation in sensitivity analyses. </p> </section> </section> <section id="CD004048-sec-0078"> <h4 class="title">Assessment of heterogeneity</h4> <p>We first investigated heterogeneity between studies by visual inspection of the forest plots. If the 95% CIs of the ORs for each study in the pooled analysis did not include means of other studies, we investigated potential sources of heterogeneity. We also calculated the I<sup>2</sup> statistic (<a href="./references#CD004048-bbs2-0102" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). The I<sup>2</sup> statistic describes approximately the proportion of variation in point estimates due to heterogeneity rather than sampling error. We used the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>’ rough guide to its interpretation as follows: 0% to 40% might not be important; 30% to 60% may represent moderate heterogeneity; 50% to 90% may represent substantial heterogeneity; and 75% to 100% considerable heterogeneity (<a href="./references#CD004048-bbs2-0086" title="DeeksJJ , HigginsJP , Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). We also kept in mind that the importance of the observed value of the I<sup>2</sup> statistic depends on the magnitude and direction of effects and the strength of evidence for heterogeneity (for example P value from the Chi<sup>2</sup> test, or a CI for I<sup>2</sup>). If the I<sup>2</sup> value was below 50% but the direction and magnitude of treatment effects was suggestive of important heterogeneity, we investigated the potential sources of heterogeneity. Finally, we performed subgroup analyses to investigate heterogeneity. We used random‐effects models to investigate the sensitivity of results to the choice of statistical method. </p> </section> <section id="CD004048-sec-0079"> <h4 class="title">Assessment of reporting biases</h4> <p>We entered data from included studies into a funnel plot (study effect against study variance) to investigate small‐study effects. We used the test for funnel plot asymmetry when we included at least 10 studies in the meta‐analysis. When using a funnel plot, we interpreted results cautiously, with visual inspection of the funnel plots (<a href="./references#CD004048-bbs2-0137" title="SterneJA , EggerM , MoherD , BoutronI (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Sterne 2017</a>). If we identified evidence of small‐study effects, we investigated possible reasons for funnel plot asymmetry, including publication bias (<a href="./references#CD004048-bbs2-0087" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>). </p> </section> <section id="CD004048-sec-0080"> <h4 class="title">Data synthesis</h4> <p>For the primary analysis, we calculated the pooled OR with corresponding 95% CI for categorical outcomes. We calculated the pooled MD or SMD as appropriate with corresponding 95% CI for continuous outcomes. We presented any skewed data and non‐quantitative data descriptively. An outcome that has a minimum score of zero could be considered skewed when the mean is smaller than twice the SD. However, the skewness of change score is difficult to depict as the possibility of negative values exists. We, therefore, used change scores for meta‐analysis of MDs (<a href="./references#CD004048-bbs2-0086" title="DeeksJJ , HigginsJP , Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> <p>We considered a P value of less than 0.05 and a 95% CI that does not cross the line of no effect to be statistically significant. In forest plots with two or more studies, we used a random‐effects model for both categorical and continuous variables. We adopted the random‐effects model under these circumstances because it has the highest generalisability for empirical examination of summary effect measures in meta‐analyses (<a href="./references#CD004048-bbs2-0090" title="FurukawaTA , GuyattGH , GriffithLE . An empirical study of summary effect measures in meta‐analyses. International Journal of Epidemiology2002;31(1):72‐6. ">Furukawa 2002</a>). However, as recommended by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (10.4.4.1; <a href="./references#CD004048-bbs2-0137" title="SterneJA , EggerM , MoherD , BoutronI (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Sterne 2017</a>), when concerned about the influence of small‐study effects on the results of a meta‐analysis with between‐study heterogeneity, we examined the robustness by comparing the fixed‐effect model and the random‐effects model. We reported any material differences between the models. </p> </section> <section id="CD004048-sec-0081"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>As multiple analyses can lead to false‐positive and false‐negative conclusions, subgroup analyses should be performed and interpreted with caution (<a href="./references#CD004048-bbs2-0078" title="BrookesST , WhitelyE , EggerM , SmithGD , MulheranPA , PetersTJ . Subgroup analyses in randomized trials: risks of subgroup‐specific analyses; power and sample size for the interaction test. Journal of Clinical Epidemiology2004;57(3):229‐36. ">Brookes 2004</a>). We planned the following subgroup analysis for primary outcomes. </p> <p> <ol id="CD004048-list-0015"> <li> <p>Lithium alone and studies using lithium with a mood stabiliser or antipsychotic</p> </li> <li> <p>If data were available, analysis by length of treatment would be performed to ascertain whether any treatment differences detected varied with time. </p> </li> </ol> </p> </section> <section id="CD004048-sec-0082"> <h4 class="title">Sensitivity analysis</h4> <p>We used random‐effects models to investigate the sensitivity of results to the choice of statistical method. </p> <p>We conducted the following sensitivity analyses for primary outcomes:</p> <p> <ol id="CD004048-list-0016"> <li> <p>excluding studies that recruited participants with treatment‐resistant mania;</p> </li> <li> <p>excluding studies with a dropout rate greater than 20%;</p> </li> <li> <p>excluding studies for which the SD had to be borrowed from other studies (<a href="./references#CD004048-bbs2-0091" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7‐10. ">Furukawa 2006</a>). </p> </li> </ol> </p> <section id="CD004048-sec-0083"> <h5 class="title">'Summary of findings' table</h5> <p>We constructed a ’Summary of findings’ table for each comparison, with regard to the following four outcomes. </p> <p> <ol id="CD004048-list-0017"> <li> <p>Response</p> </li> <li> <p>Remission</p> </li> <li> <p>Main adverse events</p> </li> <li> <p>Total withdrawal from the study</p> </li> </ol> </p> <p>We used we used GRADE proGDT software (<a href="./references#CD004048-bbs2-0097" title="McMaster University (developed by Evidence Prime). GRADEproGDT. Version accessed 14 April 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEproGDT 2015</a>) to produce the ’Summary of findings’ tables, and followed the principles of the GRADE approach (<a href="./references#CD004048-bbs2-0069" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. ">Atkins 2004</a>), which assess the certainty of a body of evidence based on the extent to which there can be confidence that the obtained effect estimate reflects the true underlying effect. The certainty of a body of evidence is judged on the basis of the included studies’ risks of bias, the directness of the evidence, unexplained heterogeneity, imprecision, and the risk of publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004048-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004048-sec-0084"></div> <section id="CD004048-sec-0085"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD004048-sec-0306" title="">Characteristics of included studies</a>. </p> <section id="CD004048-sec-0086"> <h4 class="title">Results of the search</h4> <p>The process of the search is shown in <a href="#CD004048-fig-0001">Figure 1</a>. The initial database searching (updated to include searches up to May 2018) identified 1276 records and 254 were identified from other sources (primarily 'grey literature' described above). After removing duplicates 1530 remained. We then excluded 1361 records as they did not meet our inclusion criteria. We attempted to contact the primary investigators and drug companies for six studies (all listed on <a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>), but had no reply to any of our emails or telephone messages. Two of these studies are currently awaiting classification (<a href="./references#CD004048-bbs2-0061" title="FischerE , CosgroveV , SuppesT , LangeNK , GwizdowskiI , DoanG , et al. Efficacy and tolerability of divalproex sodium plus adjunctive quetiapine, lithium, or placebo for hypomanic or manic episodes in outpatients with bipolar I disorder [abstract P‐140]. Bipolar Disorders (20th annual conference of the international society for bipolar disorders)2018; Vol. 20:116. NCT00183443 . Treatment of mania symptoms with drug therapy [Divalproex extended release and placebo, lithium, or quetiapine for mania]. clinicaltrials.gov/ct2/show/NCT00183443 (first received 16 September 2005). ">NCT00183443</a>; <a href="./references#CD004048-bbs2-0062" title="DelBelloM , DuranL , StrawnJ , KleinC , WelgeJ , BlomT , et al. Neural markers of treatment effects and response in youth with first‐episode mania [64th Annual Meeting American Academy of Child and Adolescent Psychiatry, AACAP 2017]. Journal of the American Academy of Child and Adolescent Psychiatry2017;56(10):S137. NCT00893581 . Multimodal neuroimaging of treatment effects in adolescent mania. clinicaltrials.gov/ct2/show/NCT00893581 (first received 6 May 2009). ">NCT00893581</a>). We were able to match up the other three protocols to reports of included studies (with the help of a review by <a href="./references#CD004048-bbs2-0142" title="YildizA , VietaE , LeuchtS , BaldessariniAJ . Efficacy of antimanic treatments: meta‐analysis of randomized, controlled trials. Neuropsychopharmacology2011;36(2):375‐89. ">Yildiz 2011</a>): NCT00448578 is <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008;</a> NCT00485680 <a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a>; and NCT00035230 is Kushner 2006 PDMD‐008) </p> <div class="figure" id="CD004048-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD004048-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>We assessed 169 full‐text records for eligibility; 111 did not fit our inclusion criteria and there are eight studies awaiting classification (12 references) plus one ongoing study. One of the studies awaiting classification only presented the results graphically as a regression. We contacted the study authors for numerical results but had no reply (<a href="./references#CD004048-bbs2-0064" title="GyulaiL . GERI‐BD: first randomized, double blind controlled trial comparing lithium and valproate in late‐life mania [conference abstract]. Bipolar Disorders (10th international conference on bipolar disorder of the international‐society‐for‐bipolar‐disorders). 2013; Vol. 15:30. NCT00254488 . Treatment of bipolar mania in older adults (GERI‐BD). clinicaltrials.gov/ct2/show/NCT00254488 (first received 16 November 2005). YoungRC , MulsantBH , SajatovicM , GildengersAG , GyulaiL , Al JurdiRK , et al. GERI‐BD: A randomized double‐blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. American Journal of Psychiatry2017;174(11):1086‐93. ">Young 2017</a> (NCT0025448); results posted on ClinicalTrials.gov 14 August 2018). We identified 36 studies that met our inclusion criteria to May 2018 (within 35 publications). <a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a> reported combined adverse event data from two studies but did not report these data separately (attempts to contact authors for these data separately by study were unsuccessful). We judged it appropriate to include these combined adverse event data, due to similarities in trial methods used by the company, rather than exclude them from the analyses. Although <a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a> reported the effectiveness results separately, to be consistent with the adverse event data, we combined the data from these two studies (Kushner 2006 PDMD‐004 NCT00037674 and Kushner 2006 PDMD‐008 NCT00035230). </p> <p>We included all 36 studies (represented by a total of 45 references) in the qualitative and quantitative analysis. Out of the 36 studies, only three were unpublished data (<a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a>; <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a>; <a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a>) and the remainder were published. </p> <p>Studies from searches to 18 May 2018 have been incorporated into the current analyses.</p> </section> <section id="CD004048-sec-0087"> <h4 class="title">Included studies</h4> <p>The characteristics of the 36 included studies are shown in <a href="./references#CD004048-sec-0306" title="">Characteristics of included studies</a>. </p> <section id="CD004048-sec-0088"> <h5 class="title">Study design and setting</h5> <p>All of the studies used parallel‐group design. Kushner 2006 PDMD‐004 and Kushner 2006 PDMD‐008 used a complex cross‐over design; we included only the first randomisation, as outlined in the methods section. <a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a> has only been published as a conference abstract; we could not find any further information, despite attempts to contact the study authors. There is therefore a lack of data about the detailed methodology or setting of the study. Where the information was available, we have listed the country in which the study was set in the <a href="./references#CD004048-sec-0306" title="">Characteristics of included studies</a>; at least 25 countries were represented. </p> </section> <section id="CD004048-sec-0089"> <h5 class="title">Length of the studies</h5> <p>The range of study length was between two weeks and 12 weeks (<a href="#CD004048-tbl-0016">Table 1</a>). Due to the variability in study length and time points at which the studies provided data, the initial plan to analyse data at the time points of three weeks (21 days) and twelve weeks (84 days) was not possible. We therefore analysed data from baseline to end of study. </p> <div class="table" id="CD004048-tbl-0016"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>12 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>8 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>4 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2 weeks</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a> </p> <p><a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a> </p> <p><a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a> </p> <p><a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a> </p> <p><a href="./references#CD004048-bbs2-0032" title="SmallJG , KlapperMH , KellamsJJ , MillerMJ , MilsteinV , SharpleyPH , et al. Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry1988;45(8):727‐32. ">Small 1988</a> </p> <p><a href="./references#CD004048-bbs2-0033" title="SmallJG , KlapperMH , MilsteinV , KellamsJJ , MillerMJ , MarhenkeJD , et al. Carbamazepine compared with lithium in the treatment of mania. Archives of General Psychiatry1991;48:915‐21. ">Small 1991</a> </p> <p><a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a> </p> <p><a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a> </p> <p><a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a> </p> <p><a href="./references#CD004048-bbs2-0004" title="BerkM , IchimL , BrookS . Olanzapine compared to lithium in mania: a double‐blind randomized controlled trial. International Clinical Psychopharmacology1999;14:339‐43. ">Berk 1999</a> </p> <p><a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a> </p> <p><a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a> </p> <p><a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a> </p> <p><a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a> </p> <p><a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> </p> <p><a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> </p> <p><a href="./references#CD004048-bbs2-0022" title="LererB , MooreN , MeyendorffE , ChoSR , GershonS . Carbamazepine versus lithium in mania: a double‐blind study. Journal of Clinical Psychiatry1987;48:89‐93. [MEDLINE: 3546274] ">Lerer 1987</a> </p> <p><a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a> </p> <p><a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a> </p> <p><a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a> </p> <p><a href="./references#CD004048-bbs2-0029" title="ShaftiSS , ShahveisiB . Comparison between lithium and valproate in the treatment of acute mania. Journal of Clinical Psychopharmacology2008;28(6):718‐20. ">Shafti 2008</a> </p> <p><a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a> </p> <p><a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> </p> <p><a href="./references#CD004048-bbs2-0026" title="PlatmanSR . A comparison of lithium carbonate and chlorpromazine in mania. American Journal of Psychiatry1970;127:351‐3. ">Platman 1970</a> </p> <p><a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a> </p> <p><a href="./references#CD004048-bbs2-0030" title="ShaftiSS . Olanzapine vs. lithium in management of acute mania. Journal of Affective Disorders2010;122(3):273‐6. ">Shafti 2010</a> </p> <p><a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a> </p> <p><a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> </p> <p><a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a> </p> <p><a href="./references#CD004048-bbs2-0012" title="GarfinkelPE , StancerHC , PersadE . A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affective Disorders1980;2:279‐88. [MEDLINE: 6450787] ">Garfinkel 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0003" title="BarekatainM , FatemiA , BashardoostN , DaroughehA , SalehiM , AsadollahiGH . Valproate‐risperidone valproate‐lithium combination in acute mania. Journal of Research in Medical Sciences2005;10(5):274‐80. ">Barekatain 2005</a> </p> </td> </tr> </tbody> </table> </div> </section> <section id="CD004048-sec-0090"> <h5 class="title">Participants</h5> <p>In total, the 36 studies included 4220 individual participants. Only three studies included children and adolescents (<a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a>; <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a>; <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>). Studies diagnosed acute mania according to DSM‐IV criteria in 22 of the 36 studies (<a href="./references#CD004048-bbs2-0068" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV). 5th Edition. Washington, DC: American Psychiatric Association, 2013. ">APA 2013</a>). The other studies used the DSM‐III (6 studies) or the Chinese Classification of Mental Disorders (<a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a>). Six studies published before 1990 all used clinical interviews by psychiatrists (<a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a>; <a href="./references#CD004048-bbs2-0012" title="GarfinkelPE , StancerHC , PersadE . A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affective Disorders1980;2:279‐88. [MEDLINE: 6450787] ">Garfinkel 1980</a>; <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a>; <a href="./references#CD004048-bbs2-0026" title="PlatmanSR . A comparison of lithium carbonate and chlorpromazine in mania. American Journal of Psychiatry1970;127:351‐3. ">Platman 1970</a>; <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a>; <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a>), and <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a> did not describe the method of diagnosis. </p> </section> <section id="CD004048-sec-0091"> <h5 class="title">Interventions and comparisons</h5> <p>All of the studies compared lithium with one of the comparators (placebo, antimanic drugs or ECT). Lithium treatment was with either lithium carbonate or lithium citrate, with dosing aimed to reach a plasma level of 0.6 to 1.4 mmol/L. </p> <section id="CD004048-sec-0092"> <h6 class="title">Lithium versus placebo</h6> <p>Eight studies compared lithium with placebo (<a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a>; <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a>; <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; <a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a>; <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a>; <a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a>; <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a>; <a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a>). All of these studies looked at the efficacy and tolerability of using lithium to treat acute mania. Six of the studies included a third comparator (valproate, quetiapine, lamotrigine, aripiprazole or topiramate respectively for <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a>; <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a>; <a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a>; <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a>; <a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a>), whilst <a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a> had quetiapine in addition to either lithium or placebo. <a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a> was the only study conducted in children and adolescents, the others were all in adults. </p> </section> <section id="CD004048-sec-0093"> <h6 class="title">Lithium versus valproate</h6> <p>Four studies reported studies comparing the efficacy of lithium to sodium valproate (<a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a>; <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a>; <a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a>; <a href="./references#CD004048-bbs2-0029" title="ShaftiSS , ShahveisiB . Comparison between lithium and valproate in the treatment of acute mania. Journal of Clinical Psychopharmacology2008;28(6):718‐20. ">Shafti 2008</a>). None of these studies included a third comparator. Four studies compared divalproex to lithium (<a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a>; <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a>; <a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a>; <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>). <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> and <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a> enrolled children and adolescents, whereas the other studies involved adults. Dosing varied across the studies; all the studies used divided doses (typically twice or three times daily), with three studies starting a titration at 20 mg/kg/day (<a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a>; <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a>; <a href="./references#CD004048-bbs2-0029" title="ShaftiSS , ShahveisiB . Comparison between lithium and valproate in the treatment of acute mania. Journal of Clinical Psychopharmacology2008;28(6):718‐20. ">Shafti 2008</a>), whilst <a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a> titrated up to 1500 mg to 3000 mg daily. Hirschfeld had two subgroups within the divalproex arm; they gave one group a loading dose of divalproex (30 mg/kg/day for two days reducing to 20 mg/kg/day) but not the other group (starting at 20 mg/kg/day). Both of these subgroups are included in the analysis. The other studies all started a titration at divalproex 20 mg/kg/day and did not use a loading dose. As the active ingredient of both sodium valproate and divalproex is valproic acid, we combined these in the analysis. </p> </section> <section id="CD004048-sec-0094"> <h6 class="title">Lithium versus quetiapine</h6> <p>We found only two studies comparing quetiapine with lithium that fitted our study criteria (<a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a>). <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a> had a third placebo arm, whereas <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a> did not. The main difference between these studies was that <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a> ran for 12 weeks, whereas <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a> reported their outcomes at four weeks. Both studies titrated quetiapine up to 800 mg daily. </p> </section> <section id="CD004048-sec-0095"> <h6 class="title">Lithium versus clonazepam</h6> <p>Two studies compared clonazepam with lithium (<a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a>; <a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a>). <a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a> was a single‐blinded study whereas <a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a> was double‐blinded. <a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a> reports using a dose range of 9 mg to 21 mg daily, <a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a>, 2 mg to 16 mg daily. </p> </section> <section id="CD004048-sec-0096"> <h6 class="title">Lithium versus lamotrigine</h6> <p>Three studies, including data from two unpublished studies, compared lithium to lamotrigine for treatment of acute mania. Studies from Glaxosmithkline (<a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a>; <a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a>), were conducted for six and three weeks respectively, whilst <a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> reported outcomes at the interim period of four weeks. All studies reported starting lamotrigine at 25 mg daily and titrating up to at least 100 mg over three to four weeks. <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a> and <a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a> titrated to 100 mg over four weeks, then up to 200 mg over the following two weeks. </p> </section> <section id="CD004048-sec-0097"> <h6 class="title">Lithium versus carbamazepine</h6> <p>We identified data from five studies comparing carbamazepine to lithium. Four of these contributed efficacy data (<a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>; <a href="./references#CD004048-bbs2-0022" title="LererB , MooreN , MeyendorffE , ChoSR , GershonS . Carbamazepine versus lithium in mania: a double‐blind study. Journal of Clinical Psychiatry1987;48:89‐93. [MEDLINE: 3546274] ">Lerer 1987</a>; <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a>; <a href="./references#CD004048-bbs2-0033" title="SmallJG , KlapperMH , MilsteinV , KellamsJJ , MillerMJ , MarhenkeJD , et al. Carbamazepine compared with lithium in the treatment of mania. Archives of General Psychiatry1991;48:915‐21. ">Small 1991</a>), whilst one only examined and reported adverse events (<a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a>). This adverse‐events study had three arms, with haloperidol given to the third group. <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> was a study of children and adolescents, and included a third arm given divalproex, whereas the other studies were all on adults and only had two arms. The studies described a range of dosing strategies. Three studies aimed for a carbamazepine plasma level within the range of six to 12 μ/mL (<a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>; <a href="./references#CD004048-bbs2-0022" title="LererB , MooreN , MeyendorffE , ChoSR , GershonS . Carbamazepine versus lithium in mania: a double‐blind study. Journal of Clinical Psychiatry1987;48:89‐93. [MEDLINE: 3546274] ">Lerer 1987</a>; <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a>), whilst <a href="./references#CD004048-bbs2-0033" title="SmallJG , KlapperMH , MilsteinV , KellamsJJ , MillerMJ , MarhenkeJD , et al. Carbamazepine compared with lithium in the treatment of mania. Archives of General Psychiatry1991;48:915‐21. ">Small 1991</a> aimed for a higher range of 25 to 50 μg/mL. <a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a> gave a set dose of 800 mg of carbamazepine daily. </p> </section> <section id="CD004048-sec-0098"> <h6 class="title">Lithium versus chlorpromazine</h6> <p>Four studies provided data comparing chlorpromazine to lithium (<a href="./references#CD004048-bbs2-0026" title="PlatmanSR . A comparison of lithium carbonate and chlorpromazine in mania. American Journal of Psychiatry1970;127:351‐3. ">Platman 1970</a>; <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a>; <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a>; <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a>). All these studies included adults and lasted for three weeks. The mean dose of chlorpromazine was 800 mg to 900 mg in all studies, although we are unsure about <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a>, which gave inadequate information on dosing. </p> </section> <section id="CD004048-sec-0099"> <h6 class="title">Lithium versus haloperidol</h6> <p>Four studies compared haloperidol to lithium in four studies, although only three of these reported efficacy outcomes (<a href="./references#CD004048-bbs2-0012" title="GarfinkelPE , StancerHC , PersadE . A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affective Disorders1980;2:279‐88. [MEDLINE: 6450787] ">Garfinkel 1980</a>; <a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a>; <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a>). These studies gave a dose range of 10 mg to 30 mg of haloperidol daily. <a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a> only reported adverse events from a set dose of 15 mg of haloperidol daily. </p> </section> <section id="CD004048-sec-0100"> <h6 class="title">Lithium versus olanzapine</h6> <p>Three studies compared olanzapine to lithium (<a href="./references#CD004048-bbs2-0004" title="BerkM , IchimL , BrookS . Olanzapine compared to lithium in mania: a double‐blind randomized controlled trial. International Clinical Psychopharmacology1999;14:339‐43. ">Berk 1999</a>; <a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a>; <a href="./references#CD004048-bbs2-0030" title="ShaftiSS . Olanzapine vs. lithium in management of acute mania. Journal of Affective Disorders2010;122(3):273‐6. ">Shafti 2010</a>), which all reported using a standard titration from 5 mg up to maximum 20 mg. </p> </section> <section id="CD004048-sec-0101"> <h6 class="title">Lithium versus risperidone</h6> <p>Three studies compared risperidone to lithium (<a href="./references#CD004048-bbs2-0003" title="BarekatainM , FatemiA , BashardoostN , DaroughehA , SalehiM , AsadollahiGH . Valproate‐risperidone valproate‐lithium combination in acute mania. Journal of Research in Medical Sciences2005;10(5):274‐80. ">Barekatain 2005</a>; <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a>; <a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a>). <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a> had a third comparator arm treating with divalproex and <a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a> had an arm using haloperidol. All the studies reported titrating risperidone to 4 mg to 6 mg/day. </p> </section> <section id="CD004048-sec-0102"> <h6 class="title">Lithium versus aripiprazole</h6> <p>Only one study comparing aripiprazole to lithium in acute mania fitted our inclusion criteria. <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> compared lithium (titrated to mean plasma level 0.76 mmol/L) to 30 mg of aripiprazole daily. This could be given as a single or divided doses. The study lasted three weeks. </p> </section> <section id="CD004048-sec-0103"> <h6 class="title">Lithium versus topiramate</h6> <p>Two studies from the same research group compared topiramate to lithium (Kushner 2006 PDMD‐004; Kushner 2006 PDMD‐008). These studies had a complex design of three weeks of core treatment of either placebo + topiramate or placebo + lithium and then a cross‐over in which those treated with placebo were either treated with topiramate or lithium. We have only included the first randomisation and first drug treatment in the analysis. The studies gave topiramate at 400 mg/day and lithium at 1500 mg/day. </p> </section> <section id="CD004048-sec-0104"> <h6 class="title">Lithium versus zuclopenthixol</h6> <p><a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a> was the only study comparing zuclopenthixol to lithium. They gave zuclopenthixol at 20 mg/day and titrated lithium to plasma level 0.9 mmol/L to 1.0 mmol/L. The study lasted 28 days. </p> </section> <section id="CD004048-sec-0105"> <h6 class="title">Lithium versus ECT</h6> <p><a href="./references#CD004048-bbs2-0032" title="SmallJG , KlapperMH , KellamsJJ , MillerMJ , MilsteinV , SharpleyPH , et al. Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry1988;45(8):727‐32. ">Small 1988</a> was the only study fitting the inclusion criteria that compared ECT to lithium treatment. This study had 17 participants in each arm. The lithium group had a mean plasma level of 0.69 mmol/L and the ECT arm received an average of nine bilateral ECT treatments over three to five weeks. </p> </section> <section id="CD004048-sec-0106"> <h6 class="title">Lithium versus all antimanic agents</h6> <p>We were able to combine data from 16 studies comparing lithium to all the other antimanic agents for a categorical outcome of response (n = 3856), and 20 studies for a continuous outcome (n = 2410). We also combined withdrawals for any cause, including 4211 participants. </p> </section> </section> <section id="CD004048-sec-0107"> <h5 class="title">Outcomes</h5> <p>The outcome measures used by studies varied considerably. All studies bar one either reported a continuous measure of manic symptoms as their primary outcome or a categorical outcome, whereby an arbitrary relative improvement of a reduction of at least 50% from baseline in the scale rating mania was taken to signify a response, or both. It should be noted that whilst this is a commonly used method of defining 'response', a 50% improvement in a scale may not necessarily indicate a clinically relevant improvement. The one study that did not use this method of reporting was <a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a>, whose study was aimed at reporting adverse events only. </p> <section id="CD004048-sec-0108"> <h6 class="title">Mental state</h6> <p>The most common scales used to assess mental state were as follows.</p> <p> <ol id="CD004048-list-0018"> <li> <p>Young Mania Rating Scale (YMRS; <a href="./references#CD004048-bbs2-0144" title="YoungRC , BiggsJT , ZeiglerVE , MeyerDA . A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry1978;133:429‐35. ">Young 1978</a>). This scale, used by <a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a>; <a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a>; <a href="./references#CD004048-bbs2-0003" title="BarekatainM , FatemiA , BashardoostN , DaroughehA , SalehiM , AsadollahiGH . Valproate‐risperidone valproate‐lithium combination in acute mania. Journal of Research in Medical Sciences2005;10(5):274‐80. ">Barekatain 2005</a>; <a href="./references#CD004048-bbs2-0004" title="BerkM , IchimL , BrookS . Olanzapine compared to lithium in mania: a double‐blind randomized controlled trial. International Clinical Psychopharmacology1999;14:339‐43. ">Berk 1999</a>; <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a>; <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a>; <a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a>; <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a>; <a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a>; <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a>; <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>; <a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a>; <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a>; <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a>; <a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a>; <a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a>; <a href="./references#CD004048-bbs2-0029" title="ShaftiSS , ShahveisiB . Comparison between lithium and valproate in the treatment of acute mania. Journal of Clinical Psychopharmacology2008;28(6):718‐20. ">Shafti 2008</a>; <a href="./references#CD004048-bbs2-0030" title="ShaftiSS . Olanzapine vs. lithium in management of acute mania. Journal of Affective Disorders2010;122(3):273‐6. ">Shafti 2010</a>; <a href="./references#CD004048-bbs2-0032" title="SmallJG , KlapperMH , KellamsJJ , MillerMJ , MilsteinV , SharpleyPH , et al. Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry1988;45(8):727‐32. ">Small 1988</a>; and <a href="./references#CD004048-bbs2-0033" title="SmallJG , KlapperMH , MilsteinV , KellamsJJ , MillerMJ , MarhenkeJD , et al. Carbamazepine compared with lithium in the treatment of mania. Archives of General Psychiatry1991;48:915‐21. ">Small 1991</a>, has 11 items that are rated after a clinical interview. Irritability, speech rate and amount, content of thought and disruptive behaviour items are given extra weight in the total by being scored from 0 to 8, whereas the remaining items are scored from 0 to 4. Higher scores indicate more symptoms. </p> </li> <li> <p>SADS‐C Manic Syndrome Subscale (<a href="./references#CD004048-bbs2-0089" title="EndicottV , SpitzerRL . A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry1978;35:837‐48. ">Endicott 1978</a>). The SADS scale was developed with the primary aim of differentiating between schizophrenia and mood disorders. The scale makes use of collateral information and past history. The SADS‐C scale is adapted to measure change over time. The manic syndrome subscale score examines elevated mood, sleep, energy activity and grandiosity. Higher scores indicate more symptoms. </p> </li> <li> <p>Brief Psychiatric Rating Scale (BPRS) (<a href="./references#CD004048-bbs2-0121" title="OverallJE , GorhamDR . The Brief Psychiatric Rating Scale. Psychological Reports1962;10:799. ">Overall 1962</a>). This scale rates 24 symptoms from 1 to 7 and gives a generalised view of how abnormal the mental state is. Higher scores indicate more symptoms. </p> </li> <li> <p>Montgomery Asberg Depression Rating scale (MADRS) (<a href="./references#CD004048-bbs2-0116" title="MontgomerySA , AsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134(4):382. ">Montgomery 1979</a>). This is a 10‐item diagnostic questionnaire used to measure the severity of depression. Higher scores indicate more severe depression. </p> </li> <li> <p>Hamilton Rating Scale for Depression (HAMD) (<a href="./references#CD004048-bbs2-0100" title="HamiltonM . A Rating Scale for Depression. Journal of Neurology, Neurosurgery and Psychiatry1960;23:56‐62. ">Hamilton 1960</a>). This is a questionnaire that can be used to diagnose depression. It is validated for adults and can rate the severity of depression. Higher scores indicate more severe depression. </p> </li> <li> <p>Positive and Negative symptom scale (PANSS) (<a href="./references#CD004048-bbs2-0106" title="KaySR , FiszbeinA , OplerLA . The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13(2):261‐76. ">Kay 1987</a>). This is a scale used to measure the severity of symptoms of psychosis, originally validated in schizophrenia. It is a standardised diagnostic interview. </p> </li> </ol> </p> <p>For all of the above scales, a reduction of at least 50% in score from baseline during a study (definition of a 'response') represents a substantial decrease in symptom severity. </p> </section> <section id="CD004048-sec-0109"> <h6 class="title">Global state of health</h6> <p>Some studies reported an outcome assessing global state of health or recent change in health. </p> <p> <ol id="CD004048-list-0019"> <li> <p>Clinical Global Impression (CGI) (<a href="./references#CD004048-bbs2-0099" title="GuyW . ECDEU Assessment Manual for Psychopharmacology. Revised. Rockville, MD: National institute of Mental Health, 1976. ">Guy 1976</a>). The majority of studies used this scale, which assesses both severity of illness and clinical improvement by comparing the condition of the patient standardised against others with the same diagnosis. The 7‐point scoring system is usually employed, with low scores showing decreased severity and overall improvement. Some studies used a modification of the Clinical Global Impressions Scale for use in bipolar illness: the CGI‐BP. Modifications include the correction of perceived inconsistencies in scaling, detailed definitions of illness severity and change, the inclusion of time frames and the separation of the assessment of improvement in illness from the assessment of the adverse events of treatment. Previous phases of illness are also used as comparators for the assessed period. A CGI score of greater than 3 is often taken to indicate a response. </p> </li> <li> <p>Global Assessment Scale (<a href="./references#CD004048-bbs2-0136" title="SpitzerRL , GibbonM , EndicottJ . ECDEU Assessment Manual for Psychopharmacology. Washington DC: US Department of Health, 1976. ">Spitzer 1970</a>) (GAS). The Global Assessment Scale evaluates the overall functioning of a patient. Their general functioning is given a score following consideration of any behavioural disturbance, levels of distress, social functioning, self‐care, impulsivity and reality testing. Higher scores indicate a higher level of functioning. </p> </li> </ol> </p> <p>A few studies used different outcomes:</p> <p> <ol id="CD004048-list-0020"> <li> <p>Inpatient Multidimensional Psychiatric Scale (IMPS) (<a href="./references#CD004048-bbs2-0108" title="LoorM , KlettCJ . Inpatient Multidimensional Psychiatric Scale. Palo Alto, California: Consulting Psychiatrists' Press, 1966. ">Lorr 1966</a>) was used by <a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a> and <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a>. It includes a manic subscale that scores 5 items (overactivity, elevated mood, pressure of speech, logorrhea and insight) each out of 7. This is a clinician‐rated scale. Higher scores reflect more severe symptoms. </p> </li> <li> <p>Bech‐Rafachen Mania Rating Scale (<a href="./references#CD004048-bbs2-0072" title="BechP , BolwigTG , KrampP , RafaelsenOJ . The Bech‐Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatrica Scandinavica1979;59:420‐30. ">Bech 1979</a>) is a clinician‐rated scale in which 11 manic symptoms are each rated on a scale of 0 to 4. Higher scores reflect more severe symptoms (<a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a>; <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a>). </p> </li> <li> <p><a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a> investigated the side effect profiles of lithium, carbamazepine and haloperidol for acute mania. They used a side‐effect checklist published by the World Health Organization (<a href="./references#CD004048-bbs2-0140" title="World Health Organization (WHO). WHO Multicentric Collaborative Study. Geneva: World Health Organization, 1986. ">WHO 1986</a>). </p> </li> <li> <p><a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> did not use a scale to measure response to treatment. They had a team of three psychiatrists who independently rated the participants on target symptoms: euphoria, expansiveness, grandiosity, flight of ideas, distractibility, pressured speech, motor activity and sleep disturbance. It is worth noting that this study occurred before the majority of the validated scales above were published. </p> </li> </ol> </p> </section> <section id="CD004048-sec-0110"> <h6 class="title">Assessment of adverse events</h6> <p>In general, adverse events experienced by participants were either listed in tables with statements of frequency, or were described in the text. A few studies (in addition) used specific scales: </p> <p> <ol id="CD004048-list-0021"> <li> <p>Simpson‐Angus Scale: <a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a>; <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> and <a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a> used this scale, which assesses extra‐pyramidal symptoms (signs relating to the abnormality of gait, muscle rigidity and resistance to movement, the glabellar tap, tremor and salivation). These items are scored from 0 to 4. The score increases with the severity of symptoms. </p> </li> <li> <p>Abnormal Involuntary Movement Scale (<a href="./references#CD004048-bbs2-0099" title="GuyW . ECDEU Assessment Manual for Psychopharmacology. Revised. Rockville, MD: National institute of Mental Health, 1976. ">Guy 1976</a>): <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a> used this scale. It scores facial and oral movements (four items), movements of the limbs and the trunk (three items), dental problems (two items) and global judgements, such as the severity of abnormal movements, their resultant incapacitation and patient's awareness of abnormal movements (three items). Each item, with the exception of dental problems, is scored on a 5‐point scale, from normal to severe. </p> </li> </ol> </p> </section> </section> </section> <section id="CD004048-sec-0111"> <h4 class="title">Excluded studies</h4> <p>There are 21 studies formally excluded from this review, please see <a href="./references#CD004048-sec-0307" title="">Characteristics of excluded studies</a> for details. </p> <section id="CD004048-sec-0112"> <h5 class="title">Ongoing studies</h5> <p>There is one ongoing study (<a href="./references#CD004048-bbs2-0065" title="NCT01893229 . Comparative efficacy and acceptability of antimanic drugs in acute mania [Comparative efficacy and acceptability of lithium, valproate, oxcarbazepine, quetiapine, olanzapine, and ziprasidone in bipolar I disorder, manic or mixed phase]. clinicaltrials.gov/ct2/show/record/NCT01893229 (first received 8 July 2013). ">NCT01893229</a>), which is a study of adults with a manic or mixed episode being randomised to one of lithium, valproate, oxcarbazepine, quetiapine, olanzapine or ziprasidone for 14 days. Please see <a href="./references#CD004048-sec-0309" title="">Characteristics of ongoing studies</a> for details. </p> </section> <section id="CD004048-sec-0113"> <h5 class="title">Studies awaiting classification</h5> <p>There are eight studies currently awaiting classification:</p> <p> <ol id="CD004048-list-0022"> <li> <p><a href="./references#CD004048-bbs2-0057" title="GrunzeH . Efficacy and safety of valproate and lithium in acute and continuation treatment of bipolar mania. Abstract from 2nd Biennial Conference of the Association of Bipolar Disorders. 2006. ">Grunze 2006</a> is a conference abstract for a study examining the effects of valproate and lithium in acute and continuation treatment of bipolar mania. The abstract doesn't include any results data, randomisation or blinding strategies and we were unable to get any further details of this study. </p> </li> <li> <p><a href="./references#CD004048-bbs2-0058" title="ItohK . Comparison of efficacy of lithium carbonate and chlorpromazine in mania by double‐blind controlled study. Rinsho Hyoka1974;2(1):23‐45. ">Itoh 1974</a> is a double‐blind comparison of lithium carbonate and chlorpromazine in mania but we were unable to retrieve the full‐text. </p> </li> <li> <p><a href="./references#CD004048-bbs2-0059" title="KumarM . The efficacy and side effect profile of lamotrigine in acute mania: a double‐blind comparison with lithium conference abstract. Indian Journal of Psychiatry (abstracts from the 61st Annual National Conference of Indian Psychiatric Society, ANCIPS Agra India)2009;Not stated:Not stated. ">Kumar 2009</a> is a conference abstract for a study comparing the efficacy and side effects of lamotrigine compared with lithium in acute mania. The methodology is unclear and there is no efficacy data reported, only side effects. We were unable to get further information. </p> </li> <li> <p><a href="./references#CD004048-bbs2-0060" title="MaggsR . Treatment of manic illness with lithium carbonate. British Journal of Psychiatry1963;109:56‐65. ">Maggs 1963</a> is a comparative study of lithium carbonate in the treatment of manic illness but the full‐text report is ambiguous. Unclear number of participants, unclear methodology and poor reporting of the findings. </p> </li> <li> <p><a href="./references#CD004048-bbs2-0061" title="FischerE , CosgroveV , SuppesT , LangeNK , GwizdowskiI , DoanG , et al. Efficacy and tolerability of divalproex sodium plus adjunctive quetiapine, lithium, or placebo for hypomanic or manic episodes in outpatients with bipolar I disorder [abstract P‐140]. Bipolar Disorders (20th annual conference of the international society for bipolar disorders)2018; Vol. 20:116. NCT00183443 . Treatment of mania symptoms with drug therapy [Divalproex extended release and placebo, lithium, or quetiapine for mania]. clinicaltrials.gov/ct2/show/NCT00183443 (first received 16 September 2005). ">NCT00183443</a> is a published conference abstract of a randomised double‐blind study of open‐label divalproex plus adjunctive lithium, quetiapine or placebo in manic patients with bipolar disorder. A full methodology is needed to determine if the study fits inclusion criteria. We emailed the Principal Investigator via the address on clinicaltrials.gov to request results but the email bounced back as an invalid address. (Results posted on ClinicalTrials.gov 17 July 2018.) </p> </li> <li> <p><a href="./references#CD004048-bbs2-0062" title="DelBelloM , DuranL , StrawnJ , KleinC , WelgeJ , BlomT , et al. Neural markers of treatment effects and response in youth with first‐episode mania [64th Annual Meeting American Academy of Child and Adolescent Psychiatry, AACAP 2017]. Journal of the American Academy of Child and Adolescent Psychiatry2017;56(10):S137. NCT00893581 . Multimodal neuroimaging of treatment effects in adolescent mania. clinicaltrials.gov/ct2/show/NCT00893581 (first received 6 May 2009). ">NCT00893581</a> is a neuroimaging study examining the effects of quetiapine and lithium on neural function in adolescents with a first episode of mania. Only a conference abstract is available: a full methodology is required to determine if this study fits inclusion criteria. We contacted the study authors via clinicaltrials.gov but we had no reply to our email. </p> </li> <li> <p><a href="./references#CD004048-bbs2-0063" title="PenickSB , PrienRF . Controlled evaluation of lithium carbonate and chlorpromazine in the treatment of manic states. World Congress of Psychiatry1971;Not stated:Not stated. [V World Congress of Psychiatry, 1971 Nov 28‐Dec 4, Ciudad De Mexico: 941] ">Penick 1971</a> is another conference abstract for a study comparing lithium carbonate and chlorpromazine in the treatment of manic states, but we were unable to contact the authors or to get further details of this study. </p> </li> <li> <p><a href="./references#CD004048-bbs2-0064" title="GyulaiL . GERI‐BD: first randomized, double blind controlled trial comparing lithium and valproate in late‐life mania [conference abstract]. Bipolar Disorders (10th international conference on bipolar disorder of the international‐society‐for‐bipolar‐disorders). 2013; Vol. 15:30. NCT00254488 . Treatment of bipolar mania in older adults (GERI‐BD). clinicaltrials.gov/ct2/show/NCT00254488 (first received 16 November 2005). YoungRC , MulsantBH , SajatovicM , GildengersAG , GyulaiL , Al JurdiRK , et al. GERI‐BD: A randomized double‐blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. American Journal of Psychiatry2017;174(11):1086‐93. ">Young 2017</a> is a randomised double‐blind study of lithium and divalproex to treat mania in older patients with bipolar disorder (GERI‐bd). The results for this study were presented graphically &amp; as a logistical regression; we contacted the study authors to ask for the numerical results but received no answer to our emails. If this information were received the study would otherwise fit criteria for inclusion. (Results posted on ClinicalTrials.gov 14 August 2018.) </p> </li> </ol> </p> </section> </section> </section> <section id="CD004048-sec-0114"> <h3 class="title">Risk of bias in included studies</h3> <p>For details of the 'Risk of bias' judgements for each study, see <a href="./references#CD004048-sec-0306" title="">Characteristics of included studies</a>. We have presented a graphical representation of the overall risk of bias in included studies in <a href="#CD004048-tbl-0017">Table 2</a>, <a href="#CD004048-fig-0002">Figure 2</a> and <a href="#CD004048-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD004048-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study" data-id="CD004048-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <div class="figure" id="CD004048-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias graph': review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD004048-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias graph': review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="table" id="CD004048-tbl-0017"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Risk of bias summary table</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Area of potential bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Number of studies (N = 35)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High risk</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Unclear risk</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low risk</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blinding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incomplete outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> </tr> </tbody> </table> </div> <section id="CD004048-sec-0115"> <h4 class="title">Allocation</h4> <section id="CD004048-sec-0116"> <h5 class="title">Randomisation and concealment of allocation</h5> <p>All included studies described themselves as 'randomised'. Using the Cochrane 'Risk of bias' criteria, which rate the adequacy and concealment of random allocation, we rated 28 studies as unclear, seven as low and one as high risk of bias (<a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a>). The studies rated unclear all described 'randomisation' without further explanation. <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> probably used a quasi‐randomisation method, but this was unclear. </p> </section> </section> <section id="CD004048-sec-0117"> <h4 class="title">Blinding</h4> <p>Thirty‐four studies described themselves as double‐blinded, but unfortunately all 34 of these studies gave no further explanation as to what they meant by this term. We therefore deemed these at unclear risk of bias. This included <a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a>, which was singled‐blinded, with only the rater being blind to the allocation. As in any study, it is always possible that both the assessors and participants previously in receipt of the study medications may have been unblinded by the distinctive adverse effect profile of the study drugs. <a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a> and <a href="./references#CD004048-bbs2-0032" title="SmallJG , KlapperMH , KellamsJJ , MillerMJ , MilsteinV , SharpleyPH , et al. Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry1988;45(8):727‐32. ">Small 1988</a> gave no description of their blinding techniques and we therefore deemed them at high risk. Regarding performance bias, no specific differences in the care provided to different groups were identified in any study, however, the number of studies published before detailed methodologies were required is high. This therefore puts a element of uncertainty into the picture. Similarly, for detection bias, there were no reported differences in the outcome determination methods between groups in any study. <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> reported that the participants and treating clinician were blinded during the study, but the rater of outcomes at the end of the study was not. This appears to have been for both arms. </p> </section> <section id="CD004048-sec-0118"> <h4 class="title">Incomplete outcome data</h4> <p>In general the studies were comprehensive in their reporting of the flow of participants and the outcomes. We deemed 22 studies at low risk, with all participants accounted for and all outcomes well reported. Ten studies had a high (more than 20%) dropout rate from the study, which we deemed high risk (<a href="./references#CD004048-bbs2-0003" title="BarekatainM , FatemiA , BashardoostN , DaroughehA , SalehiM , AsadollahiGH . Valproate‐risperidone valproate‐lithium combination in acute mania. Journal of Research in Medical Sciences2005;10(5):274‐80. ">Barekatain 2005</a>; <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a>; <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a>; <a href="./references#CD004048-bbs2-0012" title="GarfinkelPE , StancerHC , PersadE . A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affective Disorders1980;2:279‐88. [MEDLINE: 6450787] ">Garfinkel 1980</a>; <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a>; <a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a>; <a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a>; <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a>; <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>, <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a>) For four studies it was unclear if the reporting was comprehensive, as the process was poorly described (<a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a>; <a href="./references#CD004048-bbs2-0004" title="BerkM , IchimL , BrookS . Olanzapine compared to lithium in mania: a double‐blind randomized controlled trial. International Clinical Psychopharmacology1999;14:339‐43. ">Berk 1999</a>; <a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a> ‐ both studies). </p> </section> <section id="CD004048-sec-0119"> <h4 class="title">Selective reporting</h4> <p>On the whole, the study authors comprehensively reported the studies. Five studies were poorly reported, with either outcome data missing or adverse effect data not described, so we deemed these at high risk of bias (<a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a>; <a href="./references#CD004048-bbs2-0004" title="BerkM , IchimL , BrookS . Olanzapine compared to lithium in mania: a double‐blind randomized controlled trial. International Clinical Psychopharmacology1999;14:339‐43. ">Berk 1999</a>; <a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a>; <a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a>; <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a>;) In addition, in <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a>, it was unclear what the time point of the last data collection was. </p> </section> <section id="CD004048-sec-0120"> <h4 class="title">Other potential sources of bias</h4> <section id="CD004048-sec-0121"> <h5 class="title">Handling of withdrawals: intention‐to‐treat analyses and use of last observation carried forward </h5> <p>The studies included in this review date from a 45‐year time period. Many were published well before the ITT and LOCF methods were introduced. Given this, 21 papers (19 published prior to the year 2000) did not use either ITT or LOCF. Four studies described using LOCF, all of which only included participants who had had at least one dose of the randomised treatment (<a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a>; <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; <a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a>; <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a>). The more recent publications (nine studies) all reported using ITT and LOCF, where the participant needed to have had at least one dose of the treatment they were randomised to, and had at least one outcome measure (e.g. a YMRS) done post‐baseline (<a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a>; <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a>; <a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a>; <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>; <a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a>; <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a>; <a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a>; <a href="./references#CD004048-bbs2-0029" title="ShaftiSS , ShahveisiB . Comparison between lithium and valproate in the treatment of acute mania. Journal of Clinical Psychopharmacology2008;28(6):718‐20. ">Shafti 2008</a>; <a href="./references#CD004048-bbs2-0030" title="ShaftiSS . Olanzapine vs. lithium in management of acute mania. Journal of Affective Disorders2010;122(3):273‐6. ">Shafti 2010</a>). For, <a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a> it is unclear which, if any, of these techniques were employed. The LOCF approach is usually thought to give a conservative estimate of the effectiveness of a treatment in an acute illness, but when withdrawal is non‐random (i.e. associated with one of the treatments, perhaps through failure of blinding), it can give a biased estimate of that treatment effect. The withdrawal rates from the studies are variable (more than 50% of placebo‐treated participants withdrew in <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a> and <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> but there were no withdrawals in <a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a>). The use of LOCF introduces more uncertainty and potential for bias the higher the withdrawal rate and this should be considered when interpreting the findings of this review. </p> </section> <section id="CD004048-sec-0122"> <h5 class="title">Numbers of participants</h5> <p>Many of the included studies, especially the older ones, were too small to reliably detect moderate but clinically important treatment effects. Their small size limits their ability to detect small differences in acceptability or differences in the rates of rare outcomes and rendered them prone to potential confounding by baseline differences between groups. Several of the most recent papers reported power calculations (<a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a>; <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a>; <a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a>; <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a>; <a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a>). </p> </section> <section id="CD004048-sec-0123"> <h5 class="title">Selection of participants</h5> <p>The participants of all the studies except two were adults (either inpatients or outpatients), who met operationally defined diagnostic criteria for acute mania. <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> and <a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a> studied children and adolescents. </p> <p>Inevitably, the participants of all the studies were selected in one way or another. Only some of the most recent studies provided a clear indication of the manner in which they had selected participants for the study, as recommended by the CONSORT statement (<a href="./references#CD004048-bbs2-0130" title="SchulzKF , AltmanDG , MoherD , CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.. BMJ2010;340:c332. ">Schulz 2010</a>). One identified problem was the tendency to exclude severely affected participants. The majority of the studies mentioned that participants were able to give informed consent to participate, potentially excluding those with severe mania. Similarly, the majority excluded participants who had axis‐I comorbidities or comorbid substance misuse difficulties. <a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a> and <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> defined a manic episode on the basis of a low threshold YMRS Score of 14 or more, whereas the standard cut‐off is 20. Another difficulty was a tendency to select on the grounds of previous experience of study medications. <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a> divided participants into known and unknown lithium responders; however, these participants were all included in the analysis. <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a> and <a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a> excluded those with previous experience of valproate. <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a> and <a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a> excluded those who had previously experienced severe adverse events on lithium, and those who had shown an intolerance to valproate or lithium respectively. Helpfully, in their study of lithium versus ECT, <a href="./references#CD004048-bbs2-0032" title="SmallJG , KlapperMH , KellamsJJ , MillerMJ , MilsteinV , SharpleyPH , et al. Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry1988;45(8):727‐32. ">Small 1988</a> clearly state that they did not exclude participants with previous non‐response to lithium. </p> </section> <section id="CD004048-sec-0124"> <h5 class="title">Discontinuation effects</h5> <p>Although some study authors dispute its existence (<a href="./references#CD004048-bbs2-0129" title="SchouM . Is there a lithium withdrawal syndrome? An examination of the evidence. British Journal of Psychiatry1993;163:514‐8. ">Schou 1993</a>), it is widely accepted that 'rebound mania' occurs in some people with bipolar disorder on discontinuation of lithium (<a href="./references#CD004048-bbs2-0095" title="GoodwinG . Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. British Journal of Psychiatry1994;164:149‐52. ">Goodwin 1994</a>). In acute treatment studies, discontinuation of lithium prior to the experimental phase might lead to exacerbation of mania, possibly affecting the observed response to the study drug. It is not clear whether a similar effect exists on anticonvulsant withdrawal. </p> <p>The majority of studies report that they used a washout period prior to the start of the study, typically three to five days. Few of the studies appeared to have given specific consideration to the discontinuation effects. The exception to this was <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a>, who clearly state that the washout period was reduced if there were signs of discontinuation effects. However, most studies reported the withdrawal of psychotropic medication prior to randomisation. This occurred three to 14 days previously. It was unclear in almost all studies how many participants had been on lithium (or any other given psychotropic) prior to randomisation. <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a> specified that plasma lithium was undetectable prior to randomisation. </p> </section> <section id="CD004048-sec-0125"> <h5 class="title">Use of rescue medication and adjustment of dose of investigational drug</h5> <p>The doses of medication used were well described by all 36 studies. These are described under '<a href="#CD004048-sec-0085">Description of studies</a>' above. In general, similar dose regimes were used across comparator groups. In all studies where an explanation of how dose changes were made, lithium was titrated according to lithium plasma levels and not clinical symptoms. The target range for lithium was very similar between studies. This was similar for carbamazepine and divalproex; drugs were titrated to predetermined serum ranges. Valproate was the comparator with the most variation of dose. Half of the studies used a titration starting at 20 mg/kg/day whilst the others used a fixed‐dose titration up to 1500 to 3000 mg daily. <a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a> did not give details of the doses used. It should be noted that <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a> had one characteristic different to the other studies: it allowed the dosage of the study drug to be altered in response to clinical deterioration. </p> <p>All the studies used other psychotropic agents as rescue medication. The agents used depended upon the publication date of the study. The older studies tended to use anticholinergics (e.g. orphenadrine) or benzodiazepines. One study used chloral hydrate as a sleep aid (<a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a>). The use of these was typically poorly reported. The majority of more modern studies clearly reported the use of benzodiazepines (usually lorazepam) in terms of either a categorical use/did not use or the mean dose used over the study. <a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a> used haloperidol as a rescue medication, as the active comparator to lithium was the benzodiazepine clonazepam. </p> </section> <section id="CD004048-sec-0126"> <h5 class="title">Publication bias</h5> <p>We did not examine the presence of publication bias in this systematic review because there were insufficient studies in each intervention category to allow meaningful formal assessment using funnel plots. </p> </section> </section> </section> <section id="CD004048-sec-0127"> <h3 class="title" id="CD004048-sec-0127">Effects of interventions</h3> <p>See: <a href="./full#CD004048-tbl-0001"><b>Summary of findings for the main comparison</b> Lithium compared to placebo for acute mania</a>; <a href="./full#CD004048-tbl-0002"><b>Summary of findings 2</b> Lithium compared to valproate for acute mania</a>; <a href="./full#CD004048-tbl-0003"><b>Summary of findings 3</b> Lithium compared to lamotrigine for acute mania</a>; <a href="./full#CD004048-tbl-0004"><b>Summary of findings 4</b> Lithium compared to carbamazepine for acute mania</a>; <a href="./full#CD004048-tbl-0005"><b>Summary of findings 5</b> Lithium compared to quetiapine for acute mania</a>; <a href="./full#CD004048-tbl-0006"><b>Summary of findings 6</b> Lithium compared to olanzapine for acute mania</a>; <a href="./full#CD004048-tbl-0007"><b>Summary of findings 7</b> Lithium compared to chlorpromazine for acute mania</a>; <a href="./full#CD004048-tbl-0008"><b>Summary of findings 8</b> Lithium compared to haloperidol for acute mania</a>; <a href="./full#CD004048-tbl-0009"><b>Summary of findings 9</b> Lithium compared to zuclopenthixol for acute mania</a>; <a href="./full#CD004048-tbl-0010"><b>Summary of findings 10</b> Lithium compared to risperidone for acute mania</a>; <a href="./full#CD004048-tbl-0011"><b>Summary of findings 11</b> Lithium compared to aripiprazole for acute mania</a>; <a href="./full#CD004048-tbl-0012"><b>Summary of findings 12</b> Lithium compared to topiramate for acute mania</a>; <a href="./full#CD004048-tbl-0013"><b>Summary of findings 13</b> Lithium compared to clonazepam for acute mania</a>; <a href="./full#CD004048-tbl-0014"><b>Summary of findings 14</b> Lithium compared to electroconvulsive therapy (ECT) for acute mania</a>; <a href="./full#CD004048-tbl-0015"><b>Summary of findings 15</b> Lithium compared to all antimanic agents for acute mania</a> </p> <section id="CD004048-sec-0128"> <h4 class="title">Lithium versus placebo</h4> <section id="CD004048-sec-0129"> <h5 class="title">Comparison 1: lithium versus placebo</h5> <p>Eight studies (including 1991 participants) contributed data to this comparison. See also: <a href="./full#CD004048-tbl-0001">summary of findings Table for the main comparison</a> </p> <p>We found eight RCTs, which are included in the outcomes, although only a maximum of six studies provided efficacy data that fitted any of our primary outcomes. We identified seven studies via the database search, and we found one (<a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a>), in the grey literature (<a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>). </p> <section id="CD004048-sec-0130"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0131"> <p><b>Efficacy: response (categorical). At least 50% reduction on YMRS or Mania Rating Scale (MRS) by end of the study</b></p> <p>Six studies contributed to the comparison (<a href="./references#CD004048-fig-0004" title="">Analysis 1.1</a>). Lithium was twice as effective as placebo at achieving a response (OR 2.13, 95% CI 1.73 to 2.63; participants = 1707; studies = 6; I<sup>2</sup> = 16%; high‐certainty evidence). </p> </section> <section id="CD004048-sec-0132"> <p><b>Efficacy: response (continuous). Mean change in YMRS from baseline to end of the study</b></p> <p>Participants treated with lithium had a greater mean reduction in YMRS by day 21 of treatment than those on placebo (MD −2.85, 95% CI −3.14 to −2.55; participants = 935; studies = 4; I<sup>2</sup> = 84%; high‐certainty evidence). Six studies reported this outcome (<a href="./references#CD004048-fig-0005" title="">Analysis 1.2</a>), but we were unable to include two studies (n = 276 participants), in the meta‐analysis as we could not obtain or calculate SDs (<a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; <a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a>). These studies both reported a statistically greater reduction in YMRS in the lithium group compared to placebo. </p> </section> <section id="CD004048-sec-0133"> <p><b>Efficacy (categorical): remission. YMRS less than 12 at end of study</b></p> <p>Five studies reported the outcome of remission measured by YMRS less than 12 at end of study when comparing lithium with placebo (<a href="./references#CD004048-fig-0007" title="">Analysis 1.4</a>). Lithium was twice as effective in achieving remission as placebo (OR 2.16, 95% CI 1.73 to 2.69; participants = 1597; studies = 5; I<sup>2</sup> = 21%; high‐certainty evidence). </p> </section> <section id="CD004048-sec-0134"> <p><b>Acceptability: adverse events</b></p> <p> <ol id="CD004048-list-0023"> <li> <p>Depression (categorical): four studies measured the emergence of depression during treatment (<a href="./references#CD004048-fig-0009" title="">Analysis 1.6</a>). The lithium group were half as likely to develop depression as those treated with placebo (OR 0.57, 95% CI 0.33 to 0.98; participants = 1360; studies = 4; I<sup>2</sup> = 0%). </p> </li> <li> <p>Mania (categorical): four studies reported on the proportion of participants who developed further manic symptoms during the study (<a href="./references#CD004048-fig-0010" title="">Analysis 1.7</a>). The lithium group were less likely to experience worsened symptoms than those on placebo (OR 0.59, 95% CI 0.38 to 0.93; participants = 1296; studies = 4; I<sup>2</sup> = 0%). </p> </li> <li> <p>Somnolence (categorical): we included seven studies in the analysis; lithium was twice as likely to cause somnolence as placebo (OR 2.28, 95% CI 1.46 to 3.58; participants = 1351; studies = 7; I<sup>2</sup> = 0%; high‐certainty evidence <a href="./references#CD004048-fig-0015" title="">Analysis 1.12</a>). </p> </li> <li> <p>Dizziness (categorical): five studies were included in the analysis for dizziness during the study; lithium was more likely to cause dizziness than placebo (OR 2.12, 95% CI 1.21 to 3.74; participants = 873; studies = 5; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0016" title="">Analysis 1.13</a>). </p> </li> <li> <p>Nausea (categorical): participants treated with lithium were more likely to report nausea that those on placebo (OR 2.32, 95% CI 1.54 to 3.50; participants = 1220; studies = 6; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0019" title="">Analysis 1.16</a>). </p> </li> <li> <p>Vomiting (categorical): participants treated with lithium were more likely to report vomiting that those on placebo (OR 6.06, 95% CI 3.21 to 11.45; participants = 1028; studies = 6; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0020" title="">Analysis 1.17</a>). </p> </li> <li> <p>Pain (categorical): three studies (n = 396) reported that the lithium group had significantly fewer participants presenting with pain compared to placebo (OR 0.23, 95% CI 0.07 to 0.79; participants = 396; studies = 3; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0022" title="">Analysis 1.19</a>). </p> </li> <li> <p>Tremor (categorical): six studies contributed to the analysis. Lithium was three times more likely to cause a tremor than placebo (OR 3.25, 95% CI 2.10 to 5.04; participants = 1241; studies = 6; I<sup>2</sup> = 0%; high‐certainty evidence; <a href="./references#CD004048-fig-0024" title="">Analysis 1.21</a>). </p> </li> <li> <p>Attempted suicide (categorical): two studies reported the incidence of attempted suicide during the study. We could not use these data for meta‐analysis due to the low incidence (only one attempted suicide out of 811 participants). <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a> reported one attempted suicide from the placebo group and zero in the lithium group; <a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a> reported no suicide attempts across the study. </p> </li> <li> <p>Other adverse events: meta‐analysis showed no significant difference between lithium and placebo for the following adverse events. </p> <ol id="CD004048-list-0024"> <li> <p>Weight gain ‐ categorical (OR 1.48, 95% CI 0.56 to 3.92; participants = 735, I<sup>2</sup>= 51%; high‐certainty evidence; <a href="./references#CD004048-fig-0011" title="">Analysis 1.8</a>) </p> </li> <li> <p>Weight gain ‐ continuous (MD 0.16, 95% CI −0.50 to 0.82; participants = 599; I<sup>2</sup> = 90%; <a href="./references#CD004048-fig-0012" title="">Analysis 1.9</a>) </p> </li> <li> <p>Akathisia (OR 0.86, 95% CI 0.39 to 1.91; participants = 673; I<sup>2</sup> = 32%; <a href="./references#CD004048-fig-0013" title="">Analysis 1.10</a>) </p> </li> <li> <p>Headache (OR 1.06, 95% CI 0.76 to 1.48; participants = 1270; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0014" title="">Analysis 1.11</a>) </p> </li> <li> <p>Insomnia (OR 0.76, 95% CI 0.44 to 1.29; participants = 706; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0017" title="">Analysis 1.14</a>) </p> </li> <li> <p>Diarrhoea (OR 1.51, 95% CI 0.90 to 2.54; participants = 1028; I<sup>2</sup> = 16%; <a href="./references#CD004048-fig-0018" title="">Analysis 1.15</a>) </p> </li> <li> <p>Dry mouth (OR 1.10, 95% CI 0.58 to 2.09; participants = 682; I<sup>2</sup> = 33%; <a href="./references#CD004048-fig-0021" title="">Analysis 1.18</a>) </p> </li> <li> <p>Extrapyramidal side effects (EPSEs) (OR 1.23, 95% CI 0.68 to 2.19; participants = 478; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0023" title="">Analysis 1.20</a>) </p> </li> <li> <p>Constipation (OR 1.28, 95% CI 0.81 to 2.01; participants = 1075; I<sup>2</sup> = 20%; <a href="./references#CD004048-fig-0025" title="">Analysis 1.22</a>) </p> </li> <li> <p>Fever (OR 1.63, 95% CI 0.75 to 3.55; participants = 466; I<sup>2</sup> = 41%; <a href="./references#CD004048-fig-0026" title="">Analysis 1.23</a>) </p> </li> <li> <p>Rash (OR 0.91, 95% CI 0.37 to 2.29; participants = 367; I<sup>2</sup> = 48%; <a href="./references#CD004048-fig-0027" title="">Analysis 1.24</a>) </p> </li> </ol> </li> </ol> </p> <p>Only one study reported data for each of the other adverse events. The data are shown in <a href="./references#CD004048-fig-0221" title="">Analysis 16.1</a> to <a href="./references#CD004048-fig-0252" title="">Analysis 16.32</a>. </p> </section> <section id="CD004048-sec-0135"> <p><b>Acceptability: all‐cause dropouts from the study</b></p> <p>All eight publications contributed data to this analysis. Participants treated with lithium were less likely to withdraw from the study than those taking a placebo. However, there was considerable heterogeneity between the results (OR 0.76; 95% CI 0.46 to 1.25; participants = 1353; I<sup>2</sup> = 75%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0008" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD004048-sec-0136"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0137"> <p><b>Efficacy: response (continuous). CGI change from baseline to end of study</b></p> <p>Four studies demonstrated a greater decrease in mean CGI score in lithium‐treated participants compared to placebo (MD −0.25, 95% CI −0.35 to −0.16; participants = 1147; studies = 4; I<sup>2</sup> = 95%; <a href="./references#CD004048-fig-0006" title="">Analysis 1.3</a>). A fifth study (<a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; n=195), provided CGI data but we could not use it in the meta‐analysis due to a lack of standard deviations. </p> </section> <section id="CD004048-sec-0138"> <p><b>Efficacy: response (continuous). Mean change in MADRS from baseline to the end of the study</b></p> <p>Two studies contributed to the analysis; lithium was superior in reducing mean MADRS scores compared to placebo (MD −0.58, 95% CI −0.78 to −0.37; participants = 862; studies = 2; I<sup>2</sup> = 87%; <a href="./references#CD004048-fig-0031" title="">Analysis 1.28</a>). We could not combine one study (n = 195) due to lack of SD (<a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>). </p> </section> <section id="CD004048-sec-0139"> <p><b>Efficacy: response (continuous). Mean change in MRS from baseline to end of the study</b></p> <p>There was no significant difference in the mean change in MRS scores between the lithium and placebo groups (MD −1.19, 95% CI −2.78 to 0.39; participants = 285; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0032" title="">Analysis 1.29</a>). </p> </section> <section id="CD004048-sec-0140"> <p><b>Efficacy (continuous). Mean change in MRS (16‐item scale from SAD‐C) from baseline to end of study</b></p> <p>Using the 16‐item scale from SAD‐C, lithium‐treated participants showed a greater reduction in mean scores across the length of the study (MD −3.67, 95% CI −7.27 to −0.07; participants = 285; studies = 2; I<sup>2</sup> = 46%; <a href="./references#CD004048-fig-0032" title="">Analysis 1.29</a>). </p> </section> <section id="CD004048-sec-0141"> <p><b>Efficacy (continuous). Manic subscale of MRS, mean change from baseline to end of study</b></p> <p>There was no significant difference in the mean change in MRS ‐manic subscale scores between the lithium and placebo groups (MD −1.19, 95% CI −2.78 to 0.39; participants = 285; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0032" title="">Analysis 1.29</a>). </p> </section> <section id="CD004048-sec-0142"> <p><b>Efficacy (continuous). Mean change in the HAMD‐31 scale from baseline to end of study</b></p> <p>There was no significant difference in the mean change in HAMD scores between the lithium and placebo groups (MD −1.12, 95% CI −7.69 to 5.44; participants = 285; studies = 2; I<sup>2</sup> = 91%; <a href="./references#CD004048-fig-0034" title="">Analysis 1.31</a>). </p> </section> <section id="CD004048-sec-0143"> <p><b>Efficacy (continuous). Mean change in the BPRS from baseline to end of study</b></p> <p>Two studies contributed to the analysis; lithium was no better than placebo in reducing mean BPRS scores (MD −1.74, 95% CI −3.70 to 0.23; participants = 285; studies = 2; I<sup>2</sup> = 33%; <a href="./references#CD004048-fig-0035" title="">Analysis 1.32</a>). </p> </section> <section id="CD004048-sec-0144"> <p><b>Efficacy (continuous). Mean change in the PANSS cognitive subscale from baseline to end of study</b></p> <p>Two studies contributed to this analysis; the lithium group showed greater improvement than placebo (MD −2.86, 95% CI −4.33 to −1.39; participants = 629; studies = 2; I<sup>2</sup> = 98%; <a href="./references#CD004048-fig-0036" title="">Analysis 1.33</a>). </p> </section> <section id="CD004048-sec-0145"> <p><b>Other efficacy results</b></p> <p>Several of our secondary outcomes were only reported by one study. Many of these did not provide statistical analysis or the means to do this ourselves. The following outcome was reported by <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> as showing a greater effect in the lithium group compared to placebo: </p> <p>Change in CGI‐BP severity of illness score (MD −2.00, 95% CI −2.02 to −1.98; participants = 316; studies = 1; <a href="./references#CD004048-fig-0037" title="">Analysis 1.34</a>). </p> <p>The following outcome did not find a significant difference between lithium and placebo:</p> <p>Change in CGI‐BP depression score (MD 0.00, 95% CI −0.02 to 0.02; participants = 316; studies = 1; <a href="./references#CD004048-fig-0037" title="">Analysis 1.34</a>). </p> </section> <section id="CD004048-sec-0146"> <p><b>Acceptability: withdrawal from the study due to lack of efficacy</b></p> <p>Participants treated with lithium were less likely to withdraw from the study due to lack of efficacy than those taking a placebo (OR 0.56, 95% CI 0.29 to 1.08; participants = 1243; studies = 6; I<sup>2</sup> = 60%; <a href="./references#CD004048-fig-0008" title="">Analysis 1.5</a>). It should be noted that the withdrawal rates between studies were quite variable. </p> </section> <section id="CD004048-sec-0147"> <p><b>Acceptability: withdrawal from the study due to adverse events</b></p> <p>There was no significant difference between the number of participants who withdrew for adverse events on lithium compared to placebo (OR 0.92, 95% CI 0.50 to 1.69; participants = 1158; studies = 6; I<sup>2</sup> = 50%; <a href="./references#CD004048-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD004048-sec-0148"> <p><b>Use of rescue medications</b></p> <p>Three studies looked at these outcomes; there was no significant difference between lithium and placebo for the use of: </p> <p> <ol id="CD004048-list-0025"> <li> <p>any allowed concomitant medication, including anxiolytics, benzodiazepines and z‐drugs (OR 0.90, 95% CI 0.52 to 1.57; participants = 479; studies = 2; I<sup>2</sup> = 40%; <a href="./references#CD004048-fig-0038" title="">Analysis 1.35</a>); </p> </li> <li> <p>use of sleep medications (OR 0.90, 95% CI 0.51 to 1.58; participants = 195; studies = 1; <a href="./references#CD004048-fig-0039" title="">Analysis 1.36</a>); </p> </li> <li> <p>use of anticholinergic medications (OR 1.39, 95% CI 0.73 to 2.62; participants = 520; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0040" title="">Analysis 1.37</a>). </p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD004048-sec-0149"> <h4 class="title">Lithium versus mood stabilisers</h4> <section id="CD004048-sec-0150"> <h5 class="title">Comparison 2: lithium versus valproate</h5> <p>Eight studies including 801 participants contributed data to this comparison (<a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a>; <a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a>; <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a>; <a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a>; <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a>; <a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a>; <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>; <a href="./references#CD004048-bbs2-0029" title="ShaftiSS , ShahveisiB . Comparison between lithium and valproate in the treatment of acute mania. Journal of Clinical Psychopharmacology2008;28(6):718‐20. ">Shafti 2008</a>). See also <a href="./full#CD004048-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD004048-sec-0151"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0152"> <p><b>Efficacy: response (categorical). YMRS/SADS‐C decrease by at least 50% by end of study</b></p> <p>Five studies (n = 607) contributed to the analysis: there was no significant difference between lithium and valproate/divalproex in terms of efficacy using this outcome measure (OR 1.22, 95% CI 0.87 to 1.70; participants = 607; studies = 5; I<sup>2</sup> = 22%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0043" title="">Analysis 2.1</a>). When we considered only adults (by removing <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>), there was no significant difference in the results (OR 1.30, 95% CI 0.84 to 1.99; participants = 579; studies = 4; I<sup>2</sup> = 25%; <a href="./references#CD004048-fig-0044" title="">Analysis 2.2</a>). </p> </section> <section id="CD004048-sec-0153"> <p><b>Efficacy: response (continuous). Change in YMRS (ITT‐LOCF) from baseline to end of study (12 weeks)</b></p> <p>There was no significant difference in the mean change in YMRS scores between the lithium and valproate/divalproex groups by the end of the study (MD 0.43, 95% CI −0.36 to 1.23; participants = 398; studies = 5; I<sup>2</sup> = 26%; low‐certainty evidence; <a href="./references#CD004048-fig-0045" title="">Analysis 2.3</a>). </p> </section> <section id="CD004048-sec-0154"> <p><b>Efficacy: response (continuous). Change in CGI‐BP from baseline to the end of the study (3 weeks)</b></p> <p>Two studies (n = 287) contributed to the comparison; there was no significant difference in change in CGI scores between the groups (MD −0.02, 95% CI −0.29 to 0.25; participants = 287; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0046" title="">Analysis 2.4</a>). </p> </section> <section id="CD004048-sec-0155"> <p><b>Efficacy: remission (categorical). YMRS 12 or less and a reduction of at least 2 points on the CGI‐BP at 12 weeks</b></p> <p>This outcome is a more restrictive definition of remission than outlined in our predetermined outcomes; it was the definition of remission used by the study authors. Only one study reported this outcome (<a href="./references#CD004048-fig-0049" title="">Analysis 2.7</a>). Under this definition, fewer lithium‐treated participants achieved remission compared to valproate/ divalproex (OR 0.57, 95% CI 0.34 to 0.96; participants = 257; studies = 1, moderate‐certainty evidence). </p> </section> <section id="CD004048-sec-0156"> <p><b>Acceptability: adverse events</b></p> <p> <ol id="CD004048-list-0026"> <li> <p>Tremor: participants taking lithium were more likely to experience a tremor than those on valproate or divalproex (OR 10.51, 95% CI 1.96 to 56.48; participants = 449; studies = 2; I<sup>2</sup> = 0%; high‐certainty evidence). It should be noted that the absolute number of events was fairly small, so the confidence intervals on both studies contributing data were very wide (<a href="./references#CD004048-fig-0052" title="">Analysis 2.10</a>). </p> </li> <li> <p>Headache: headache was more commonly reported by the participants in the lithium group compared to valproate or divalproex (OR 2.64, 95% CI 1.52 to 4.59; participants = 286; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0050" title="">Analysis 2.8</a>). </p> </li> <li> <p>Somnolence: participants taking sodium valproate/divalproex were more likely than those on lithium to report somnolence (OR 0.47, 95% CI 0.29 to 0.76; participants = 575; studies = 4; I<sup>2</sup> = 27%; high‐certainty evidence; <a href="./references#CD004048-fig-0051" title="">Analysis 2.9</a>). </p> </li> <li> <p>Other adverse events: we found no significant difference between lithium and valproate/ divalproex for the following adverse events (P &gt; 0.05 for each): </p> <ol id="CD004048-list-0027"> <li> <p>any adverse effect (OR 0.99, 95% CI 0.62 to 1.57; participants = 298; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0061" title="">Analysis 2.19</a>); </p> </li> <li> <p>diarrhoea (OR 1.09, 95% CI 0.59 to 2.01; participants = 583; studies = 4; I<sup>2</sup> = 46%; <a href="./references#CD004048-fig-0063" title="">Analysis 2.21</a>); </p> </li> <li> <p>nausea (OR 1.53, 95% CI 0.97 to 2.40; participants = 583; studies = 4; I<sup>2</sup> = 0%; high‐certainty evidence; <a href="./references#CD004048-fig-0064" title="">Analysis 2.22</a>). </p> </li> <li> <p>There was no significant difference between lithium and valproate for a series of less common or important adverse events, or both; data shown in <a href="./references#CD004048-fig-0253" title="">Analysis 17.1</a> onwards. </p> </li> </ol> </li> </ol> </p> </section> <section id="CD004048-sec-0157"> <p><b>Acceptability: withdrawals</b></p> <p>There was no significant difference in withdrawal rates between those participants taking valproate and those on lithium (OR 1.20, 95% CI 0.86 to 1.69; participants = 629; studies = 5; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0053" title="">Analysis 2.11</a>). </p> </section> </section> <section id="CD004048-sec-0158"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0159"> <p><b>Outcomes for which a single study reported data</b></p> <p>Only the first of these single studies reported a significant difference between lithium and valproate/divalproex. </p> <p> <ol id="CD004048-list-0028"> <li> <p>SADS‐C mania score change from baseline (MD −16.90, 95% CI −28.85 to −4.95; participants = 27; studies = 1; <a href="./references#CD004048-fig-0055" title="">Analysis 2.13</a>). </p> </li> <li> <p>Change in MADRS (ITT‐LOCF) from baseline to end of study (12 weeks) (MD 0.40, 95% CI −0.73 to 1.53; participants = 257; studies = 1; <a href="./references#CD004048-fig-0047" title="">Analysis 2.5</a>). </p> </li> <li> <p>SADS‐C depression score (MD −3.40, 95% CI −9.62 to 2.82; participants = 27; studies = 1; <a href="./references#CD004048-fig-0056" title="">Analysis 2.14</a>). </p> </li> <li> <p>Mean change in MADRS (MD 0.20, 95% CI −0.83 to 1.23; participants = 257; studies = 1; <a href="./references#CD004048-fig-0054" title="">Analysis 2.12</a>). </p> </li> <li> <p>GAS post‐treatment score (MD 9.30, 95% CI −4.18 to 22.78; participants = 27; studies = 1; <a href="./references#CD004048-fig-0057" title="">Analysis 2.15</a>). </p> </li> <li> <p>Mean CGI‐BP score at end of study (MD 0.20, 95% CI −0.13 to 0.53; participants = 257; studies = 1; <a href="./references#CD004048-fig-0058" title="">Analysis 2.16</a>). </p> </li> </ol> </p> </section> <section id="CD004048-sec-0160"> <p><b>Use of rescue medications</b></p> <p><a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a> and <a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a> compared the use of various other psychotropic medications, unfortunately we could not combine any of these for meta‐analysis due to <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a> providing only categorical data and <a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a> providing only continuous data. </p> <p><a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a> found that there was no significant difference in the amount of either lorazepam (MD 1.25, 95% CI 0.28 to 5.59; participants = 39; studies = 1; <a href="./references#CD004048-fig-0065" title="">Analysis 2.23</a>) or chloral hydrate (MD 1.50, 95% CI −2.76 to 5.76; participants = 27; studies = 1; <a href="./references#CD004048-fig-0066" title="">Analysis 2.24</a>) used by either lithium or valproate/divalproex; <a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a> also found no significant difference in use of lorazepam between the two groups (MD −0.70, 95% CI −5.04 to 3.64; participants = 27; studies = 1; <a href="./references#CD004048-fig-0067" title="">Analysis 2.25</a>). </p> <p>Similarly, <a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a> also found no significant difference in the categorical use of anxiolytics (OR 1.24, 95% CI 0.75 to 2.05; participants = 257; studies = 1; <a href="./references#CD004048-fig-0068" title="">Analysis 2.26</a>), or antidepressants (OR 2.17, 95% CI 0.55 to 8.58; participants = 257; studies = 1; <a href="./references#CD004048-fig-0069" title="">Analysis 2.27</a>), between lithium and valproate/divalproex treated participants). </p> </section> </section> </section> <section id="CD004048-sec-0161"> <h5 class="title">Comparison 3: lithium versus lamotrigine</h5> <p>We found three studies, with 304 participants.</p> <section id="CD004048-sec-0162"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0163"> <p><b>Efficacy (continuous): change in BPRS from baseline to end of study</b></p> <p>There was no significant difference in the change in BPRS score in the lithium compared to the lamotrigine group (MD −1.82, 95% CI −3.78 to 0.14; participants = 301; studies = 2; I<sup>2</sup> = 0%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0070" title="">Analysis 3.1</a>). <a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> did not report SDs, but we used the method recommended by <a href="./references#CD004048-bbs2-0091" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7‐10. ">Furukawa 2006</a> to impute them. Inclusion or exclusion of the data from <a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> had minimal effects on the result estimate. </p> </section> <section id="CD004048-sec-0164"> <p><b>Efficacy (continuous): change in MRS‐16 item from SAD‐C from baseline to end of study</b></p> <p>There was a trend towards lithium being more efficacious than lamotrigine (MD −3.74, 95% CI −7.55 to 0.08; participants = 271; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0071" title="">Analysis 3.2</a>). It may be, however, that the change in scores is too small to make a clinically relevant difference </p> </section> <section id="CD004048-sec-0165"> <p><b>Acceptability: adverse events</b></p> <p>There was no significant difference in the frequency of the following adverse events between the lithium and lamotrigine groups. </p> <p> <ol id="CD004048-list-0029"> <li> <p>Vomiting (OR 1.77, 95% CI 0.75 to 4.18; participants = 272; studies = 2; I<sup>2</sup> = 46%; <a href="./references#CD004048-fig-0079" title="">Analysis 3.10</a>) </p> </li> <li> <p>Worsening of manic symptoms (OR 0.63, 95% CI 0.16 to 2.46; participants = 272; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0080" title="">Analysis 3.11</a>) </p> </li> <li> <p>Diarrhoea (OR 3.83, 95% CI 0.92 to 15.92; participants = 272; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0081" title="">Analysis 3.12</a>) </p> </li> <li> <p>Headache (OR 0.96, 95% CI 0.45 to 2.02; participants = 272; studies = 2; I<sup>2</sup> = 35%; <a href="./references#CD004048-fig-0082" title="">Analysis 3.13</a>) </p> </li> <li> <p>Tremor (OR 1.28, 95% CI 0.48 to 3.41; participants = 272; studies = 2; I<sup>2</sup> = 30%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0083" title="">Analysis 3.14</a>) </p> </li> <li> <p>Rash (OR 0.58, 95% CI 0.17 to 1.97; participants = 272; studies = 2; I<sup>2</sup> = 35%; <a href="./references#CD004048-fig-0084" title="">Analysis 3.15</a>) </p> </li> <li> <p>Somnolence (OR 1.14, 95% CI 0.34 to 3.85; participants = 272; studies = 2; I<sup>2</sup> = 0%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0085" title="">Analysis 3.16</a>) </p> </li> <li> <p>Any side effect (OR 0.89, 95% CI 0.47 to 1.70; participants = 272; studies = 2; I<sup>2</sup> = 31%; <a href="./references#CD004048-fig-0086" title="">Analysis 3.17</a>) </p> </li> <li> <p>Constipation (OR 0.78, 95% CI 0.18 to 3.40; participants = 272; studies = 2; I<sup>2</sup> = 72%; <a href="./references#CD004048-fig-0088" title="">Analysis 3.19</a>) </p> </li> <li> <p>Accidental injury (OR 1.32, 95% CI 0.43 to 4.08; participants = 272; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0089" title="">Analysis 3.20</a>) </p> </li> <li> <p>Pain (OR 0.34, 95% CI 0.07 to 1.65; participants = 272; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0090" title="">Analysis 3.21</a>) </p> </li> </ol> </p> <p>A large number of adverse events were only reported by one study; these are shown in data analysis <a href="./references#CD004048-fig-0306" title="">Analysis 19.1</a> onwards. </p> </section> <section id="CD004048-sec-0166"> <p><b>Acceptability: total withdrawal from the study</b></p> <p>Three studies reported total withdrawal data. They did not find any significant difference between lithium and lamotrigine, but there was high heterogeneity in the data (OR 0.80, 95% CI 0.50 to 1.29; participants = 303; studies = 3; I<sup>2</sup> = 82%; low‐certainty evidence; <a href="./references#CD004048-fig-0074" title="">Analysis 3.5</a>). </p> </section> </section> <section id="CD004048-sec-0167"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0168"> <p><b>Efficacy (continuous): change in CGI from baseline to tend of study</b></p> <p>There was no significant difference in the change in CGI severity score in the lithium compared to the lamotrigine group (MD −0.35, 95% CI −1.24 to 0.53; participants = 304; studies = 2; I<sup>2</sup> = 83%; <a href="./references#CD004048-fig-0072" title="">Analysis 3.3</a>). There was considerable heterogeneity between these two studies. <a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> also reported this outcome, but could not be included in the meta‐analysis as it was not possible to impute SDs. They reported no significant difference between the groups. </p> </section> <section id="CD004048-sec-0169"> <p><b>Efficacy (continuous): change in GAS from baseline to end of study</b></p> <p>Two studies contributed to the analysis. There was no significant difference in the change in GAS scores between groups (MD 4.36, 95% CI −0.65 to 9.37; participants = 270; studies = 2; I<sup>2</sup> = 47%; <a href="./references#CD004048-fig-0073" title="">Analysis 3.4</a>). </p> </section> <section id="CD004048-sec-0170"> <p><b>Efficacy (continuous): mean change in HAMD‐31 score from baseline to end of study</b></p> <p>There was no evidence that lithium caused the emergence of more depressive symptoms, as scored by the HAMD‐31, compared to lamotrigine (MD −1.74, 95% CI −3.72 to 0.24; participants = 271; studies = 2; I<sup>2</sup> = 26%). In both groups, and across the two contributing studies, treatment actually reduced depressive symptoms by a small amount (<a href="./references#CD004048-fig-0075" title="">Analysis 3.6</a>). </p> </section> <section id="CD004048-sec-0171"> <p><b>Efficacy results reported by only one study</b></p> <p>Efficacy results reported by only one study showed no significant differences:</p> <p> <ol id="CD004048-list-0030"> <li> <p>MRS reduction by at least 50% at end of study (OR 1.31, 95% CI 0.31 to 5.58; participants = 30; studies = 1; <a href="./references#CD004048-fig-0077" title="">Analysis 3.8</a>); </p> </li> <li> <p>BPRS reduction by at least 50% at end of study (OR 0.42, 95% CI 0.09 to 1.92; participants = 30; studies = 1; <a href="./references#CD004048-fig-0076" title="">Analysis 3.7</a>). </p> </li> </ol> </p> </section> <section id="CD004048-sec-0172"> <p><b>Acceptability: withdrawal due to lack of efficacy/adverse events</b></p> <p>There was no significant difference in withdrawal due to lack of efficacy (OR 1.06, 95% CI 0.48 to 2.32; participants = 273; studies = 2; I<sup>2</sup> = 20%) or adverse events (OR 0.93, 95% CI 0.42 to 2.06; participants = 273; studies = 2; I<sup>2</sup> = 41%) between the lithium and lamotrigine treatment groups (<a href="./references#CD004048-fig-0074" title="">Analysis 3.5</a>). </p> </section> <section id="CD004048-sec-0173"> <p><b>Use of rescue medications</b></p> <p>There were no combinable outcomes for this data. <a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a> found that the lithium group used significantly lower doses of concomitant psychotropic medications (these were not further identified) than the lamotrigine group (OR 0.25, 95% CI 0.07 to 0.95; participants = 151; studies = 1; <a href="./references#CD004048-fig-0091" title="">Analysis 3.22</a>). <a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> reported no significant difference between the mean dose of lorazepam used by their lithium versus lamotrigine participants, but they did not provide SDs for this data (<a href="./references#CD004048-fig-0092" title="">Analysis 3.23</a>). </p> </section> </section> </section> <section id="CD004048-sec-0174"> <h5 class="title">Comparison 4: lithium versus carbamazepine</h5> <p>Five studies included 123 participants in this comparison.</p> <section id="CD004048-sec-0175"> <h6 class="title">Primary outcomes</h6> <p>Five studies compared carbamazepine to lithium, of which one (<a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a>), only reported data on adverse events. The studies did not report the majority of primary outcomes. There were no adverse events reported by more than one study. <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> reported that significantly more participants experienced nausea, sedation, a rash or dizziness with carbamazepine treatment than with lithium. They did not give any statistics in their publication (<a href="./references#CD004048-fig-0104" title="">Analysis 4.12</a>; <a href="./references#CD004048-fig-0105" title="">Analysis 4.13</a>; <a href="./references#CD004048-fig-0106" title="">Analysis 4.14</a>; <a href="./references#CD004048-fig-0107" title="">Analysis 4.15</a>). </p> <section id="CD004048-sec-0176"> <p><b>Efficacy: response (continuous). Change in YMRS/BPRS from baseline to end of study</b></p> <p>Three studies contributed to this outcome. We found no significant difference in the improvement in scale scores between the lithium and carbamazepine groups (SMD 0.21, 95% CI −0.18 to 0.60; participants = 102; studies = 3; I<sup>2</sup> = 0%; very low‐certainty evidence; <a href="./references#CD004048-fig-0093" title="">Analysis 4.1</a>). The fourth study, <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a>, reported data from the Bech‐Rafaelsen mania scale, but only in graph format, and with no raw data available, so we did not combine this within the meta‐analysis. They reported that there was no significant difference in the reduction in scores between their two groups. </p> </section> <section id="CD004048-sec-0177"> <p><b>Acceptability: withdrawals</b></p> <p><a href="./references#CD004048-bbs2-0022" title="LererB , MooreN , MeyendorffE , ChoSR , GershonS . Carbamazepine versus lithium in mania: a double‐blind study. Journal of Clinical Psychiatry1987;48:89‐93. [MEDLINE: 3546274] ">Lerer 1987</a> reported that there was no significant difference in the number of withdrawals between the lithium and carbamazepine groups (OR 0.20, 95% CI 0.02 to 1.94; participants = 34; studies = 1, low‐certainty evidence; <a href="./references#CD004048-fig-0096" title="">Analysis 4.4</a>). </p> </section> </section> </section> <section id="CD004048-sec-0178"> <h5 class="title">Secondary outcomes</h5> <section id="CD004048-sec-0179"> <h6 class="title">Efficacy: response (continuous). CGI change from baseline to end of study</h6> <p>There was no significant difference in the change in CGI score in the lithium compared to the carbamazepine group (MD 0.68, 95% CI −0.40 to 1.76; participants = 76; studies = 2; I<sup>2</sup> = 88%; low‐certainty evidence; <a href="./references#CD004048-fig-0094" title="">Analysis 4.2</a>). </p> <section id="CD004048-sec-0180"> <p><b>Proxy measure of efficacy: mean length of treatment in weeks</b></p> <p>Although not a pre‐stated outcome, three studies reported the mean length of treatment in weeks (<a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>; <a href="./references#CD004048-bbs2-0022" title="LererB , MooreN , MeyendorffE , ChoSR , GershonS . Carbamazepine versus lithium in mania: a double‐blind study. Journal of Clinical Psychiatry1987;48:89‐93. [MEDLINE: 3546274] ">Lerer 1987</a>; <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a>). In each of these studies the participants were admitted to hospital and treated as inpatients. Unfortunately it was not possible to meta‐analyse these data due to lack of SDs. All three studies reported no significant difference in the treatment length between participants on lithium versus carbamazepine (<a href="./references#CD004048-fig-0095" title="">Analysis 4.3</a>). </p> </section> <section id="CD004048-sec-0181"> <p><b>Acceptability: change in adverse events scores from baseline to end of study (day 28)</b></p> <p><a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a> used a side‐effect score to explore the relative adverse events of carbamazepine and lithium. They reported that there was no significant difference between treatments in the overall side‐effect score changes across the study (MD 0.90, 95% CI −0.80 to 2.60; participants = 27; studies = 1) They did, however, note that for all participants who experienced any side effects, they tended to decrease in the second week of treatment and had resolved by the end of the fourth week (<a href="./references#CD004048-fig-0097" title="">Analysis 4.5</a>). </p> </section> <section id="CD004048-sec-0182"> <p><b>Acceptability: withdrawals due to adverse events</b></p> <p> <ol id="CD004048-list-0031"> <li> <p>Rash: <a href="./references#CD004048-bbs2-0033" title="SmallJG , KlapperMH , MilsteinV , KellamsJJ , MillerMJ , MarhenkeJD , et al. Carbamazepine compared with lithium in the treatment of mania. Archives of General Psychiatry1991;48:915‐21. ">Small 1991</a> did not find a difference in the numbers of participants who experienced a rash in the lithium compared to carbamazepine arms (OR 0.29, 95% CI 0.01 to 7.70; participants = 27; studies = 1; <a href="./references#CD004048-fig-0106" title="">Analysis 4.14</a>). </p> </li> </ol> </p> </section> </section> </section> <section id="CD004048-sec-0183"> <h5 class="title">Comparison 5: lithium versus quetiapine</h5> <p>We found two studies with 359 participants for this comparison.</p> <section id="CD004048-sec-0184"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0185"> <p><b>Efficacy: response (categorical). YMRS decrease by at least 50% from baseline to end of study (day 21)</b></p> <p>There was no significant difference in the number of participants who responded to treatment between the lithium and quetiapine groups (OR 0.66, 95% CI 0.28 to 1.55; participants = 335; studies = 2; I<sup>2</sup> = 71%; low‐certainty evidence; <a href="./references#CD004048-fig-0111" title="">Analysis 5.1</a>). </p> </section> <section id="CD004048-sec-0186"> <p><b>Efficacy (continuous): mean change in YMRS score from baseline to the end of the study (day 21)</b></p> <p>No meta‐analysis was possible for this outcome. Two studies reported a mean change in YMRS, but only one provided SDs (<a href="./references#CD004048-fig-0112" title="">Analysis 5.2</a>). We were unable to impute the SDs for <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>. Both studies reported that there was no significant difference between the change in YMRS scores between groups. Both studies showed a considerable improvement in manic symptoms (about 20 points on YMRS) with both lithium or quetiapine therapy. </p> </section> <section id="CD004048-sec-0187"> <p><b>Efficacy (categorical): remission. Number of participants who achieved YMRS 12 or less by end of study</b></p> <p>Neither lithium nor quetiapine was shown to be more effective in achieving remission than the other treatment (OR 0.64, 95% CI 0.26 to 1.57; participants = 359; studies = 2; I<sup>2</sup> = 77%; low‐certainty evidence; <a href="./references#CD004048-fig-0113" title="">Analysis 5.3</a>). </p> </section> <section id="CD004048-sec-0188"> <p><b>Acceptability: adverse events</b></p> <p> <ol id="CD004048-list-0032"> <li> <p>Dizziness: participants treated with lithium were less likely to report dizziness than those treated with quetiapine (OR 0.47, 95% CI 0.23 to 0.97; participants = 360; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0115" title="">Analysis 5.5</a>). </p> </li> <li> <p>Diarrhoea: there was no significant difference in the numbers of participants reporting diarrhoea in the lithium compared to the quetiapine group (OR 0.79, 95% CI 0.34 to 1.86; participants = 360; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0116" title="">Analysis 5.6</a>). </p> </li> <li> <p>Weight gain: both <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a> and <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a> reported the mean change in weight (kg) across the study. Neither study provided SDs. <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a> reported a greater weight gain in the quetiapine group compared to lithium (2.6 kg versus 0.7 kg), but there was no statistical analysis. <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a> reported a significantly greater increase in weight in the quetiapine group compared to lithium (1.45 kg versus 0.25 kg); again, this was not accompanied by a P value (<a href="./references#CD004048-fig-0117" title="">Analysis 5.7</a>). </p> </li> <li> <p>Other adverse events: the majority of adverse events showed no significant difference between those treated with lithium compared to quetiapine. These are shown in <a href="./references#CD004048-fig-0267" title="">Analysis 18.1</a> onwards. </p> </li> </ol> </p> </section> <section id="CD004048-sec-0189"> <p><b>Acceptability: total withdrawal from the study</b></p> <p>There was no significant difference in the number of withdrawals in the lithium compared to the quetiapine group (OR 1.38, 95% CI 0.83 to 2.28; participants = 359; studies = 2; I<sup>2</sup> = 82%; very low‐certainty evidence; <a href="./references#CD004048-fig-0118" title="">Analysis 5.8</a>). </p> </section> </section> <section id="CD004048-sec-0190"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0191"> <p><b>Efficacy (continuous): MADRS mean change from baseline to end of study (day 21)</b></p> <p>Two studies reported this outcome; no meta‐analysis was possible due to a lack of SDs, which we could not impute (<a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a>). Both studies reported no significant differences between the reduction in depression scores on the MADRS between lithium and quetiapine groups (<a href="./references#CD004048-fig-0114" title="">Analysis 5.4</a>). </p> </section> <section id="CD004048-sec-0192"> <p><b>Efficacy (continuous): PANSS score change from baseline to end of study</b></p> <p>Only <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a> reported this outcome; there was no significant difference between lithium and quetiapine (MD −3.20, 95% CI −6.71 to 0.31; participants = 154; studies = 1; <a href="./references#CD004048-fig-0119" title="">Analysis 5.9</a>). </p> </section> <section id="CD004048-sec-0193"> <p><b>Acceptability: withdrawal due to lack of efficacy/withdrawal due to adverse events</b></p> <p>Only one study reported each of these outcomes (<a href="./references#CD004048-fig-0118" title="">Analysis 5.8</a>): there was no significant difference between lithium and quetiapine (lack of efficacy: <a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a>; adverse events: <a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a>). </p> </section> <section id="CD004048-sec-0194"> <p><b>Use of rescue medications</b></p> <p>Two studies compared the use of rescue medications. Meta‐analysis showed no difference between sleep medications (benzodiazepines or z‐drugs, (OR 1.21, 95% CI 0.78 to 1.87; participants = 359; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0121" title="">Analysis 5.11</a>), nor anticholinergics (OR 1.19, 95% CI 0.61 to 2.30; participants = 359; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0123" title="">Analysis 5.13</a>), between lithium and quetiapine groups. </p> </section> </section> </section> <section id="CD004048-sec-0195"> <h5 class="title">Comparison 6: lithium versus olanzapine</h5> <p>We found three studies with 210 participants for this comparison.</p> <section id="CD004048-sec-0196"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0197"> <p><b>Efficacy: response (categorical). MSRS/YMRS at least 50% reduction from baseline to end of study</b></p> <p>Lithium was less likely to improve manic symptoms than olanzapine (OR 0.44, 95% CI 0.20 to 0.94; participants = 180; studies = 2; I<sup>2</sup> = 0%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0124" title="">Analysis 6.1</a>). </p> </section> <section id="CD004048-sec-0198"> <p><b>Efficacy (categorical): remission. YMRS 12 or less at the end of the study</b></p> <p>Only <a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a> reported this outcome. They did not find a difference between lithium and olanzapine at inducing remission (OR (non‐event) 2.00, 95% CI 0.89 to 4.46; participants = 140; studies = 1; <a href="./references#CD004048-fig-0127" title="">Analysis 6.4</a>). </p> </section> <section id="CD004048-sec-0199"> <p><b>Acceptability: adverse events</b></p> <p> <ol id="CD004048-list-0033"> <li> <p>Tremor: significantly more participants in the lithium arm reported a tremor than those taking olanzapine (OR 0.34, 95% CI 0.06 to 1.99; participants = 46; studies = 1). </p> </li> <li> <p>Other adverse events: only <a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a> reported data on other adverse events (from <a href="./references#CD004048-fig-0328" title="">Analysis 20.1</a> onwards). They reported no significant difference between olanzapine and lithium for nausea, EPSEs, constipation, somnolence, gastrointestinal disorders, dizziness, cough, tachycardia, fatigue, headache, tonsillitis, upper respiratory tract infection, dry mouth, haemorrhoids, metabolic disorders, hepatic disorders, high cholesterol or high glucose. They did find a significantly greater weight gain in the participants treated with olanzapine: weight gain more than 7% of baseline at end of study (<a href="./references#CD004048-fig-0355" title="">Analysis 20.28</a>). </p> </li> </ol> </p> </section> <section id="CD004048-sec-0200"> <p><b>Acceptability: total withdrawal</b></p> <p>Participants treated with lithium were more likely to withdraw from the study than those on olanzapine (OR 2.60, 95% CI 1.13 to 5.99; participants = 210; studies = 3; I<sup>2</sup> = 0%; low‐certainty evidence; <a href="./references#CD004048-fig-0128" title="">Analysis 6.5</a>). </p> </section> </section> <section id="CD004048-sec-0201"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0202"> <p><b>Efficacy: response (continuous). CGI severity score at the end of the study</b></p> <p>Three studies contributed data to this analysis (<a href="./references#CD004048-fig-0126" title="">Analysis 6.3</a>); all reported that there were no significant differences in CGI score between groups by the end of the study (MD 0.35, 95% CI −0.04 to 0.74; participants = 210; studies = 3; I<sup>2</sup> = 87%; low‐certainty evidence). </p> </section> <section id="CD004048-sec-0203"> <p><b>Efficacy (continuous): change in CGI score from baseline to end of study</b></p> <p>Lithium caused a greater reduction in CGI score than olanzapine but this was objectively a small effect (MD 0.58, 95% CI 0.52 to 0.64; participants = 170; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0125" title="">Analysis 6.2</a>). </p> <p>Only <a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a> (n = 140) reported any other secondary outcomes; they found olanzapine to be favourable (by a small amount in each case) for the following outcomes: </p> <p> <ol id="CD004048-list-0034"> <li> <p>change in BPRS from baseline to end of study (MD 2.12, 95% CI 1.87 to 2.37: <a href="./references#CD004048-fig-0131" title="">Analysis 6.8</a>); </p> </li> <li> <p>change in CGI‐BP depression score (MD 0.03, 95% CI 0.01 to 0.05; <a href="./references#CD004048-fig-0132" title="">Analysis 6.9</a>); </p> </li> <li> <p>change in MADRS from baseline to end of study (MD 0.75, 95% CI 0.60 to 0.90; <a href="./references#CD004048-fig-0133" title="">Analysis 6.10</a>). </p> </li> </ol> </p> </section> <section id="CD004048-sec-0204"> <p><b>Acceptability: withdrawals due to lack of efficacy/adverse events</b></p> <p>Only <a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a> reported these withdrawal figures; they found no significant difference between lithium and olanzapine for lack of efficacy (OR 1.67, 95% CI 0.38 to 7.26; participants = 140; studies = 1; <a href="./references#CD004048-fig-0129" title="">Analysis 6.6</a>), and adverse events (OR 2.96, 95% CI 0.12 to 73.85; participants = 140; studies = 1; <a href="./references#CD004048-fig-0130" title="">Analysis 6.7</a>). </p> </section> <section id="CD004048-sec-0205"> <p><b>Use of rescue medications</b></p> <p>Regarding rescue medications (benzodiazepines), there was no significant difference in the use between participants taking lithium or olanzapine (OR 1.66, 95% CI 0.63 to 4.35; participants = 140; studies = 1; <a href="./references#CD004048-fig-0134" title="">Analysis 6.11</a>). </p> </section> </section> </section> </section> <section id="CD004048-sec-0206"> <h4 class="title">Lithium versus antipsychotics</h4> <section id="CD004048-sec-0207"> <h5 class="title">Comparison 7: lithium versus chlorpromazine</h5> <p>Four studies with 313 participants met the inclusion criteria in this category (<a href="./references#CD004048-bbs2-0026" title="PlatmanSR . A comparison of lithium carbonate and chlorpromazine in mania. American Journal of Psychiatry1970;127:351‐3. ">Platman 1970</a>; <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a>; <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a>; <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a>). They were all published in the 1970s and used variable outcome measures; this limited the amount of meta‐analysis possible. </p> <section id="CD004048-sec-0208"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0209"> <p><b>Efficacy (continuous): change in BPRS score from baseline to end of study</b></p> <p>Two studies reported this outcome (<a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a>; <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a>). There was no significant difference in efficacy between lithium and chlorpromazine (MD −0.59, 95% CI −1.75 to 0.57; participants = 284; studies = 2; I<sup>2</sup> = 90%; low‐certainty evidence; <a href="./references#CD004048-fig-0138" title="">Analysis 7.1</a>). </p> </section> <section id="CD004048-sec-0210"> <p><b>Efficacy (continuous): Psychiatric Evaluation Scale at end of study</b></p> <p><a href="./references#CD004048-bbs2-0026" title="PlatmanSR . A comparison of lithium carbonate and chlorpromazine in mania. American Journal of Psychiatry1970;127:351‐3. ">Platman 1970</a> reported the Psychiatric Evaluation Scale as their only efficacy outcome and did not provide SDs or any statistical analysis. They found a score of 2/6 in the lithium group and 2.7/6 in the chlorpromazine group (n = 23). The small size and lack of analysis makes this result hard to place in context (<a href="./references#CD004048-fig-0139" title="">Analysis 7.2</a>). </p> </section> <section id="CD004048-sec-0211"> <p><b>Efficacy: response (categorical): defined by the study authors at 21 days</b></p> <p><a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> used a categorical outcome measure of efficacy, with a clinician scoring presence (3 degrees) or absence of euphoria, expansiveness, flight or ideas, pressured speech, activity and sleep disturbance. They found that chlorpromazine was more effective at treating manic symptoms than lithium (OR 4.00, 95% CI 0.25 to 63.95; participants = 12; studies = 1). However, this was an extremely small study (<a href="./references#CD004048-fig-0140" title="">Analysis 7.3</a>). Note: this was a quasi‐randomised study. </p> </section> <section id="CD004048-sec-0212"> <p><b>Acceptability: adverse events</b></p> <p>There were no outcomes for which it was possible to perform meta‐analysis. <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a> reported an array of common adverse events, but only provided comparative analysis for the overall number of participants who experienced any "serious side effect". They reported no significant difference in the numbers of participants on lithium or chlorpromazine: 31% versus 18%; n = 255, P = 0.1 (Chi<sup>2</sup> analysis). <a href="./references#CD004048-bbs2-0026" title="PlatmanSR . A comparison of lithium carbonate and chlorpromazine in mania. American Journal of Psychiatry1970;127:351‐3. ">Platman 1970</a>, <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a> and <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> provided only narrative comments about common side effects experienced by participants. </p> </section> <section id="CD004048-sec-0213"> <p><b>Acceptability: total withdrawals</b></p> <p>There were no more total withdrawals from the study in the lithium group compared to the chlorpromazine group (OR 1.75, 95% CI 0.92 to 3.31; participants = 262; studies = 2; I<sup>2</sup> = 0%; very ow certainty evidence; <a href="./references#CD004048-fig-0141" title="">Analysis 7.4</a>). There was no change to the result removing <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a>, which was quasi‐randomised. </p> </section> </section> </section> <section id="CD004048-sec-0214"> <h5 class="title">Comparison 8: lithium versus haloperidol</h5> <p>Four studies investigated treatment of acute mania with lithium or haloperidol; three of these examined efficacy (<a href="./references#CD004048-bbs2-0012" title="GarfinkelPE , StancerHC , PersadE . A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affective Disorders1980;2:279‐88. [MEDLINE: 6450787] ">Garfinkel 1980</a>; <a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a>; <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a>; n = 80) and one examined adverse events (<a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a>). </p> <section id="CD004048-sec-0215"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0216"> <p><b>Efficacy (continuous): change in BPRS score from baseline to end of study</b></p> <p>Three studies reported efficacy data (<a href="./references#CD004048-fig-0142" title="">Analysis 8.1</a>); there was no significant difference found between lithium or haloperidol (MD −2.40, 95% CI −6.31 to 1.50; participants = 80; studies = 3; I<sup>2</sup> = 95%; low‐certainty evidence). We investigated heterogeneity by removing <a href="./references#CD004048-bbs2-0012" title="GarfinkelPE , StancerHC , PersadE . A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affective Disorders1980;2:279‐88. [MEDLINE: 6450787] ">Garfinkel 1980</a>, a result outlier, but the heterogeneity remained high and the result did not change. The long timescale over which these three studies were published (1975 to 1998) may be a cause of unknown methodological differences. </p> </section> <section id="CD004048-sec-0217"> <p><b>Acceptability: adverse events. Changes in side‐effect scores from baseline to day 28</b></p> <p><a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a> used a side‐effect score to explore the relative adverse events of haloperidol and lithium. They reported that there was no significant difference between treatments in the overall side‐effect score changes across the study (MD −0.20, 95% CI −2.05 to 1.65; participants = 28; studies = 1; <a href="./references#CD004048-fig-0144" title="">Analysis 8.3</a>). </p> </section> <section id="CD004048-sec-0218"> <p><b>Acceptability: total withdrawal</b></p> <p>Only <a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a> reported withdrawal data; they reported no significant difference between the lithium and haloperidol groups, but this was a very small study (OR 0.29, 95% CI 0.03 to 3.12; participants = 30; very low‐certainty evidence; <a href="./references#CD004048-fig-0145" title="">Analysis 8.4</a>). </p> </section> </section> <section id="CD004048-sec-0219"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0220"> <p><b>Efficacy (continuous): change in CGI score from baseline to end of study</b></p> <p>Two studies reported this outcome (<a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a>; <a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a>), but we could not carry out meta‐analysis as neither study provided SDs or the data to calculate them. Both studies reported a reduction in scores for both lithium and haloperidol but that this was not significantly different between groups (<a href="./references#CD004048-fig-0143" title="">Analysis 8.2</a>). </p> </section> <section id="CD004048-sec-0221"> <p><b>Use of rescue medications</b></p> <p>Only <a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a> reported the use of rescue medications. They did not find any significant difference between the use of either orphenadrine (OR 0.05, 95% CI 0.00 to 0.94; participants = 30; <a href="./references#CD004048-fig-0146" title="">Analysis 8.5</a>), or lorazepam between the lithium and haloperidol groups. They did not provide any SDs for the lorazepam data (<a href="./references#CD004048-fig-0147" title="">Analysis 8.6</a>). </p> </section> </section> </section> <section id="CD004048-sec-0222"> <h5 class="title">Comparison 9: lithium versus zuclopenthixol</h5> <p>Only <a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a> fitted the inclusion criteria; this was a small study with only 28 participants. </p> <section id="CD004048-sec-0223"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0224"> <p><b>Efficacy: response (categorical). Reduction of at least 50% in Bech‐Rafaelsen Mania Scale by end of study</b></p> <p><a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a> found no significant difference between lithium and zuclopenthixol (OR 1.33, 95% CI 0.30 to 5.91; participants = 28; studies = 1, very‐low‐certainty evidence; <a href="./references#CD004048-fig-0148" title="">Analysis 9.1</a>). </p> </section> <section id="CD004048-sec-0225"> <p><b>Acceptability: adverse events</b></p> <p><a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a> divided adverse events into 'neurological', 'psychological' and 'autonomic'. They found no significant difference between lithium and zuclopenthixol for the psychological or autonomic categories. Zuclopenthixol was associated with more frequent reporting of neurological symptoms, including EPSEs (mean side‐effect score lithium 0.3, zuclopenthixol 1.8, no SD/CI provided, n = 28, P value reported as &lt; 0.05; <a href="./references#CD004048-fig-0151" title="">Analysis 9.4</a>; <a href="./references#CD004048-fig-0152" title="">Analysis 9.5</a>; <a href="./references#CD004048-fig-0153" title="">Analysis 9.6</a>; <a href="./references#CD004048-fig-0154" title="">Analysis 9.7</a>). </p> </section> <section id="CD004048-sec-0226"> <p><b>Acceptability: total withdrawal</b></p> <p>There was no significant difference in the number of withdrawals from the lithium and zuclopenthixol arms of the study (OR 0.78, 95% CI 0.17 to 3.49; participants = 28; studies = 1, very low‐certainty evidence; <a href="./references#CD004048-fig-0149" title="">Analysis 9.2</a>). </p> </section> </section> <section id="CD004048-sec-0227"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0228"> <p><b>Use of rescue medications: mean dose of clonazepam</b></p> <p>There was no significant difference in the amount of clonazepam used by the lithium or zuclopenthixol groups (2.8 mg versus 4 mg, no SD or statistics provided; <a href="./references#CD004048-fig-0150" title="">Analysis 9.3</a>). </p> </section> </section> </section> <section id="CD004048-sec-0229"> <h5 class="title">Comparison 10: lithium versus risperidone</h5> <p>We found three studies with 255 participants for this comparison.</p> <section id="CD004048-sec-0230"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0231"> <p><b>Efficacy: response (continuous). Change in YMRS score from baseline to end of study</b></p> <p>Meta‐analysis found that risperidone was more effective at reducing manic symptoms than lithium (MD 7.28, 95% CI 5.22 to 9.34; participants = 241; studies = 3; I<sup>2</sup> = 49%; low‐certainty evidence; <a href="./references#CD004048-fig-0155" title="">Analysis 10.1</a>). </p> </section> <section id="CD004048-sec-0232"> <p><b>Efficacy: remission (categorical). YMRS less than 12 or absence of DSM‐IV mania by the end of the study</b></p> <p>There was considerable heterogeneity between the studies, and no significant difference between lithium or risperidone (OR 1.30, 95% CI 0.11 to 14.95; participants = 211; studies = 2; I<sup>2</sup> = 89%; low‐certainty evidence; <a href="./references#CD004048-fig-0156" title="">Analysis 10.2</a>). </p> </section> <section id="CD004048-sec-0233"> <p><b>Acceptability: adverse events</b></p> <p>Just one study reported most of the common adverse events. <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a> reported no significant difference between frequency in participants treated with lithium or risperidone for the majority of adverse events. The exceptions included appetite increase (OR 0.31, 95% CI 0.16 to 0.59; participants = 173; <a href="./references#CD004048-fig-0166" title="">Analysis 10.12</a>), weight gain (OR 0.10, 95% CI 0.03 to 0.32; participants = 173; <a href="./references#CD004048-fig-0169" title="">Analysis 10.15</a>), dry mouth (OR 2.42, 95% CI 1.02 to 5.75; participants = 173; <a href="./references#CD004048-fig-0170" title="">Analysis 10.16</a>), and abdominal pain (OR 3.98, 95% CI 1.91 to 8.27; participants = 173; <a href="./references#CD004048-fig-0171" title="">Analysis 10.17</a>), which were all more common in lithium‐treated participants. </p> <p>More participants treated with risperidone than lithium reported somnolence or drowsiness (OR 0.43, 95% CI 0.24 to 0.75; participants = 219; studies = 2; I<sup>2</sup> = 50%; <a href="./references#CD004048-fig-0158" title="">Analysis 10.4</a>). </p> <p>Data from two studies (<a href="./references#CD004048-bbs2-0003" title="BarekatainM , FatemiA , BashardoostN , DaroughehA , SalehiM , AsadollahiGH . Valproate‐risperidone valproate‐lithium combination in acute mania. Journal of Research in Medical Sciences2005;10(5):274‐80. ">Barekatain 2005</a>; <a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a>), found that lithium was more likely than risperidone to cause the following adverse events: </p> <p> <ol id="CD004048-list-0035"> <li> <p>diarrhoea (OR 4.14, 95% CI 1.12 to 15.26; participants = 219; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0159" title="">Analysis 10.5</a>); </p> </li> <li> <p>nausea (OR 2.49, 95% CI 1.32 to 4.69; participants = 219; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0160" title="">Analysis 10.6</a>); </p> </li> <li> <p>vomiting (OR 2.80, 95% CI 1.22 to 6.42; participants = 219; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0163" title="">Analysis 10.9</a>); </p> </li> <li> <p>frequent urination (OR 5.29, 95% CI 2.12 to 13.21; participants = 219; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0168" title="">Analysis 10.14</a>). </p> </li> </ol> </p> </section> <section id="CD004048-sec-0234"> <p><b>Acceptability: total withdrawal</b></p> <p>Three studies reported total withdrawal data. The participants in the lithium group were more likely to withdraw than those treated with risperidone (OR 1.85, 95% CI 1.02 to 3.34; participants = 255; studies = 3; I<sup>2</sup> = 29%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0162" title="">Analysis 10.8</a>). </p> </section> </section> <section id="CD004048-sec-0235"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0236"> <p><b>Efficacy: response (continuous). CGI change from baseline to end of study</b></p> <p>The meta‐analysis found a small but significantly greater reduction in CGI score in those treated with lithium compared to risperidone (MD 0.90, 95% CI 0.39 to 1.41; participants = 62; studies = 2; I<sup>2</sup> = 0%; <a href="./references#CD004048-fig-0157" title="">Analysis 10.3</a>). </p> </section> <section id="CD004048-sec-0237"> <p><b>Acceptability: withdrawal due to adverse events</b></p> <p><a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a> reported no significant difference in the number of withdrawals between the lithium and risperidone groups (OR 2.80, 95% CI 0.72 to 10.91; participants = 179; <a href="./references#CD004048-fig-0164" title="">Analysis 10.10</a>). </p> </section> <section id="CD004048-sec-0238"> <p><b>Use of rescue medications</b></p> <p><a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a> was the only study to report use of lorazepam or orphenadrine in addition to the randomised medication. They did not provide SDs or any means to calculate these, but reported in the paper that there was no significant difference between the use of these between the lithium and risperidone groups (<a href="./references#CD004048-fig-0172" title="">Analysis 10.18</a>; <a href="./references#CD004048-fig-0173" title="">Analysis 10.19</a>). </p> </section> </section> </section> <section id="CD004048-sec-0239"> <h5 class="title">Comparison 11: lithium versus aripiprazole</h5> <p>Only one study with 309 participants met the inclusion criteria for lithium compared to aripiprazole (<a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a>). </p> <section id="CD004048-sec-0240"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0241"> <p><b>Efficacy: response (categorical). YMRS reduction by at least 50% from baseline</b></p> <p>There was no significant difference between lithium and aripiprazole (OR 0.96, 95% CI 0.62 to 1.51; participants = 309; moderate‐certainty evidence; <a href="./references#CD004048-fig-0174" title="">Analysis 11.1</a>). </p> </section> <section id="CD004048-sec-0242"> <p><b>Efficacy: remission (categorical). YMRS 12 or less at end of study</b></p> <p>Neither lithium or aripiprazole were better at inducing remission from mania (OR 0.99, 95% CI 0.63 to 1.56; participants = 309; moderate‐certainty evidence; <a href="./references#CD004048-fig-0176" title="">Analysis 11.3</a>). </p> </section> <section id="CD004048-sec-0243"> <p><b>Acceptability: adverse events</b></p> <p><a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> did not find any significant difference in the frequency of akathisia, constipation, headache, nausea, somnolence, tremor or EPSEs between lithium and aripiprazole (<a href="./references#CD004048-fig-0183" title="">Analysis 11.10</a>; <a href="./references#CD004048-fig-0184" title="">Analysis 11.11</a>; <a href="./references#CD004048-fig-0185" title="">Analysis 11.12</a>; <a href="./references#CD004048-fig-0186" title="">Analysis 11.13</a>; <a href="./references#CD004048-fig-0187" title="">Analysis 11.14</a>; <a href="./references#CD004048-fig-0188" title="">Analysis 11.15</a>; <a href="./references#CD004048-fig-0189" title="">Analysis 11.16</a>). There was a trend towards more participants in the lithium group gaining weight than in the aripiprazole group but this was not significant (OR 2.07, 95% CI 0.18 to 23.21; n = 184, P = 0.56, low‐certainty evidence; <a href="./references#CD004048-fig-0190" title="">Analysis 11.17</a>). </p> </section> <section id="CD004048-sec-0244"> <p><b>Acceptability: withdrawals</b></p> <p>There was no significant difference between total withdrawals in the lithium compared to aripiprazole groups (<a href="./references#CD004048-fig-0178" title="">Analysis 11.5</a>), however, <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> did find that significantly more participants withdrew from the lithium group than from the aripiprazole group when just withdrawals due to lack of efficacy were considered (OR 3.15, 95% CI 1.42 to 6.96; participants = 315, moderate‐certainty evidence; <a href="./references#CD004048-fig-0193" title="">Analysis 11.20</a>). </p> </section> </section> <section id="CD004048-sec-0245"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0246"> <p><b>Efficacy: response (continuous). Change CGI‐BP severity score from baseline to end of study</b></p> <p>There was a greater reduction in CGI scores in the aripiprazole group compared to lithium (MD 0.20, 95% CI 0.18 to 0.22; participants = 309; studies = 1; <a href="./references#CD004048-fig-0175" title="">Analysis 11.2</a>). </p> </section> <section id="CD004048-sec-0247"> <p><b>Efficacy (continuous): change in PANSS scores from baseline</b></p> <p>Aripiprazole treatment led to a greater reduction in PANSS scores than lithium (MD 2.50, 95% CI 2.16 to 2.84; participants = 268; studies = 1; <a href="./references#CD004048-fig-0177" title="">Analysis 11.4</a>). </p> </section> <section id="CD004048-sec-0248"> <p><b>Use of rescue medications</b></p> <p>The use of anxiolytics between lithium‐ and aripiprazole‐treated participants did not differ (<a href="./references#CD004048-fig-0195" title="">Analysis 11.22</a>), but the lithium group was significantly less likely to use anticholinergics (OR 0.34, 95% CI 0.17 to 0.69; participants = 315; studies = 1; <a href="./references#CD004048-fig-0197" title="">Analysis 11.24</a>). </p> </section> </section> </section> </section> <section id="CD004048-sec-0249"> <h4 class="title">Lithium versus anti‐epileptic mood stabiliser</h4> <section id="CD004048-sec-0250"> <h5 class="title">Comparison 12: lithium versus topiramate</h5> <p>Two studies with 660 participants, from the same research group, investigated the comparative efficacy of lithium and topiramate for acute mania (Kushner 2006 PDMD‐004; Kushner 2006 PDMD‐008). These were published in one publication and the methodology for both studies was identical, except for the experimental dose of topiramate, so the results have been combined. </p> <section id="CD004048-sec-0251"> <h6 class="title">Primary outcomes</h6> <p>Lithium was more effective than topiramate at reducing the symptoms of mania for the following outcomes. </p> <p> <ol id="CD004048-list-0036"> <li> <p>Efficacy: response (categorical). YMRS reduction by at least 50% by the end of the study (OR 2.28 (95% CI 1.63 to 3.20; participants = 660; studies = 1, high‐certainty evidence; <a href="./references#CD004048-fig-0198" title="">Analysis 12.1</a>). </p> </li> <li> <p>Efficacy (categorical): remission. YMRS 12 or less at the end of the study (OR 2.24 (95% CI 1.58 to 3.15; participants = 660; studies = 1, high‐certainty evidence; <a href="./references#CD004048-fig-0199" title="">Analysis 12.2</a>). </p> </li> </ol> </p> <section id="CD004048-sec-0252"> <p><b>Acceptability: adverse events</b></p> <p>There were no adverse events found to be significantly different between the groups at the end of the studies. </p> </section> <section id="CD004048-sec-0253"> <p><b>Acceptability: withdrawals due to lack of efficacy/adverse events</b></p> <p><a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a> did not find a significant difference between withdrawals for any reason between lithium and topiramate (OR 1.28, 95% CI 0.66 to 2.48; participants = 1352; studies = 1; I<sup>2</sup> = 53%; high‐certainty evidence; Analysis 12.8). </p> </section> </section> </section> </section> <section id="CD004048-sec-0254"> <h4 class="title">Lithium versus benzodiazepines</h4> <section id="CD004048-sec-0255"> <h5 class="title">Comparison 13: lithium versus clonazepam</h5> <p>Two studies with only 41 participants met the inclusion criteria.</p> <section id="CD004048-sec-0256"> <h6 class="title">Primary outcomes</h6> <p>None of the included studies reported any of our primary outcomes.</p> </section> <section id="CD004048-sec-0257"> <h6 class="title">Secondary outcomes</h6> <section id="CD004048-sec-0258"> <p><b>Efficacy: response (continuous). Change in CGI scores from baseline to end of the study</b></p> <p>Two studies contributed to this analysis; there was no significant difference between participants treated with lithium versus clonazepam (MD −0.41, 95% CI −1.46 to 0.65; participants = 41; studies = 2; I<sup>2</sup> = 0%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0205" title="">Analysis 13.1</a>). A sensitivity analysis removing <a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a>, the only single‐blinded study, left only one set of results, which show no significant difference between lithium and clonazepam (<a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a>; <a href="./references#CD004048-fig-0206" title="">Analysis 13.2</a>). </p> <p><a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a> also reported that there was no significant difference in change in MRS or IMPS scores between groups from baseline to end of the study (<a href="./references#CD004048-fig-0207" title="">Analysis 13.3</a>; <a href="./references#CD004048-fig-0209" title="">Analysis 13.5</a>). </p> </section> <section id="CD004048-sec-0259"> <p><b>Acceptability: adverse events</b></p> <p><a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a> reported the Angus‐Simpson scale of adverse events. They found no significant difference in the side effects reported by those in the lithium arm compared to those treated with clonazepam (MD −0.17, 95% CI −0.83 to 0.49; participants = 30; studies = 1; <a href="./references#CD004048-fig-0211" title="">Analysis 13.7</a>). </p> </section> <section id="CD004048-sec-0260"> <p><b>Use of rescue medications</b></p> <p><a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a> reported the use of their stipulated rescue medication (haloperidol), to be no greater in the lithium compared to haloperidol group. However, this study was extremely small, leading to very wide confidence intervals and limiting the application of this finding (OR 4.00, 95% CI 0.27 to 60.32; participants = 11; studies = 1; <a href="./references#CD004048-fig-0212" title="">Analysis 13.8</a>). </p> </section> </section> </section> </section> <section id="CD004048-sec-0261"> <h4 class="title">Lithium versus electroconvulsive therapy (ECT)</h4> <section id="CD004048-sec-0262"> <h5 class="title">Comparison 14: lithium versus ECT</h5> <p>There was only one study with 38 participants that fitted the inclusion criteria (<a href="./references#CD004048-bbs2-0032" title="SmallJG , KlapperMH , KellamsJJ , MillerMJ , MilsteinV , SharpleyPH , et al. Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry1988;45(8):727‐32. ">Small 1988</a>). This publication did not provide SEs or SDs but did report P values relating to t‐tests. </p> <section id="CD004048-sec-0263"> <h6 class="title">Primary outcomes</h6> <p>ECT was more effective at reducing manic symptoms than lithium (P &lt; 0.05) on the following outcomes: mean change in MRS (<a href="./references#CD004048-fig-0213" title="">Analysis 14.1</a>, low‐certainty evidence), and in BPRS (<a href="./references#CD004048-fig-0214" title="">Analysis 14.2</a>, low‐certainty evidence), from baseline to end of week 8. </p> <p><a href="./references#CD004048-bbs2-0032" title="SmallJG , KlapperMH , KellamsJJ , MillerMJ , MilsteinV , SharpleyPH , et al. Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry1988;45(8):727‐32. ">Small 1988</a> did not report data about acceptability or adverse events. </p> </section> <section id="CD004048-sec-0264"> <h6 class="title">Secondary outcomes</h6> <p>ECT was more effective at reducing scores on the following overall ratings of severity than lithium (P &lt; 0.05): change in CGI severity (<a href="./references#CD004048-fig-0215" title="">Analysis 14.3</a>), GAS (<a href="./references#CD004048-fig-0216" title="">Analysis 14.4</a>), and Hamilton Depression Scale ratings (<a href="./references#CD004048-fig-0217" title="">Analysis 14.5</a>), from baseline to end of week 8. </p> </section> </section> <section id="CD004048-sec-0265"> <h5 class="title">Comparison 15: lithium versus all antimanic agents</h5> <p>We compared data from all antimanic agents that had combinable primary outcome measures to lithium. </p> <section id="CD004048-sec-0266"> <h6 class="title">Primary outcomes</h6> <section id="CD004048-sec-0267"> <p><b>Efficacy: response (categorical). At least 50% reduction on YMRS/MRS/BPRS by end of the study</b></p> <p>Fourteen studies (including 18 datasets, as four studies had two arms), contributed to the analysis. Lithium was more effective at inducing a response in acute mania than placebo (OR 1.36, 95% CI 1.01 to 1.83; participants = 3666; studies = 14; I<sup>2</sup> = 70%; high‐certainty evidence; <a href="./references#CD004048-fig-0218" title="">Analysis 15.1</a>). </p> </section> <section id="CD004048-sec-0268"> <p><b>Efficacy: response (continuous). Change from baseline YMRS/BPRS score to end of study</b></p> <p>There was no significant difference between the efficacy of lithium and the other antimanic agents (MD −0.30, 95% CI −1.45 to 0.85; participants = 2231; studies = 18; I<sup>2</sup> = 99%; moderate‐certainty evidence; <a href="./references#CD004048-fig-0219" title="">Analysis 15.2</a>). </p> </section> <section id="CD004048-sec-0269"> <p><b>Acceptability: total withdrawals</b></p> <p>We compared lithium to all other antimanic agents (whose studies provided data, studies = 23, datasets =28) in terms of withdrawals for any reason; there was no significant difference between groups (OR 1.11, 95% CI 0.84 to 1.47; participants = 3832; studies = 23; I<sup>2</sup> = 62%; high‐certainty evidence; <a href="./references#CD004048-fig-0220" title="">Analysis 15.3</a>). </p> </section> </section> </section> </section> <section id="CD004048-sec-0270"> <h4 class="title">Subgroup analyses</h4> <p>Due to the limited number of studies per comparison, we could not perform any of the originally planned subgroup analyses. </p> </section> <section id="CD004048-sec-0271"> <h4 class="title">Sensitivity analyses</h4> <p>We could not perform a sensitivity analysis excluding studies that recruited participants with treatment‐resistant mania, because none of the included studies recruited such participants. Almost all the studies reported an all‐cause dropout rate greater than 20%, so it was not possible to carry out this sensitivity analysis. However, our routine comparisons of random‐effects and fixed‐effect models, as well as our secondary outcomes of remission rates and continuous severity measures, may be considered additional forms of sensitivity analyses. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004048-sec-0272" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004048-sec-0272"></div> <section id="CD004048-sec-0273"> <h3 class="title" id="CD004048-sec-0273">Summary of main results</h3> <p>We aimed to identify, synthesise and assess the available evidence from double‐ and single‐blinded randomised controlled studies to answer the following questions. </p> <p> <ol id="CD004048-list-0037"> <li> <p>How does the efficacy of lithium compare with placebo or other active treatment in alleviating the acute symptoms of a manic or mixed episode in people with bipolar disorder? </p> </li> <li> <p>How does the acceptability and tolerability of lithium compare with placebo or other active treatments in alleviating the acute symptoms of a manic or mixed episode in people with bipolar disorder? </p> </li> </ol> </p> <p>We identified 36 studies that fitted our inclusion criteria. The studies were published over a wide time scale (1970‐2015) and were mostly small in size. The earlier studies tended to have fewer participants. All the studies included men and women, but three studies only enrolled participants under 18 years. The duration of follow‐up varied across studies, within the range of three to 12 weeks and studies included a variety of measures of efficacy from our primary and secondary outcomes. Overall, meta‐analysis for adverse events was limited by only one or two studies tending to report any given outcome. </p> <section id="CD004048-sec-0274"> <h4 class="title">Lithium versus placebo</h4> <p>We included eight studies that compared lithium treatment with placebo for acute mania (1991 participants). Lithium was found to be superior to placebo in achieving response or remission; this was high‐certainty evidence. Greater decreases in continuous outcome scales (YMRS, CGI, MADRS) were also seen in the lithium groups compared to placebo, but objectively these were small reductions and imprecision led to a grading of only moderate‐certainty evidence. There was insufficient evidence to analyse speed of response to lithium, or the optimal dosing strategies. The short time scale (e.g. three to four weeks) of many of the studies may well fail to capture the full effect of lithium on the treatment of acute mania compared to fast‐acting antipsychotics. Most other mood stabilisers (lamotrigine, carbamazepine, valproate) also take time to act ‐ but even if longer head‐to‐head studies of mood stabilisers in mania were conducted, there is often a substantial clinical benefit to a rapid treatment effect. </p> <p>The data on adverse events are less robust, as only a few studies reported outcomes that could be combined. Moderate‐certainty evidence showed that participants treated with lithium were less likely to develop an episode of depression or a worsening of their mania. Tremor, dizziness, somnolence and gastrointestinal symptoms were more common in the lithium group than placebo (moderate‐ or low‐certainty evidence). It is notable that for the majority of the adverse events, these were reported equally by those on active treatment and placebo. No significant difference was found for weight gain, but as the mean length of follow‐up was only five weeks, this is unsurprising. Participants on lithium were less likely to withdraw from a study for any reason or for lack of efficacy than those on placebo. </p> </section> <section id="CD004048-sec-0275"> <h4 class="title">Lithium versus anticonvulsants/mood stabilisers</h4> <p>We found no evidence of a difference in the efficacy of valproate/divalproex and lithium in treating mania in either categorical or continuous outcomes. The heterogeneity of results was high, leading to moderate‐certainty evidence. Both drugs appeared to be tolerated equally; the only exceptions were that participants on lithium were more likely to experience a tremor, whilst those on valproate/divalproex were more sedated. Withdrawals from the study for any reason were not significantly different between the two groups (high‐certainty evidence). </p> <p>Moderate‐certainty evidence compared the efficacy of lithium to lamotrigine (three studies): we found no significant difference for any measure of efficacy in treating acute mania or in total study withdrawals. We found no significant differences between lithium and lamotrigine in terms of tolerability (low‐certainty evidence). It is notable that lamotrigine needs to be slowly titrated to therapeutic level over several weeks: the length of these studies was three to six weeks, which may not have been long enough to see the full effects of lamotrigine. </p> <p>There was high‐certainty evidence that lithium was superior to topiramate in causing a response or remission from mania. Weight loss was seen in those treated with topiramate but not in those on lithium. There was no significant difference in total withdrawals between lithium and topiramate (moderate‐certainty evidence). </p> </section> <section id="CD004048-sec-0276"> <h4 class="title">Lithium versus antipsychotics</h4> <p>Lithium was less likely to induce a response than olanzapine, but this was low‐certainty evidence from only two studies. Continuous outcomes of efficacy showed a very small, but significant improvement in manic symptoms in those on olanzapine (moderate‐certainty evidence). More participants treated with lithium reported a tremor (moderate‐certainty evidence). Unfortunately, there was inadequate data to comment on the relative effects of these interventions on weight gain. By contrast, there was no evidence that risperidone was more effective than lithium in terms of reducing manic symptoms (moderate‐certainty evidence) or inducing remission (low‐certainty evidence). Evidence covering adverse events was all low in certainty, and suggested that risperidone was more sedating but gastrointestinal symptoms and polyuria were more common with lithium. </p> <p>There was no evidence that quetiapine was more effective than lithium in terms of response or remission (low‐certainty evidence). However, as the analysis only contained two studies with heterogeneous results, we deemed all efficacy outcomes to be of low certainty. Total withdrawals from the study were not significantly different between the two groups (low‐certainty evidence). We found only one study comparing lithium with aripiprazole, and there was no evidence that either drug was superior in inducing a response. </p> <p>Chlorpromazine was not found to be more effective in reducing manic symptoms compared to lithium (moderate‐ or low‐certainty evidence). The evidence available for meta‐analysis was limited and several of the studies were very small; the four studies were all published in the 1970s. No side effects were reported by more than one study. Efficacy was not significantly different between the two groups (moderate‐certainty evidence) and neither were total withdrawals. Three studies looking at efficacy compared haloperidol to lithium, but these included only 80 participants. We found no significant difference in efficacy between groups (moderate‐certainty evidence). Adverse events outcomes only had single studies or could not be meta‐analysed. </p> </section> <section id="CD004048-sec-0277"> <h4 class="title">Lithium versus benzodiazepines</h4> <p>We found only two studies comparing lithium to clonazepam. There was no significant difference in efficacy found between the two comparators, but the number of participants was low and results heterogeneous. </p> </section> <section id="CD004048-sec-0278"> <h4 class="title">Lithium versus ECT</h4> <p>We found one small, single‐blinded study from 1988, which compared lithium with ECT: this reported narratively that ECT was more effective than lithium at treating acute mania but did not provide adequate data for analysis. </p> </section> <section id="CD004048-sec-0279"> <h4 class="title">Lithium versus all antimanic comparators</h4> <p>When compared to all the antimanic comparators, lithium was more effective at inducing a categorical response. This combining of data led to high heterogeneity, but this is primarily explainable by the small sample sizes in many studies and variable methodology used over the period 1970 to 2017. The meta‐analysis size led to a precise estimate and therefore high‐certainty evidence. Similarly, there was high‐certainty evidence that participants randomised to lithium were not more likely to drop out of a study than those randomised to another antimanic agent or placebo. </p> </section> </section> <section id="CD004048-sec-0280"> <h3 class="title" id="CD004048-sec-0280">Overall completeness and applicability of evidence</h3> <p>We completed a comprehensive search and reviewed a large quantity of potential published and unpublished studies. We found 36 studies that directly addressed our review questions. Thirty‐five of these investigated the efficacy of lithium versus comparator(s), plus or minus adverse events, whilst one reported adverse events only. Overall the reporting of the studies was very good, only a few reported adverse events poorly. As we looked at 14 different comparisons, the overall amount of evidence for each comparison (except lithium versus placebo) was smaller than expected. The maximum number of studies within any meta‐analysis for our 14 key comparisons was nine, which clearly demonstrates that there are limitations in the available data. Overall the studies reported appropriate efficacy outcomes, but the range of categorical/continuous outcomes used made it hard to combine data. We were able address the question of efficacy in lithium versus placebo well, but for all other outcomes the evidence is less robust due to insufficient data. </p> <p>In terms of adverse events, the study authors reported information about many adverse events but available data were sparse and we did not manage to carry out a meta‐analysis from a large number of included studies. Some of the most problematic side effects (for instance, renal dysfunction) are uncommon but not rare consequences of long‐term treatment with lithium, however special attention should also be devoted to elderly patients during the acute treatment, as they carry a particular risk for chronic kidney disease, given the age‐related decline in estimate glomerular filtration rate (eGFR), age‐related comorbidities and polypharmacy (<a href="./references#CD004048-bbs2-0077" title="BocchettaA . Reconsidering risk factors for renal dysfunction in lithium‐treated patients. Evidence‐Based Mental Health2016;19(4):e22. ">Bocchetta 2016</a>). </p> <p>The studies all included people formally diagnosed with bipolar disorder, and 33 out of 36 were in adults.There is therefore a lack of evidence for people with bipolar disorder under 18 years of age. The studies were mainly in inpatient settings, but some outpatients, and were conducted across high‐ and middle‐income countries. There is no particular reason why the findings should not be applicable to any clinical setting and all countries. </p> <p>Given that lithium has been in continuous use since 1949, and over that period the number of potential interventions for mania has gradually increased, we would have expected to find considerably more studies. In order to try and maintain the highest quality of findings, we excluded studies that were open‐label or did not use a standardised diagnostic process; this did reduce the amount of data considerably. </p> </section> <section id="CD004048-sec-0281"> <h3 class="title" id="CD004048-sec-0281">Quality of the evidence</h3> <p>We assessed the certainty of the evidence collected using the GRADE system, which takes into consideration the risk of bias, consistency of effect, indirectness, publication bias and imprecision. Individual GRADE assessments can be seen within the 'Summary of findings' tables. In view of the large number of outcomes retrieved, this was only done for the most important outcomes. </p> <section id="CD004048-sec-0282"> <h4 class="title">Overall GRADE assessments</h4> <p>Overall, two comparisons (lithium versus placebo and lithium versus topiramate) had high‐certainty evidence for our main efficacy outcomes. This means that we are confident in our result and feel further research is unlikely to change the direction of the effect. This is especially so for lithium versus placebo, which had significantly more studies included. The evidence for adverse events was more heterogeneous, with somnolence/tremor in lithium versus placebo being downgraded to moderate certainty due to imprecision. </p> <p>All the other comparisons had moderate‐, low‐ or very low‐certainty evidence. We are therefore less confident in our estimate of the effect. We downgraded the majority of outcomes due to small quantities of data, studies of extremely variable size, and imprecision in single study estimates. This can be summarised as follows. </p> <p> <ol id="CD004048-list-0038"> <li> <p>Lithium versus valproate/divalproex: efficacy outcomes ‐ moderate certainty. The majority of the studies that looked at divalproex had wide confidence intervals, high dropout rates and there was a suspicion of publication bias. </p> </li> <li> <p>Lithium versus quetiapine: low‐certainty evidence for all outcomes due to high heterogeneity and likely publication bias (only two studies found) </p> </li> <li> <p>Lithium versus clonazepam: moderate‐certainty evidence from two studies, likely publication bias </p> </li> <li> <p>Lithium versus lamotrigine: moderate‐certainty evidence for efficacy results (downgraded due to likely publication bias), low‐certainty evidence for adverse events (downgraded for potential publication bias and imprecision) </p> </li> <li> <p>Lithium versus carbamazepine: low‐ to moderate‐certainty evidence. Downgraded as two studies had very poor reporting (selective reporting bias) and likely publication bias </p> </li> <li> <p>Lithium versus chlorpromazine: moderate‐certainty evidence ‐ we could include only two studies published a long time ago, these did not give as robust an account of study protocols as would be expected in modern studies and we suspected publication bias </p> </li> <li> <p>Lithium versus haloperidol: moderate‐certainty evidence due to lack of SDs meaning pooled analysis was very limited </p> </li> <li> <p>Lithium versus olanzapine: moderate‐ to low‐certainty evidence ‐ downgrading was due to the limited number of studies available, wide confidence intervals in the data and minimal reporting of certain important side effects such as weight gain </p> </li> <li> <p>Lithium versus risperidone: low‐certainty evidence due to the limited number and variable size of studies with imprecise estimates </p> </li> <li> <p>Lithium versus aripiprazole: moderate‐certainty evidence but from a single study; publication bias seems very likely </p> </li> <li> <p>Lithium versus zuclopenthixol: the evidence was found to be of very low certainty, due to the single study, small sample size and wide confidence intervals </p> </li> <li> <p>Lithium versus ECT: low‐certainty evidence from one small, single‐blinded study that did not report adequate statistical analysis </p> </li> <li> <p>Lithium versus valproate or divalproex: moderate‐certainty evidence ‐ downgrading was due to imprecision from variable size studies and wide confidence intervals. </p> </li> </ol> </p> </section> <section id="CD004048-sec-0283"> <h4 class="title">Risk of bias</h4> <p>The primary bias we identified in multiple comparisons was the likelihood of publication bias. We would have expected considerably more research over the 60 years since lithium has been in regular usage. We attempted to contact study authors to get access to unpublished data or to try and get raw data missing from publications to facilitate meta‐analysis. Unfortunately we were not fruitful in this approach. We did not assess publication bias through a funnel plot as none of the outcomes examined yielded more than 10 studies. </p> </section> <section id="CD004048-sec-0284"> <h4 class="title">Inconsistency</h4> <p>We found significant heterogeneity across the studies, which limited the reliability of the evidence. We believed that this was largely down to the effect of small studies. The amount of data available meant that it was difficult to do subanalyses to investigate this further. </p> </section> <section id="CD004048-sec-0285"> <h4 class="title">Indirectness</h4> <p>Overall, the available evidence matched our objective questions very well. The included studies treated most participants in inpatient settings, which would be expected given the pathology studied. All ages and both sexes were included from a wide range of countries. Furthermore, studies used rescue medications (usually benzodiazepines) for both lithium and all comparators, which further added to the generalisability of this data. Some studies allowed for the use of stimulants (<a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a>), which may have had an impact on the results. Generally the outcomes measured were directly related to symptoms of mania. One potential limitation is that due to all studies requiring the participants to be able to give informed consent, many participants who were severely unwell (e.g. psychotic, highly behaviourally disturbed or with co‐morbidities affecting their cognition) may well have been excluded. Another is that whilst the outcomes of response/remission are very concrete, those of reduction on a scale may be statistically significant but were often too small to be likely to be clinically significant. Most studies followed up for about four weeks (range 3 to 12); a longer length of study would improve generalisability and reliability of results. </p> </section> <section id="CD004048-sec-0286"> <h4 class="title">Imprecision</h4> <p>The precision of our outcome estimates was significantly hampered by several factors.</p> <p> <ol id="CD004048-list-0039"> <li> <p>Studies tending to report one or two results from a large range of different outcomes (e.g. YMRS, BPRS, CGI, GAS, BMRS, MADRS, HAMD etc). This limited our ability to combine data and yield more precise estimates of effect size. </p> </li> <li> <p>Missing SDs or data to impute these. This further limited our ability to meta‐analyse.</p> </li> <li> <p>Variable size of studies. The number of participants in the studies seems to have gradually increased as time has gone by; those in the 1970s especially included very few participants. </p> </li> <li> <p>Wide confidence intervals. This is in part relating to the small size of some of the studies. </p> </li> </ol> </p> </section> </section> <section id="CD004048-sec-0287"> <h3 class="title" id="CD004048-sec-0287">Potential biases in the review process</h3> <p>In order to capture as much data as possible, we made a comprehensive search of the literature, including multiple sources of published and unpublished data. Two literature searches were conducted, firstly in 2014 and then when the complexity of the review meant considerable time had passed, we repeated the searches in 2017 and 2018 to make sure the review was up to date. As one of our review authors (BA) was unavailable in 2017 and 2018, another review author (SD) carried out the second screening. RM was involved in both searches. A third review author (AC) settled any disputes about whether studies should be included. Two review authors independently checked all data entered to avoid errors. </p> <p>Unfortunately, our requests to study authors/drug companies about studies registered on clinicaltrials.gov that had not been published or reported online all went unanswered so there is a gap surrounding several modern studies. It is unclear if any of these studies have actually occurred (<a href="./references#CD004048-bbs2-0061" title="FischerE , CosgroveV , SuppesT , LangeNK , GwizdowskiI , DoanG , et al. Efficacy and tolerability of divalproex sodium plus adjunctive quetiapine, lithium, or placebo for hypomanic or manic episodes in outpatients with bipolar I disorder [abstract P‐140]. Bipolar Disorders (20th annual conference of the international society for bipolar disorders)2018; Vol. 20:116. NCT00183443 . Treatment of mania symptoms with drug therapy [Divalproex extended release and placebo, lithium, or quetiapine for mania]. clinicaltrials.gov/ct2/show/NCT00183443 (first received 16 September 2005). ">NCT00183443</a>; NCT00448578; NCT00485680). We also attempted to contact study authors regarding <a href="./references#CD004048-bbs2-0062" title="DelBelloM , DuranL , StrawnJ , KleinC , WelgeJ , BlomT , et al. Neural markers of treatment effects and response in youth with first‐episode mania [64th Annual Meeting American Academy of Child and Adolescent Psychiatry, AACAP 2017]. Journal of the American Academy of Child and Adolescent Psychiatry2017;56(10):S137. NCT00893581 . Multimodal neuroimaging of treatment effects in adolescent mania. clinicaltrials.gov/ct2/show/NCT00893581 (first received 6 May 2009). ">NCT00893581</a>; <a href="./references#CD004048-bbs2-0061" title="FischerE , CosgroveV , SuppesT , LangeNK , GwizdowskiI , DoanG , et al. Efficacy and tolerability of divalproex sodium plus adjunctive quetiapine, lithium, or placebo for hypomanic or manic episodes in outpatients with bipolar I disorder [abstract P‐140]. Bipolar Disorders (20th annual conference of the international society for bipolar disorders)2018; Vol. 20:116. NCT00183443 . Treatment of mania symptoms with drug therapy [Divalproex extended release and placebo, lithium, or quetiapine for mania]. clinicaltrials.gov/ct2/show/NCT00183443 (first received 16 September 2005). ">NCT00183443</a> and <a href="./references#CD004048-bbs2-0064" title="GyulaiL . GERI‐BD: first randomized, double blind controlled trial comparing lithium and valproate in late‐life mania [conference abstract]. Bipolar Disorders (10th international conference on bipolar disorder of the international‐society‐for‐bipolar‐disorders). 2013; Vol. 15:30. NCT00254488 . Treatment of bipolar mania in older adults (GERI‐BD). clinicaltrials.gov/ct2/show/NCT00254488 (first received 16 November 2005). YoungRC , MulsantBH , SajatovicM , GildengersAG , GyulaiL , Al JurdiRK , et al. GERI‐BD: A randomized double‐blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. American Journal of Psychiatry2017;174(11):1086‐93. ">Young 2017</a>, which are studies published as conference abstracts or that did not publish data in the paper such that it could be numerically extracted. Disappointingly, we did not get any replies to our emails. </p> <p>Given that significant amounts of research occurred on lithium in the period 1950 to 1980, we would have expected more studies to be found between these dates. However, this was an era when registering studies pre‐emptively was not the norm, and many studies were observational in design so did not fit our inclusion criteria. Early randomised studies frequently did not meet inclusion criteria (e.g. early studies were often not blinded or used non‐standard diagnostic criteria) or may not have been published in journals linked to modern databases. This reduces the comprehensive nature of the review but does increase the homogeneity and quality of included data. </p> <p>We did not examine the doses or regime of any drugs given during the study. We included lithium carbonate and lithium citrate, although most studies clearly stated that they used lithium carbonate. There are some differences in pharmacokinetics between preparations, but no evidence for a difference in clinical efficacy (<a href="./references#CD004048-bbs2-0098" title="GuelenPJ , JanssenTJ , DeWitteTC . Bioavailability of lithium from lithium‐citrate syrup versus conventional lithium‐carbonate tablets. Biopharmaceutics &amp; Drug Disposition1992;13(7):503‐11. ">Guelen 1992</a>; <a href="./references#CD004048-bbs2-0132" title="ShelleyRK , SilverstoneT . Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects. International Clinical Psychopharmacology1986;1(4):324‐31. ">Shelley 1986</a>). The target range of serum levels of lithium was variable: this represents differing practice internationally, but also changes in prescribing patterns over time. These differences are unlikely to have changed the outcome of the meta‐analyses, but could have impacted upon the strength of associations. </p> <p>We did not further analyse the reasons for withdrawal from each study. The reason for this was the heterogeneity in the way studies reported withdrawals, meaning that the data were impossible to combine. Early studies typically gave no explanation for withdrawals. </p> <p>Given the nature of mania, if severely unwell participants did not respond to medication and deteriorated, there is a high risk they would have been withdrawn from the study. Similarly, the most unwell patients would not have had capacity to consent for research and would not have been included in the studies. </p> <p>The outcomes reported by studies were numerous, including both categorical and quantitative measures. We tried to capture as much data as possible by including a wide range of primary and secondary outcomes. Inevitably, we could not include all data from studies or combined them with other studies for analysis; this was mostly from older papers using non‐standard non‐validated questionnaires or qualitative measures. </p> <p>As many of the included studies were published before it became routine to use/report using ITT or LOCF analysis, there was inadequate quantity of data to allow subgroup analyses dividing the studies between those that did and did not use these strategies. As LOCF introduces more uncertainty and potential for bias than only using collected end‐of‐study data, this may have inadvertently introduced bias. </p> </section> <section id="CD004048-sec-0288"> <h3 class="title" id="CD004048-sec-0288">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge this is the first comprehensive systematic review and meta‐analysis focusing on the effects of lithium in acute mania and comparing it to a wide range of other interventions. </p> <p>We found four primary studies that we did not include in this review due to being open‐label but that otherwise fitted our inclusion criteria (<a href="./references#CD004048-bbs2-0037" title="BowdenC , GogusA , GrunzeH , HaggstromL , RybakowskiJ , VietaE . A 12‐week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. International Clinical Psychopharmacology2008;23(5):252‐62. ">Bowden 2008</a>; <a href="./references#CD004048-bbs2-0040" title="CalabreseJR , SheltonMD , RapportDJ , YoungstromEA , JacksonK , BilaliS , et al. A 20‐month, double‐blind, maintenance trial of lithium versus divalproex in rapid‐cycling bipolar disorder. American Journal of Psychiatry2005;162(11):2152‐61. ">Calabrese 2005</a>; <a href="./references#CD004048-bbs2-0042" title="ChristieJE , WhalleyLJ , HunterR , BennieJ , FinkG . Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment. Journal of Affective Disorders1989;16(2‐3):115‐20. ">Christie 1989</a>; <a href="./references#CD004048-bbs2-0053" title="PavuluriMN , HenryDB , CarbrayJA , SampsonG , NaylorMW , JanicakPG . Open‐label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. Journal of Affective Disorders2004;82 Suppl 1:S103‐11. [PUBMED: 15571784] ">Pavuluri 2004</a>). Three of these studies reported no significant difference in efficacy or withdrawal outcomes between lithium and the comparator (valproate or sulpiride). This is similar to our findings for valproate. <a href="./references#CD004048-bbs2-0042" title="ChristieJE , WhalleyLJ , HunterR , BennieJ , FinkG . Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment. Journal of Affective Disorders1989;16(2‐3):115‐20. ">Christie 1989</a> was primarily a maintenance study with an open, randomised, acute stabilisation: they did not report efficacy data for the acute phase. </p> <p>Two high‐quality network meta‐analyses (NMA) have been published examining the comparative efficacy of psychotropics in treating acute mania (<a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a>; <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a>). Both of these studies used inclusion criteria that were very similar to ours. One important difference was that <a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a> included combination or augmentation studies (e.g. both arms given lithium plus drug X in one arm or both arms treated with an antipsychotic whilst valproate was added to one and lithium to the other), whereas neither <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a> nor this review did. The reason for excluding these reviews was that we wanted to be able to isolate the effects of individual comparators from that of lithium. This meant that only 59% of data included in <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a> was present in the first as well. Similarly to this review, the quality of evidence was variable in both NMAs, mostly due to high dropout rates or data heterogeneity. Neither of these reviews included ECT or clonazepam. </p> <p><a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a> reported that lithium was more effective than placebo, finding an OR 2.33 (95% CI 1.39 to 3.85), for a response. <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a> also found lithium to be more effective than placebo by approximately two‐fold. These results are very similar to our findings. </p> <p>Analysis between active comparators by <a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a> found that with the exception of topiramate, all the antimanic drugs included were more efficacious than placebo. They did not find any significant difference in efficacy between lithium and risperidone, olanzapine, quetiapine, aripiprazole, carbamazepine, valproate, ziprasidone or lamotrigine. Lithium was more efficacious than topiramate. Except for olanzapine, which we found to be more effective than lithium (but this was low‐certainty evidence), these findings are in line with our own. <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a> also reported that they found no significant difference in efficacy between lithium and risperidone, olanzapine, carbamazepine, aripiprazole, quetiapine, zuclopenthixol, valproate and lamotrigine. As previously, lithium was found to be more efficacious than topiramate. Taken together, this evidence strongly suggests that lithium is effective in treating acute mania, and is superior to topiramate, but there is no high‐certainty evidence that it is better than other antimanic treatments. Further investigation of the relative efficacies of lithium and olanzapine would be worthwhile. </p> <p>This review found that participants on lithium were less likely to withdraw from the study than those on placebo. Neither of the NMAs found a significant difference between lithium and placebo withdrawals. Interpretation of our data for withdrawal from studies was limited by low‐certainty evidence in many comparisons. Excluding placebo, we did not find any evidence for a difference in withdrawals between lithium and any comparator. <a href="./references#CD004048-bbs2-0082" title="CiprianiA , BarbuiC , SalantiG , RendellJ , BrownR , StocktonS , et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: multiple‐treatments meta‐analysis. Lancet 378;9799:1306‐15. ">Cipriani 2011</a> found that participants on risperidone or olanzapine were less likely to withdraw than those on lithium. <a href="./references#CD004048-bbs2-0143" title="YildizA , NikodemM , VietaE , CorrellCU , BaldessariniRJ . A network meta‐analysis on comparative efficacy and all‐cause discontinuation of antimanic treatments in acute bipolar mania. Psychological Medicine2015;45(2):299‐317. ">Yildiz 2015</a> reported no significant difference for risperidone, but found results favouring olanzapine in terms of withdrawals compared to lithium. Whilst the results are all broadly similar, these variations in findings could be due to differences in our inclusion criteria, or perhaps due to data quality. </p> <p>A recently published systematic review (<a href="./references#CD004048-bbs2-0084" title="DeFazio , P . Lithium in late‐life mania: a systematic review. Neuropsychiatric Disease and Treatment2017;13:755‐66. ">De Fazio 2017</a>), examined the efficacy of lithium in treating mania in "late‐life" (this was defined as patients aged over 50 years). <a href="./references#CD004048-bbs2-0084" title="DeFazio , P . Lithium in late‐life mania: a systematic review. Neuropsychiatric Disease and Treatment2017;13:755‐66. ">De Fazio 2017</a>'s inclusion criteria were the same as in this review, except that there was no definition of what was meant by 'a diagnosis of bipolar disorder'. <a href="./references#CD004048-bbs2-0084" title="DeFazio , P . Lithium in late‐life mania: a systematic review. Neuropsychiatric Disease and Treatment2017;13:755‐66. ">De Fazio 2017</a> gave a narrative results section as they did not find data compatible with meta‐analysis. The authors reported that the evidence suggests that lithium is more effective than placebo in older patients, but there appears to be no difference in efficacy between lithium and valproate or lamotrigine. It is difficult to compare our findings to this narrative approach, but the results are broadly similar. </p> <p>There is clear evidence that lithium is effective in treating acute mania. Evidence is also emerging that strongly suggests that mood in bipolar disorder is much more complex than discrete episodes of illness with a return to baseline euthymia in between (<a href="./references#CD004048-bbs2-0113" title="McKnightRF , BilderbeckAC , MiklowitzDJ , HindsC , GoodwinGM , GeddesJR . Longitudinal mood monitoring in bipolar disorder: course of illness as revealed through a short messaging service. Journal of Affective Disorders2017;223:139‐45. ">McKnight 2017</a>). Mood instability is a strong component of bipolar disorder, and the effect of lithium on this instability is yet to be characterised. The OxLith Trial is the first RCT to examine the potential role of lithium in early mood stabilisation (<a href="./references#CD004048-bbs2-0093" title="GeddesJR , RendellJ , CiprianiA , SaundersKE , AttenburrowMJ , BilderbeckAC , et al. Rationale and design of OxLith: a randomised placebo controlled trial exploring the short‐term physical and psychological effects of lithium on mood instability. Bipolar Disorders2015;17(S1):110. ">Geddes 2015</a>). It is using portable technology to capture continuous physiological responses to lithium in the first six weeks of treatment and record weekly mood ratings. This will be linked to longer‐term data. If a manic individual's physiological response to lithium in the very early stages of treatment can be used to predict longer‐term efficacy, then this could be used to determine if lithium is an appropriate treatment for mania or if they should be switched to another proven antimanic agent. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004048-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD004048-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study" data-id="CD004048-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias graph': review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD004048-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias graph': review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 1 Efficacy ‐ response (categorical): YMRS/MRS decrease by =&gt;50% at end of trial." data-id="CD004048-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 1 Efficacy ‐ response (categorical): YMRS/MRS decrease by =&gt;50% at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 2 Efficacy ‐ response (continuous): YMRS change from baseline at end of trial." data-id="CD004048-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 2 Efficacy ‐ response (continuous): YMRS change from baseline at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 3 Efficacy ‐ response (continuous): CGI change from baseline at end of trial." data-id="CD004048-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 3 Efficacy ‐ response (continuous): CGI change from baseline at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 4 Efficacy ‐ remission (categorical): YMRS &lt; 12 at end of trial." data-id="CD004048-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 4 Efficacy ‐ remission (categorical): YMRS &lt; 12 at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 5 Acceptability: withdrawals." data-id="CD004048-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 5 Acceptability: withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 6 Adverse event: depression." data-id="CD004048-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 6 Adverse event: depression.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 7 Adverse event: mania." data-id="CD004048-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 7 Adverse event: mania.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 8 Adverse event: weight gain (categorical)." data-id="CD004048-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 8 Adverse event: weight gain (categorical).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 9 Adverse event: weight gain (continuous)." data-id="CD004048-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 9 Adverse event: weight gain (continuous).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 10 Adverse event: akathisia." data-id="CD004048-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 10 Adverse event: akathisia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 11 Adverse event: headache." data-id="CD004048-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 11 Adverse event: headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 12 Adverse event: somnolence." data-id="CD004048-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 12 Adverse event: somnolence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 13 Adverse event: dizziness." data-id="CD004048-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 13 Adverse event: dizziness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 14 Adverse event: insomnia." data-id="CD004048-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 14 Adverse event: insomnia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 15 Adverse event: diarrhoea." data-id="CD004048-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 15 Adverse event: diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 16 Adverse event: nausea." data-id="CD004048-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 16 Adverse event: nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 17 Adverse event: vomiting." data-id="CD004048-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 17 Adverse event: vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 18 Adverse event: dry mouth." data-id="CD004048-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 18 Adverse event: dry mouth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 19 Adverse event: pain." data-id="CD004048-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 19 Adverse event: pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 20 Adverse event: EPS." data-id="CD004048-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 20 Adverse event: EPS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 21 Adverse event: tremor." data-id="CD004048-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 21 Adverse event: tremor.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 22 Adverse event: constipation." data-id="CD004048-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 22 Adverse event: constipation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 23 Adverse event: fever." data-id="CD004048-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 23 Adverse event: fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 24 Adverse event: rash." data-id="CD004048-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 24 Adverse event: rash.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 25 Efficacy ‐ response (continuous): CGI change from baseline to end of trial." data-id="CD004048-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 25 Efficacy ‐ response (continuous): CGI change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 26 Response: YMRS decrease by ≥ 50% end of the trial." data-id="CD004048-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 26 Response: YMRS decrease by ≥ 50% end of the trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 27 Response: remission YMRS &lt; 12 at end of trial." data-id="CD004048-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 27 Response: remission YMRS &lt; 12 at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 28 Efficacy ‐ response (continuous): MADRS change from baseline to end of trial." data-id="CD004048-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 28 Efficacy ‐ response (continuous): MADRS change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 29 Efficacy ‐ response (continuous): MRS score change from baseline to end of trial." data-id="CD004048-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 29 Efficacy ‐ response (continuous): MRS score change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 30 Efficacy ‐ (continuous): GAS score at end of trial." data-id="CD004048-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 30 Efficacy ‐ (continuous): GAS score at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 31 Efficacy ‐ HAMD‐31 score at end of trial." data-id="CD004048-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 31 Efficacy ‐ HAMD‐31 score at end of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 32 Efficacy ‐ BPRS score at end of trial." data-id="CD004048-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 32 Efficacy ‐ BPRS score at end of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 33 PANSS change from baseline to end of trial." data-id="CD004048-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 33 PANSS change from baseline to end of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 34 CGI‐BP change from baseline to end of trial." data-id="CD004048-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 34 CGI‐BP change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 35 Use of concomitant medications." data-id="CD004048-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 35 Use of concomitant medications.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 36 Use of sleep medications over course of trial." data-id="CD004048-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 36 Use of sleep medications over course of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 37 Use of anticholinergic medications." data-id="CD004048-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 37 Use of anticholinergic medications.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 38 Concomitant use of analgesics/antipyretics." data-id="CD004048-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 38 Concomitant use of analgesics/antipyretics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Lithium vs placebo, Outcome 39 Acceptability: withdrawal due to adverse events." data-id="CD004048-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 Lithium vs placebo, Outcome 39 Acceptability: withdrawal due to adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 1 Efficacy ‐ response (categorical): YMRS/SADS‐C decrease ≥ 50% by end of trial." data-id="CD004048-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 1 Efficacy ‐ response (categorical): YMRS/SADS‐C decrease ≥ 50% by end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 2 Efficacy ‐ response (categorical, adults): YMRS/SADS‐C decrease ≥ 50% by end of trial ADULTS only." data-id="CD004048-fig-0044" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 2 Efficacy ‐ response (categorical, adults): YMRS/SADS‐C decrease ≥ 50% by end of trial ADULTS only. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 3 Efficacy ‐ response (continuous): change in YMRS (ITT‐LOCF) change from baseline to end of trial." data-id="CD004048-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 3 Efficacy ‐ response (continuous): change in YMRS (ITT‐LOCF) change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 4 Efficacy ‐ response (continuous): CGI‐BP change from baseline to end of trial." data-id="CD004048-fig-0046" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 4 Efficacy ‐ response (continuous): CGI‐BP change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 5 Efficacy ‐ response (continuous): Change in MADRS (ITT‐LOCF) change from baseline to end of trial." data-id="CD004048-fig-0047" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 5 Efficacy ‐ response (continuous): Change in MADRS (ITT‐LOCF) change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 6 Efficacy ‐ remission (categorical): YMRS ≤ 12 and no increase in MADRS at end of trial." data-id="CD004048-fig-0048" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 6 Efficacy ‐ remission (categorical): YMRS ≤ 12 and no increase in MADRS at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 7 Efficacy ‐ remission (categorical): YMRS ≤ 12 and a reduction of at least 2 points on the CGI‐BP at end of trial." data-id="CD004048-fig-0049" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 7 Efficacy ‐ remission (categorical): YMRS ≤ 12 and a reduction of at least 2 points on the CGI‐BP at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 8 Adverse event: headache." data-id="CD004048-fig-0050" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 8 Adverse event: headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 9 Adverse event: somnolence." data-id="CD004048-fig-0051" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 9 Adverse event: somnolence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 10 Adverse event: tremor." data-id="CD004048-fig-0052" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 10 Adverse event: tremor.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 11 Acceptability: total withdrawals." data-id="CD004048-fig-0053" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 11 Acceptability: total withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 12 Efficacy ‐ response (continuous): MADRS change from baseline to end of trial." data-id="CD004048-fig-0054" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 12 Efficacy ‐ response (continuous): MADRS change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 13 SADS‐C mania score at end of trial." data-id="CD004048-fig-0055" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 13 SADS‐C mania score at end of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 14 SADS‐C depression score at end of trial." data-id="CD004048-fig-0056" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 14 SADS‐C depression score at end of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 15 GAS score at end of trial." data-id="CD004048-fig-0057" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 15 GAS score at end of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 16 CGI‐BP end of trial score." data-id="CD004048-fig-0058" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 16 CGI‐BP end of trial score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 17 YMRS insight score at end of trial." data-id="CD004048-fig-0059" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 17 YMRS insight score at end of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 18 BPRS score at end of trial." data-id="CD004048-fig-0060" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 18 BPRS score at end of trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 19 Any adverse events." data-id="CD004048-fig-0061" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 19 Any adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 20 Serious adverse events." data-id="CD004048-fig-0062" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.20</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 20 Serious adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 21 Adverse event: diarrhoea." data-id="CD004048-fig-0063" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.21</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 21 Adverse event: diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 22 Adverse event: nausea." data-id="CD004048-fig-0064" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.22</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 22 Adverse event: nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 23 Concomitant medication: use of lorazepam." data-id="CD004048-fig-0065" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.23</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 23 Concomitant medication: use of lorazepam.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 24 Concomitant medication: use of chloral hydrate (g)." data-id="CD004048-fig-0066" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.24</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 24 Concomitant medication: use of chloral hydrate (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 25 Concomitant medication: use of lorazepam (g)." data-id="CD004048-fig-0067" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.25</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 25 Concomitant medication: use of lorazepam (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 26 Concomitant medication: use of anxiolytics." data-id="CD004048-fig-0068" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.26</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 26 Concomitant medication: use of anxiolytics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-002-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-002-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Lithium vs valproate, Outcome 27 Concomitant medication: use of antidepressants." data-id="CD004048-fig-0069" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.27</div> <div class="figure-caption"> <p>Comparison 2 Lithium vs valproate, Outcome 27 Concomitant medication: use of antidepressants.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-002-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 1 Efficacy ‐ response (continuous): change in BPRS from baseline to end of trial." data-id="CD004048-fig-0070" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 1 Efficacy ‐ response (continuous): change in BPRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 2 Efficacy ‐ response (continuous): MRS (16 item) change from baseline to end of trial." data-id="CD004048-fig-0071" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 2 Efficacy ‐ response (continuous): MRS (16 item) change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 3 Efficacy ‐ response (continuous): CGI severity change from baseline to end of trial." data-id="CD004048-fig-0072" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 3 Efficacy ‐ response (continuous): CGI severity change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 4 Efficacy ‐ response (continuous): change in GAS from baseline to end of trial." data-id="CD004048-fig-0073" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 4 Efficacy ‐ response (continuous): change in GAS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 5 Acceptability." data-id="CD004048-fig-0074" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 5 Acceptability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 6 Efficacy ‐ response (continuous): change in Hamilton depression scale (HAMD 31) from baseline to end of trial." data-id="CD004048-fig-0075" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 6 Efficacy ‐ response (continuous): change in Hamilton depression scale (HAMD 31) from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 7 Efficacy ‐ response (categorical): ≥ 50% reduction in BPRS from baseline to end of trial." data-id="CD004048-fig-0076" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 7 Efficacy ‐ response (categorical): ≥ 50% reduction in BPRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 8 Efficacy ‐ response(categorical): ≥ 50% reduction in MRS from baseline to end of trial." data-id="CD004048-fig-0077" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 8 Efficacy ‐ response(categorical): ≥ 50% reduction in MRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 9 Efficacy ‐ response (categorical): CGI scores of 1 or 2 at the end of the trial." data-id="CD004048-fig-0078" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 9 Efficacy ‐ response (categorical): CGI scores of 1 or 2 at the end of the trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 10 Adverse event: vomiting." data-id="CD004048-fig-0079" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 10 Adverse event: vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 11 Adverse event: all mania." data-id="CD004048-fig-0080" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 11 Adverse event: all mania.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 12 Adverse event: diarrhoea." data-id="CD004048-fig-0081" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 12 Adverse event: diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 13 Adverse event: headache." data-id="CD004048-fig-0082" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 13 Adverse event: headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 14 Adverse event: tremor." data-id="CD004048-fig-0083" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 14 Adverse event: tremor.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 15 Adverse event: rash." data-id="CD004048-fig-0084" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 15 Adverse event: rash.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 16 Adverse event: somnolence." data-id="CD004048-fig-0085" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 16 Adverse event: somnolence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 17 Adverse event: any side effects." data-id="CD004048-fig-0086" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 17 Adverse event: any side effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 18 Adverse event: any serious event." data-id="CD004048-fig-0087" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 18 Adverse event: any serious event.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 19 Adverse event: constipation." data-id="CD004048-fig-0088" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 19 Adverse event: constipation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 20 Adverse event: accidental injury." data-id="CD004048-fig-0089" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 20 Adverse event: accidental injury.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 21 Adverse event: pain." data-id="CD004048-fig-0090" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.21</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 21 Adverse event: pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 22 Use of concomitant psychotropic medication." data-id="CD004048-fig-0091" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.22</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 22 Use of concomitant psychotropic medication.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-003-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-003-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Lithium vs lamotrigine, Outcome 23 Mean total dose of lorazepam (g)." data-id="CD004048-fig-0092" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.23</div> <div class="figure-caption"> <p>Comparison 3 Lithium vs lamotrigine, Outcome 23 Mean total dose of lorazepam (g).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-003-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 1 Efficacy ‐ response (continuous): YMRS/BPRS change from baseline to end of trial." data-id="CD004048-fig-0093" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 1 Efficacy ‐ response (continuous): YMRS/BPRS change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 2 Efficacy ‐ response (continuous): CGI change from baseline to end of trial." data-id="CD004048-fig-0094" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 2 Efficacy ‐ response (continuous): CGI change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 3 Efficacy ‐ response (continuous): mean length of treatment in weeks." data-id="CD004048-fig-0095" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 3 Efficacy ‐ response (continuous): mean length of treatment in weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 4 Acceptability." data-id="CD004048-fig-0096" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 4 Acceptability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 5 Changes in side effect scores from baseline to end of trial." data-id="CD004048-fig-0097" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 5 Changes in side effect scores from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 6 Response rate ≥ 50% change in YMRS from baseline to end of trial." data-id="CD004048-fig-0098" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 6 Response rate ≥ 50% change in YMRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 7 Score of CGI‐BP of 1 or 2 at end of trial." data-id="CD004048-fig-0099" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 7 Score of CGI‐BP of 1 or 2 at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 8 Response: CGI change of 2 or more from baseline to end of trial." data-id="CD004048-fig-0100" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 8 Response: CGI change of 2 or more from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 9 HDRS 6 weeks." data-id="CD004048-fig-0101" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 9 HDRS 6 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 10 HDRS &gt;11." data-id="CD004048-fig-0102" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 10 HDRS &gt;11.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 11 Adverse event: serious adverse events." data-id="CD004048-fig-0103" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 11 Adverse event: serious adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 12 Adverse event: nausea." data-id="CD004048-fig-0104" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 12 Adverse event: nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 13 Adverse event: sedation." data-id="CD004048-fig-0105" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 13 Adverse event: sedation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 14 Adverse event: rash." data-id="CD004048-fig-0106" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 14 Adverse event: rash.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 15 Adverse event: dizziness." data-id="CD004048-fig-0107" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 15 Adverse event: dizziness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 16 Adverse event: increased appetite." data-id="CD004048-fig-0108" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 16 Adverse event: increased appetite.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 17 Adverse event: polyuria." data-id="CD004048-fig-0109" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.17</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 17 Adverse event: polyuria.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-004-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-004-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Lithium vs carbamazepine, Outcome 18 Adverse event: diarrhoea." data-id="CD004048-fig-0110" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.18</div> <div class="figure-caption"> <p>Comparison 4 Lithium vs carbamazepine, Outcome 18 Adverse event: diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-004-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 1 Efficacy ‐ response (categorical): YMRS decrease by ≥ 50% by end of trial." data-id="CD004048-fig-0111" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 1 Efficacy ‐ response (categorical): YMRS decrease by ≥ 50% by end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 2 Efficacy ‐ response (continuous): YMRS/MADRS change from baseline at end of trial." data-id="CD004048-fig-0112" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 2 Efficacy ‐ response (continuous): YMRS/MADRS change from baseline at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 3 Efficacy ‐ remission (categorical): Decrease in YMRS ≤ 12 by end of trial." data-id="CD004048-fig-0113" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 3 Efficacy ‐ remission (categorical): Decrease in YMRS ≤ 12 by end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 4 Efficacy ‐ response (continuous): MADRS change from baseline." data-id="CD004048-fig-0114" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 4 Efficacy ‐ response (continuous): MADRS change from baseline. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 5 Adverse event: dizziness." data-id="CD004048-fig-0115" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 5 Adverse event: dizziness.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 6 Adverse event: diarrhoea." data-id="CD004048-fig-0116" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 6 Adverse event: diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 7 Adverse event: weight gain." data-id="CD004048-fig-0117" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 7 Adverse event: weight gain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 8 Acceptability: withdrawal." data-id="CD004048-fig-0118" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 8 Acceptability: withdrawal.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 9 PANSS score change from baseline to end of trial." data-id="CD004048-fig-0119" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 9 PANSS score change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 10 Change in YMRS from baseline to end of trial." data-id="CD004048-fig-0120" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 10 Change in YMRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 11 Use of sleep medications over the whole study." data-id="CD004048-fig-0121" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 11 Use of sleep medications over the whole study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 12 Use of lorazepam over the whole study." data-id="CD004048-fig-0122" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 12 Use of lorazepam over the whole study.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Lithium vs quetiapine, Outcome 13 Use of anticholinergics over the whole study." data-id="CD004048-fig-0123" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 Lithium vs quetiapine, Outcome 13 Use of anticholinergics over the whole study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 1 Efficacy ‐ response (categorical): MSRS/YMRS ≥ 50% decrease in score by end of trial." data-id="CD004048-fig-0124" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 1 Efficacy ‐ response (categorical): MSRS/YMRS ≥ 50% decrease in score by end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 2 Efficacy ‐ response (continuous): change in CGI baseline to end of trial." data-id="CD004048-fig-0125" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 2 Efficacy ‐ response (continuous): change in CGI baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 3 Efficacy ‐ response (continuous): CGI severity score at end of trial." data-id="CD004048-fig-0126" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 3 Efficacy ‐ response (continuous): CGI severity score at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 4 Efficacy ‐ remission (categorical): YMRS ≤ 12 at end of trial." data-id="CD004048-fig-0127" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 4 Efficacy ‐ remission (categorical): YMRS ≤ 12 at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 5 Total withdrawal." data-id="CD004048-fig-0128" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 5 Total withdrawal.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 6 Withdrawal due to lack of efficacy." data-id="CD004048-fig-0129" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 6 Withdrawal due to lack of efficacy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 7 Withdrawal due to adverse event." data-id="CD004048-fig-0130" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 7 Withdrawal due to adverse event.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 8 Change in BPRS from baseline to end of trial." data-id="CD004048-fig-0131" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 8 Change in BPRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 9 Change in CGI‐BP from baseline to end of trial." data-id="CD004048-fig-0132" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 9 Change in CGI‐BP from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 10 Change in MADRS from baseline to end of trial." data-id="CD004048-fig-0133" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 10 Change in MADRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 11 Concomitant medication: benzodiazepine use." data-id="CD004048-fig-0134" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 11 Concomitant medication: benzodiazepine use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 12 Concomitant medication: mean daily dose of lorazepam." data-id="CD004048-fig-0135" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 12 Concomitant medication: mean daily dose of lorazepam. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 13 Concomitant medication: anticholinergic use." data-id="CD004048-fig-0136" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 13 Concomitant medication: anticholinergic use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-006-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-006-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lithium vs olanzapine, Outcome 14 Adverse event: tremor." data-id="CD004048-fig-0137" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.14</div> <div class="figure-caption"> <p>Comparison 6 Lithium vs olanzapine, Outcome 14 Adverse event: tremor.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-006-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Lithium vs chlorpromazine, Outcome 1 Efficacy ‐ response (continuous): BPRS score change from baseline to end of trial." data-id="CD004048-fig-0138" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Lithium vs chlorpromazine, Outcome 1 Efficacy ‐ response (continuous): BPRS score change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Lithium vs chlorpromazine, Outcome 2 Efficacy ‐ response (continuous): PES change from baseline to end of trial." data-id="CD004048-fig-0139" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Lithium vs chlorpromazine, Outcome 2 Efficacy ‐ response (continuous): PES change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Lithium vs chlorpromazine, Outcome 3 Efficacy ‐ response (categorical): ≥ 50% reduction on BPRS from baseline to end of trial." data-id="CD004048-fig-0140" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Lithium vs chlorpromazine, Outcome 3 Efficacy ‐ response (categorical): ≥ 50% reduction on BPRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Lithium vs chlorpromazine, Outcome 4 Acceptability: total withdrawals." data-id="CD004048-fig-0141" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Lithium vs chlorpromazine, Outcome 4 Acceptability: total withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lithium vs haloperidol, Outcome 1 Efficacy ‐ response (continuous): change in BPRS (total) from baseline to end of trial." data-id="CD004048-fig-0142" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Lithium vs haloperidol, Outcome 1 Efficacy ‐ response (continuous): change in BPRS (total) from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lithium vs haloperidol, Outcome 2 Efficacy ‐ response (continuous): CGI change from baseline to end of trial." data-id="CD004048-fig-0143" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Lithium vs haloperidol, Outcome 2 Efficacy ‐ response (continuous): CGI change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lithium vs haloperidol, Outcome 3 Acceptability: change in side effect scores from baseline to end of trial." data-id="CD004048-fig-0144" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Lithium vs haloperidol, Outcome 3 Acceptability: change in side effect scores from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lithium vs haloperidol, Outcome 4 Total withdrawal." data-id="CD004048-fig-0145" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Lithium vs haloperidol, Outcome 4 Total withdrawal.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lithium vs haloperidol, Outcome 5 Concomitant medication: use of orphenadrine." data-id="CD004048-fig-0146" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Lithium vs haloperidol, Outcome 5 Concomitant medication: use of orphenadrine.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lithium vs haloperidol, Outcome 6 Concomitant medication: mean total lorazepam (mg)." data-id="CD004048-fig-0147" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Lithium vs haloperidol, Outcome 6 Concomitant medication: mean total lorazepam (mg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Lithium vs zuclopenthixol, Outcome 1 Efficacy ‐ response (categorical): BMRS change ≥ 50% from baseline to end of trial." data-id="CD004048-fig-0148" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Lithium vs zuclopenthixol, Outcome 1 Efficacy ‐ response (categorical): BMRS change ≥ 50% from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Lithium vs zuclopenthixol, Outcome 2 Total withdrawal." data-id="CD004048-fig-0149" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Lithium vs zuclopenthixol, Outcome 2 Total withdrawal.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Lithium vs zuclopenthixol, Outcome 3 Mean dose (mg) of extra clonazepam." data-id="CD004048-fig-0150" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Lithium vs zuclopenthixol, Outcome 3 Mean dose (mg) of extra clonazepam.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Lithium vs zuclopenthixol, Outcome 4 Adverse event rating scale psychic." data-id="CD004048-fig-0151" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Lithium vs zuclopenthixol, Outcome 4 Adverse event rating scale psychic.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Lithium vs zuclopenthixol, Outcome 5 Adverse event rating scale neurological." data-id="CD004048-fig-0152" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Lithium vs zuclopenthixol, Outcome 5 Adverse event rating scale neurological.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0153"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Lithium vs zuclopenthixol, Outcome 6 Adverse event rating scale autonomic." data-id="CD004048-fig-0153" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Lithium vs zuclopenthixol, Outcome 6 Adverse event rating scale autonomic.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0153">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0154"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Lithium vs zuclopenthixol, Outcome 7 Adverse event rating scale other." data-id="CD004048-fig-0154" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Lithium vs zuclopenthixol, Outcome 7 Adverse event rating scale other.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0154">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0155"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 1 Efficacy ‐ response (continuous): YMRS/MRS change at the end of the study." data-id="CD004048-fig-0155" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 1 Efficacy ‐ response (continuous): YMRS/MRS change at the end of the study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0155">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0156"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 2 Efficacy ‐ remission (categorical): YMRS &lt; 12/ absence of DSM‐IV mania by end of trial." data-id="CD004048-fig-0156" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 2 Efficacy ‐ remission (categorical): YMRS &lt; 12/ absence of DSM‐IV mania by end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0156">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0157"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 3 Efficacy ‐ response (continuous): CGI change from baseline to end of trial." data-id="CD004048-fig-0157" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 3 Efficacy ‐ response (continuous): CGI change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0157">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0158"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 4 Drowsiness/ somnolence." data-id="CD004048-fig-0158" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 4 Drowsiness/ somnolence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0158">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0159"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 5 Diarrhoea." data-id="CD004048-fig-0159" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 5 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0159">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0160"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 6 Nausea." data-id="CD004048-fig-0160" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 6 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0160">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0161"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 7 Drowsiness/ somnolence." data-id="CD004048-fig-0161" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.7</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 7 Drowsiness/ somnolence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0161">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0162"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 8 Total withdrawal." data-id="CD004048-fig-0162" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.8</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 8 Total withdrawal.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0162">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0163"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 9 Vomiting." data-id="CD004048-fig-0163" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.9</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 9 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0163">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0164"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 10 Withdrawal due to adverse effects." data-id="CD004048-fig-0164" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.10</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 10 Withdrawal due to adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0164">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0165"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 11 CGI‐BP‐IM response." data-id="CD004048-fig-0165" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.11</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 11 CGI‐BP‐IM response.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0165">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0166"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 12 Appetite increase." data-id="CD004048-fig-0166" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.12</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 12 Appetite increase.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0166">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0167"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 13 Constipation." data-id="CD004048-fig-0167" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.13</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 13 Constipation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0167">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0168"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 14 Frequent urination." data-id="CD004048-fig-0168" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.14</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 14 Frequent urination.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0168">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0169"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 15 Weight gain." data-id="CD004048-fig-0169" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.15</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 15 Weight gain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0169">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0170"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 16 Dry mouth." data-id="CD004048-fig-0170" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.16</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 16 Dry mouth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0170">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0171"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 17 Abdominal Pain." data-id="CD004048-fig-0171" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.17</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 17 Abdominal Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0171">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0172"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 18 Concomitant medication: mean total lorazepam (mg)." data-id="CD004048-fig-0172" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.18</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 18 Concomitant medication: mean total lorazepam (mg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0172">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0173"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-010-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-010-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Lithium vs risperidone, Outcome 19 Concomitant medication: use of orphenadrine." data-id="CD004048-fig-0173" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.19</div> <div class="figure-caption"> <p>Comparison 10 Lithium vs risperidone, Outcome 19 Concomitant medication: use of orphenadrine.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0173">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-010-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0174"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 1 Efficacy ‐ response (continuous): YMRS change by ≥ 50% at end of trial." data-id="CD004048-fig-0174" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 1 Efficacy ‐ response (continuous): YMRS change by ≥ 50% at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0174">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0175"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 2 Efficacy ‐ response (continuous): CGI BP change from baseline to end of trial." data-id="CD004048-fig-0175" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 2 Efficacy ‐ response (continuous): CGI BP change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0175">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0176"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 3 Efficacy ‐ remission (categorical): YMRS &lt; 12 at end of trial." data-id="CD004048-fig-0176" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 3 Efficacy ‐ remission (categorical): YMRS &lt; 12 at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0176">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0177"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 4 PANSS change from baseline to end of trial." data-id="CD004048-fig-0177" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 4 PANSS change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0177">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0178"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 5 Total withdrawal." data-id="CD004048-fig-0178" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 5 Total withdrawal.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0178">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0179"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 6 CGI‐BP severity of illness score change from baseline to end of trial." data-id="CD004048-fig-0179" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 6 CGI‐BP severity of illness score change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0179">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0180"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 7 MADRS change from baseline to end of trial." data-id="CD004048-fig-0180" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.7</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 7 MADRS change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0180">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0181"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 8 CGI BP depression change from baseline to end of trial." data-id="CD004048-fig-0181" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.8</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 8 CGI BP depression change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0181">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0182"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 9 Weight." data-id="CD004048-fig-0182" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.9</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 9 Weight.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0182">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0183"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 10 Akathisia." data-id="CD004048-fig-0183" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.10</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 10 Akathisia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0183">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0184"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 11 Constipation." data-id="CD004048-fig-0184" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.11</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 11 Constipation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0184">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0185"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 12 Headache." data-id="CD004048-fig-0185" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.12</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 12 Headache.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0185">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0186"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 13 Nausea." data-id="CD004048-fig-0186" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.13</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 13 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0186">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0187"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 14 Somnolence/ sedation." data-id="CD004048-fig-0187" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.14</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 14 Somnolence/ sedation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0187">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0188"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 15 Tremor." data-id="CD004048-fig-0188" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.15</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 15 Tremor.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0188">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0189"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 16 EPSE." data-id="CD004048-fig-0189" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.16</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 16 EPSE.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0189">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0190"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 17 Clinically relevant (&gt; 7%) weight gain." data-id="CD004048-fig-0190" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.17</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 17 Clinically relevant (&gt; 7%) weight gain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0190">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0191"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 18 Simpson Angus scale EPS LOCF." data-id="CD004048-fig-0191" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.18</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 18 Simpson Angus scale EPS LOCF.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0191">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0192"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 19 BARS score." data-id="CD004048-fig-0192" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.19</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 19 BARS score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0192">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0193"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 20 Withdrawal due to lack of efficacy." data-id="CD004048-fig-0193" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.20</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 20 Withdrawal due to lack of efficacy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0193">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0194"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 21 Withdrawal due to adverse events." data-id="CD004048-fig-0194" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.21</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 21 Withdrawal due to adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0194">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0195"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 22 Concomitant use of anxiolytics." data-id="CD004048-fig-0195" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.22</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 22 Concomitant use of anxiolytics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0195">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0196"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 23 Concomitant use of analgesics/antipyretics." data-id="CD004048-fig-0196" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.23</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 23 Concomitant use of analgesics/antipyretics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0196">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0197"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-011-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-011-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lithium vs aripiprazole, Outcome 24 Concomitant use of anticholinergics." data-id="CD004048-fig-0197" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.24</div> <div class="figure-caption"> <p>Comparison 11 Lithium vs aripiprazole, Outcome 24 Concomitant use of anticholinergics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0197">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-011-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0198"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Lithium vs topiramate, Outcome 1 Efficacy ‐ response (categorical): YMRS change ≥ 50% from baseline to end of trial." data-id="CD004048-fig-0198" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Lithium vs topiramate, Outcome 1 Efficacy ‐ response (categorical): YMRS change ≥ 50% from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0198">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0199"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Lithium vs topiramate, Outcome 2 Efficacy ‐ remission (categorical): YMRS ≤ 12 at end of trial." data-id="CD004048-fig-0199" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Lithium vs topiramate, Outcome 2 Efficacy ‐ remission (categorical): YMRS ≤ 12 at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0199">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0200"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Lithium vs topiramate, Outcome 3 Treatment emergent depression." data-id="CD004048-fig-0200" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Lithium vs topiramate, Outcome 3 Treatment emergent depression.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0200">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-012-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-012-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Lithium vs topiramate, Outcome 4 DSM‐IV responders at day 21." data-id="CD004048-fig-0201" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12 Lithium vs topiramate, Outcome 4 DSM‐IV responders at day 21.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-012-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-012-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Lithium vs topiramate, Outcome 5 Mania exacerbation ≥ YMRS 10%." data-id="CD004048-fig-0202" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.5</div> <div class="figure-caption"> <p>Comparison 12 Lithium vs topiramate, Outcome 5 Mania exacerbation ≥ YMRS 10%.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-012-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-012-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Lithium vs topiramate, Outcome 6 Suicidal ideation." data-id="CD004048-fig-0203" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.6</div> <div class="figure-caption"> <p>Comparison 12 Lithium vs topiramate, Outcome 6 Suicidal ideation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-012-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-012-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Lithium vs topiramate, Outcome 7 Suicide attempt." data-id="CD004048-fig-0204" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.7</div> <div class="figure-caption"> <p>Comparison 12 Lithium vs topiramate, Outcome 7 Suicide attempt.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-012-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0205"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lithium vs clonazepam, Outcome 1 Efficacy ‐ response (continuous): change in CGI score from baseline to end of study." data-id="CD004048-fig-0205" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Lithium vs clonazepam, Outcome 1 Efficacy ‐ response (continuous): change in CGI score from baseline to end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0205">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0206"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lithium vs clonazepam, Outcome 2 Efficacy ‐ response (continuous): change in CGI score from baseline to end of study [double blind only]." data-id="CD004048-fig-0206" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Lithium vs clonazepam, Outcome 2 Efficacy ‐ response (continuous): change in CGI score from baseline to end of study [double blind only]. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0206">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0207"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-013-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-013-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lithium vs clonazepam, Outcome 3 Change in mania rating from baseline to end of trial." data-id="CD004048-fig-0207" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 Lithium vs clonazepam, Outcome 3 Change in mania rating from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0207">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0208"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-013-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-013-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lithium vs clonazepam, Outcome 4 Change in BPRS from baseline to end of trial." data-id="CD004048-fig-0208" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13 Lithium vs clonazepam, Outcome 4 Change in BPRS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0208">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0209"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-013-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-013-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lithium vs clonazepam, Outcome 5 Change in IMPS from baseline to end of trial." data-id="CD004048-fig-0209" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.5</div> <div class="figure-caption"> <p>Comparison 13 Lithium vs clonazepam, Outcome 5 Change in IMPS from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0209">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0210"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-013-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-013-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lithium vs clonazepam, Outcome 6 Change in GAF from baseline to end of trial." data-id="CD004048-fig-0210" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.6</div> <div class="figure-caption"> <p>Comparison 13 Lithium vs clonazepam, Outcome 6 Change in GAF from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0210">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0211"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-013-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-013-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lithium vs clonazepam, Outcome 7 Simpson Angus scale change from baseline to end of trial." data-id="CD004048-fig-0211" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.7</div> <div class="figure-caption"> <p>Comparison 13 Lithium vs clonazepam, Outcome 7 Simpson Angus scale change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0211">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0212"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-013-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-013-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lithium vs clonazepam, Outcome 8 Use of rescue medications (haloperidol)." data-id="CD004048-fig-0212" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.8</div> <div class="figure-caption"> <p>Comparison 13 Lithium vs clonazepam, Outcome 8 Use of rescue medications (haloperidol).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0212">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-013-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0213"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Lithium vs ECT, Outcome 1 Efficacy ‐ response (continuous): MRS mean change from baseline to end of trial." data-id="CD004048-fig-0213" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Lithium vs ECT, Outcome 1 Efficacy ‐ response (continuous): MRS mean change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0213">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0214"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Lithium vs ECT, Outcome 2 Efficacy ‐ response (continuous): BPRS mean change from baseline to end of trial." data-id="CD004048-fig-0214" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 Lithium vs ECT, Outcome 2 Efficacy ‐ response (continuous): BPRS mean change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0214">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0215"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-014-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-014-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Lithium vs ECT, Outcome 3 Efficacy ‐ response (continuous): CGI mean change from baseline to end of trial." data-id="CD004048-fig-0215" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.3</div> <div class="figure-caption"> <p>Comparison 14 Lithium vs ECT, Outcome 3 Efficacy ‐ response (continuous): CGI mean change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0215">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0216"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-014-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-014-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Lithium vs ECT, Outcome 4 Efficacy ‐ response (continuous): GAS mean change from baseline to end of trial." data-id="CD004048-fig-0216" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.4</div> <div class="figure-caption"> <p>Comparison 14 Lithium vs ECT, Outcome 4 Efficacy ‐ response (continuous): GAS mean change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0216">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0217"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-014-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-014-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Lithium vs ECT, Outcome 5 Efficacy ‐ response (continuous): Hamilton Depression Scale mean change from baseline to end of trial." data-id="CD004048-fig-0217" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.5</div> <div class="figure-caption"> <p>Comparison 14 Lithium vs ECT, Outcome 5 Efficacy ‐ response (continuous): Hamilton Depression Scale mean change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0217">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-014-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0218"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Lithium vs all antimanic agents, Outcome 1 Efficacy ‐ response (categorical): YMRS/MRS/BPRS change by ≥ 50% at end of trial." data-id="CD004048-fig-0218" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Lithium vs all antimanic agents, Outcome 1 Efficacy ‐ response (categorical): YMRS/MRS/BPRS change by ≥ 50% at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0218">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0219"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Lithium vs all antimanic agents, Outcome 2 Efficacy ‐ response (continuous): YMRS/BPRS change from baseline to end of trial." data-id="CD004048-fig-0219" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Lithium vs all antimanic agents, Outcome 2 Efficacy ‐ response (continuous): YMRS/BPRS change from baseline to end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0219">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0220"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Lithium vs all antimanic agents, Outcome 3 Acceptability ‐ total withdrawals." data-id="CD004048-fig-0220" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Lithium vs all antimanic agents, Outcome 3 Acceptability ‐ total withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0220">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0221"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 1 Clinically significant increases in TSH." data-id="CD004048-fig-0221" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 1 Clinically significant increases in TSH. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0221">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0222"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 2 Any serious adverse event." data-id="CD004048-fig-0222" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 2 Any serious adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0222">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0223"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 3 Attempted suicide." data-id="CD004048-fig-0223" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 3 Attempted suicide. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0223">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0224"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 4 Accidental injury." data-id="CD004048-fig-0224" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.4</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 4 Accidental injury. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0224">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0225"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 5 Any adverse event." data-id="CD004048-fig-0225" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.5</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 5 Any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0225">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0226"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 6 Anorexia." data-id="CD004048-fig-0226" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.6</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 6 Anorexia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0226">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0227"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 7 Infection." data-id="CD004048-fig-0227" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.7</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 7 Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0227">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0228"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 8 Weight loss." data-id="CD004048-fig-0228" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.8</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 8 Weight loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0228">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0229"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 9 Agitation." data-id="CD004048-fig-0229" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.9</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 9 Agitation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0229">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0230"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 10 Back pain." data-id="CD004048-fig-0230" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.10</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 10 Back pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0230">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0231"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 11 Convulsions." data-id="CD004048-fig-0231" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.11</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 11 Convulsions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0231">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0232"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 12 Dyspepsia." data-id="CD004048-fig-0232" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.12</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 12 Dyspepsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0232">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0233"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 13 AIMS score." data-id="CD004048-fig-0233" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.13</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 13 AIMS score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0233">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0234"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 14 Emotional lability." data-id="CD004048-fig-0234" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.14</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 14 Emotional lability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0234">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0235"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 15 Influenza." data-id="CD004048-fig-0235" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.15</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 15 Influenza. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0235">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0236"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 16 Psychotic disorder." data-id="CD004048-fig-0236" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.16</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 16 Psychotic disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0236">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0237"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 17 Suicidal ideation." data-id="CD004048-fig-0237" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.17</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 17 Suicidal ideation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0237">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0238"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 18 Simpson Angus scale EPS LOCF." data-id="CD004048-fig-0238" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.18</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 18 Simpson Angus scale EPS LOCF. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0238">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0239"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 19 Motor dysfunction." data-id="CD004048-fig-0239" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.19</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 19 Motor dysfunction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0239">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0240"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 20 Leukopenia." data-id="CD004048-fig-0240" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.20</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 20 Leukopenia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0240">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0241"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 21 Aggression/ hostility." data-id="CD004048-fig-0241" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.21</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 21 Aggression/ hostility. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0241">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0242"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 22 BARS score." data-id="CD004048-fig-0242" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.22</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 22 BARS score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0242">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0243"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 23 Gastroenteritis." data-id="CD004048-fig-0243" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.23</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 23 Gastroenteritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0243">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0244"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 24 Increased appetite." data-id="CD004048-fig-0244" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.24</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 24 Increased appetite. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0244">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0245"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 25 Hyperprolactinaemia &gt; 20 mcg for men and &gt; 30 mcg in women." data-id="CD004048-fig-0245" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.25</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 25 Hyperprolactinaemia &gt; 20 mcg for men and &gt; 30 mcg in women. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0245">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0246"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 26 Change in thyrotropin in mIU/L." data-id="CD004048-fig-0246" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.26</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 26 Change in thyrotropin in mIU/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0246">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0247"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 27 Arthralgia." data-id="CD004048-fig-0247" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.27</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 27 Arthralgia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0247">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0248"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 28 Dysarthria." data-id="CD004048-fig-0248" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.28</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 28 Dysarthria. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0248">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0249"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 29 Twitching." data-id="CD004048-fig-0249" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.29</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 29 Twitching. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0249">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0250"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 30 Exacerbation of cough." data-id="CD004048-fig-0250" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.30</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 30 Exacerbation of cough. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0250">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0251"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 31 Rhinitis." data-id="CD004048-fig-0251" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.31</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 31 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0251">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0252"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-016-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-016-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 32 Pruritus." data-id="CD004048-fig-0252" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.32</div> <div class="figure-caption"> <p>Comparison 16 Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events, Outcome 32 Pruritus. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0252">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-016-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0253"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 1 Change in weight (in kg)." data-id="CD004048-fig-0253" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 1 Change in weight (in kg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0253">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0254"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 2 Weight gain greater than 7%." data-id="CD004048-fig-0254" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 2 Weight gain greater than 7%. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0254">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0255"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 3 Change in aspartate aminotransferase IU/L." data-id="CD004048-fig-0255" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 3 Change in aspartate aminotransferase IU/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0255">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0256"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 4 Change in alanine aminotransferase IU/L." data-id="CD004048-fig-0256" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.4</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 4 Change in alanine aminotransferase IU/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0256">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0257"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 5 Change in platelet count (x10^9/L)." data-id="CD004048-fig-0257" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.5</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 5 Change in platelet count (x10^9/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0257">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0258"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 6 Fatigue." data-id="CD004048-fig-0258" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.6</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 6 Fatigue. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0258">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0259"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 7 Constipation." data-id="CD004048-fig-0259" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.7</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 7 Constipation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0259">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0260"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 8 Change in creatinine mcmol/L." data-id="CD004048-fig-0260" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.8</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 8 Change in creatinine mcmol/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0260">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0261"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 9 Thyroid function." data-id="CD004048-fig-0261" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.9</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 9 Thyroid function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0261">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0262"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 10 Change in glucose in mmol/L." data-id="CD004048-fig-0262" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.10</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 10 Change in glucose in mmol/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0262">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0263"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 11 Change in cholesterol in mmol/L." data-id="CD004048-fig-0263" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.11</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 11 Change in cholesterol in mmol/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0263">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0264"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 12 Change in triglycerides in mmol/L." data-id="CD004048-fig-0264" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.12</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 12 Change in triglycerides in mmol/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0264">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0265"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 13 Somnolence." data-id="CD004048-fig-0265" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.13</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 13 Somnolence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0265">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0266"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-017-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-017-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 14 Constipation." data-id="CD004048-fig-0266" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.14</div> <div class="figure-caption"> <p>Comparison 17 Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events, Outcome 14 Constipation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0266">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-017-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0267"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 1 Clinically significant increases in TSH." data-id="CD004048-fig-0267" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 1 Clinically significant increases in TSH. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0267">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0268"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 2 Dry mouth." data-id="CD004048-fig-0268" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 2 Dry mouth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0268">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0269"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 3 Somnolence." data-id="CD004048-fig-0269" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.3</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 3 Somnolence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0269">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0270"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 4 Akathisia." data-id="CD004048-fig-0270" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.4</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 4 Akathisia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0270">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0271"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 5 Insomnia." data-id="CD004048-fig-0271" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.5</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 5 Insomnia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0271">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0272"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 6 URTI." data-id="CD004048-fig-0272" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.6</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 6 URTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0272">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0273"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 7 Headache." data-id="CD004048-fig-0273" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.7</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 7 Headache. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0273">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0274"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 8 EPS." data-id="CD004048-fig-0274" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.8</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 8 EPS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0274">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0275"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 9 ECG changes." data-id="CD004048-fig-0275" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.9</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 9 ECG changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0275">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0276"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 10 Asthenia." data-id="CD004048-fig-0276" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.10</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 10 Asthenia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0276">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0277"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 11 Constipation." data-id="CD004048-fig-0277" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.11</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 11 Constipation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0277">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0278"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 12 Depression." data-id="CD004048-fig-0278" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.12</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 12 Depression. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0278">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0279"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 13 Cardiac disorders." data-id="CD004048-fig-0279" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.13</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 13 Cardiac disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0279">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0280"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 14 Weight loss." data-id="CD004048-fig-0280" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.14</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 14 Weight loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0280">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0281"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 15 Anorexia." data-id="CD004048-fig-0281" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.15</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 15 Anorexia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0281">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0282"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 16 Bone marrow depression." data-id="CD004048-fig-0282" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.16</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 16 Bone marrow depression. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0282">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0283"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 17 Nausea." data-id="CD004048-fig-0283" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.17</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 17 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0283">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0284"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 18 Raised neutrophils &gt; 10x109 /L." data-id="CD004048-fig-0284" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.18</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 18 Raised neutrophils &gt; 10x10<sup>9</sup> /L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0284">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0285"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 19 Deranged LFTs &gt; 3x normal range." data-id="CD004048-fig-0285" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.19</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 19 Deranged LFTs &gt; 3x normal range. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0285">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0286"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 20 Vomiting." data-id="CD004048-fig-0286" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.20</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 20 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0286">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0287"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 21 High blood glucose." data-id="CD004048-fig-0287" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.21</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 21 High blood glucose. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0287">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0288"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 22 Hyperprolactinaemia &gt; 20mcg for men and &gt; 30mcg in women." data-id="CD004048-fig-0288" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.22</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 22 Hyperprolactinaemia &gt; 20mcg for men and &gt; 30mcg in women. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0288">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0289"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 23 GI disorder." data-id="CD004048-fig-0289" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.23</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 23 GI disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0289">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0290"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 24 Nervous system disorders." data-id="CD004048-fig-0290" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.24</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 24 Nervous system disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0290">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0291"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 25 Infections and infestations." data-id="CD004048-fig-0291" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.25</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 25 Infections and infestations. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0291">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0292"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 26 Tremor." data-id="CD004048-fig-0292" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.26</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 26 Tremor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0292">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0293"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 27 Respiratory, thoracic and mediastinal disorders." data-id="CD004048-fig-0293" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.27</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 27 Respiratory, thoracic and mediastinal disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0293">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0294"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 28 Skin and subcutaneous tissue disorders." data-id="CD004048-fig-0294" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.28</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 28 Skin and subcutaneous tissue disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0294">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0295"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 29 Eye disorders." data-id="CD004048-fig-0295" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.29</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 29 Eye disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0295">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0296"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 30 Psychiatric disorders." data-id="CD004048-fig-0296" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.30</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 30 Psychiatric disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0296">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0297"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 31 Metabolism and nutritional disorders." data-id="CD004048-fig-0297" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.31</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 31 Metabolism and nutritional disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0297">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0298"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 32 MSK and connective tissue disorders." data-id="CD004048-fig-0298" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.32</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 32 MSK and connective tissue disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0298">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0299"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 33 Renal and urinary disorders." data-id="CD004048-fig-0299" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.33</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 33 Renal and urinary disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0299">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0300"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 34 Reproductive system and breast disorders." data-id="CD004048-fig-0300" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.34</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 34 Reproductive system and breast disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0300">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0301"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 35 Vascular disorders." data-id="CD004048-fig-0301" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.35</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 35 Vascular disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0301">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0302"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 36 Blood and lymphatic disorders." data-id="CD004048-fig-0302" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.36</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 36 Blood and lymphatic disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0302">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0303"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 37 Hepatobiliary disorders." data-id="CD004048-fig-0303" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.37</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 37 Hepatobiliary disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0303">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0304"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 38 Injury, poisoning and procedural complications." data-id="CD004048-fig-0304" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.38</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 38 Injury, poisoning and procedural complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0304">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0305"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-018-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-018-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 39 Weight gain." data-id="CD004048-fig-0305" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.39</div> <div class="figure-caption"> <p>Comparison 18 Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events, Outcome 39 Weight gain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0305">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-018-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0306"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 1 Convulsions." data-id="CD004048-fig-0306" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 1 Convulsions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0306">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0307"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 2 Insomnia." data-id="CD004048-fig-0307" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 2 Insomnia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0307">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0308"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 3 EPS." data-id="CD004048-fig-0308" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.3</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 3 EPS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0308">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0309"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 4 Dry Mouth." data-id="CD004048-fig-0309" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.4</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 4 Dry Mouth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0309">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0310"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 5 Infection." data-id="CD004048-fig-0310" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.5</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 5 Infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0310">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0311"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 6 Nausea." data-id="CD004048-fig-0311" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.6</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 6 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0311">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0312"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 7 Akathisia." data-id="CD004048-fig-0312" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.7</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 7 Akathisia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0312">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0313"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 8 Dyspepsia." data-id="CD004048-fig-0313" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.8</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 8 Dyspepsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0313">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0314"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 9 Agitation." data-id="CD004048-fig-0314" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.9</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 9 Agitation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0314">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0315"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 10 Emotional lability." data-id="CD004048-fig-0315" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.10</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 10 Emotional lability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0315">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0316"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 11 Influenza." data-id="CD004048-fig-0316" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.11</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 11 Influenza. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0316">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0317"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 12 Psychotic disorder." data-id="CD004048-fig-0317" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.12</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 12 Psychotic disorder. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0317">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0318"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 13 Motor dysfunction." data-id="CD004048-fig-0318" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.13</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 13 Motor dysfunction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0318">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0319"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 14 Dizziness." data-id="CD004048-fig-0319" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.14</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 14 Dizziness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0319">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0320"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 15 Syncope." data-id="CD004048-fig-0320" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.15</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 15 Syncope. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0320">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0321"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 16 Depression." data-id="CD004048-fig-0321" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.16</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 16 Depression. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0321">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0322"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 17 Arthralgia." data-id="CD004048-fig-0322" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.17</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 17 Arthralgia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0322">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0323"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 18 Back pain." data-id="CD004048-fig-0323" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.18</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 18 Back pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0323">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0324"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 19 Exacerbation of cough." data-id="CD004048-fig-0324" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.19</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 19 Exacerbation of cough. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0324">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0325"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 20 Rhinitis." data-id="CD004048-fig-0325" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.20</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 20 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0325">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0326"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 21 Pruritus." data-id="CD004048-fig-0326" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.21</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 21 Pruritus. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0326">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0327"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-019-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-019-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 22 Non fatal serious adverse events." data-id="CD004048-fig-0327" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.22</div> <div class="figure-caption"> <p>Comparison 19 Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events, Outcome 22 Non fatal serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0327">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-019-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0328"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 1 Tremor." data-id="CD004048-fig-0328" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 1 Tremor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0328">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0329"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 2 Any adverse event." data-id="CD004048-fig-0329" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 2 Any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0329">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0330"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 3 Nausea." data-id="CD004048-fig-0330" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.3</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 3 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0330">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0331"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 4 Constipation." data-id="CD004048-fig-0331" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.4</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 4 Constipation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0331">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0332"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 5 Nasopharyngitis." data-id="CD004048-fig-0332" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.5</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 5 Nasopharyngitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0332">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0333"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 6 Somnolence." data-id="CD004048-fig-0333" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.6</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 6 Somnolence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0333">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0334"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 7 Vomiting." data-id="CD004048-fig-0334" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.7</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 7 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0334">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0335"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 8 Diarrhoea." data-id="CD004048-fig-0335" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.8</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 8 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0335">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0336"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 9 Dizziness." data-id="CD004048-fig-0336" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.9</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 9 Dizziness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0336">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0337"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 10 Cough." data-id="CD004048-fig-0337" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.10</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 10 Cough. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0337">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0338"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 11 Restlessness." data-id="CD004048-fig-0338" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.11</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 11 Restlessness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0338">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0339"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 12 Tachycardia." data-id="CD004048-fig-0339" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.12</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 12 Tachycardia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0339">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0340"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 13 Fatigue." data-id="CD004048-fig-0340" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.13</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 13 Fatigue. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0340">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0341"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 14 Headache." data-id="CD004048-fig-0341" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.14</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 14 Headache. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0341">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0342"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 15 Increased appetite." data-id="CD004048-fig-0342" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.15</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 15 Increased appetite. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0342">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0343"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 16 Tonsillitis." data-id="CD004048-fig-0343" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.16</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 16 Tonsillitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0343">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0344"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 17 URTI." data-id="CD004048-fig-0344" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.17</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 17 URTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0344">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0345"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 18 Dry Mouth." data-id="CD004048-fig-0345" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.18</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 18 Dry Mouth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0345">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0346"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 19 Gingivitis." data-id="CD004048-fig-0346" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.19</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 19 Gingivitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0346">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0347"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 20 Haemorrhoids." data-id="CD004048-fig-0347" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.20</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 20 Haemorrhoids. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0347">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0348"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 21 Adverse effects possibly related to drug use." data-id="CD004048-fig-0348" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.21</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 21 Adverse effects possibly related to drug use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0348">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0349"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 22 Metabolism and nutrition disorders." data-id="CD004048-fig-0349" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.22</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 22 Metabolism and nutrition disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0349">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0350"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 23 Nervous system disorders." data-id="CD004048-fig-0350" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.23</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 23 Nervous system disorders. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0350">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0351"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 24 Abnormal hepatic function." data-id="CD004048-fig-0351" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.24</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 24 Abnormal hepatic function. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0351">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0352"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 25 EPSE." data-id="CD004048-fig-0352" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.25</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 25 EPSE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0352">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0353"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 26 Significant high cholesterol." data-id="CD004048-fig-0353" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.26</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 26 Significant high cholesterol. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0353">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0354"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 27 Significant high glucose." data-id="CD004048-fig-0354" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.27</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 27 Significant high glucose. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0354">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0355"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-020-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-020-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 28 Weight gain &gt; 7%." data-id="CD004048-fig-0355" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.28</div> <div class="figure-caption"> <p>Comparison 20 Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events, Outcome 28 Weight gain &gt; 7%. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0355">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-020-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0356"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 1 ≥ 50% change in YMRS." data-id="CD004048-fig-0356" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 1 ≥ 50% change in YMRS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0356">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0357"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 2 YMRS ≤ 12." data-id="CD004048-fig-0357" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 2 YMRS ≤ 12. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0357">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0358"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 3 Tremor." data-id="CD004048-fig-0358" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.3</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 3 Tremor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0358">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0359"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 4 Adverse events." data-id="CD004048-fig-0359" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.4</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 4 Adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0359">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0360"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 5 Dizziness." data-id="CD004048-fig-0360" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.5</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 5 Dizziness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0360">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0361"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 6 Dyspepsia." data-id="CD004048-fig-0361" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.6</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 6 Dyspepsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0361">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0362"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 7 EPSE." data-id="CD004048-fig-0362" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.7</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 7 EPSE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0362">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0363"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 8 Proportion of patients requiring seclusion." data-id="CD004048-fig-0363" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.8</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 8 Proportion of patients requiring seclusion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0363">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0364"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 9 AIMS score." data-id="CD004048-fig-0364" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.9</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 9 AIMS score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0364">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0365"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-021-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-021-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 10 YMRS change from baseline at week 3." data-id="CD004048-fig-0365" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.10</div> <div class="figure-caption"> <p>Comparison 21 Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events, Outcome 10 YMRS change from baseline at week 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0365">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-021-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0366"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 1 Toxicity." data-id="CD004048-fig-0366" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 1 Toxicity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0366">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0367"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 2 Intercurrent illness." data-id="CD004048-fig-0367" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.2</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 2 Intercurrent illness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0367">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0368"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 3 Side effects total: mildly active group." data-id="CD004048-fig-0368" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.3</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 3 Side effects total: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0368">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0369"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 4 Side effects total: highly active group." data-id="CD004048-fig-0369" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.4</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 4 Side effects total: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0369">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0370"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 5 Anorexia: mildly active group." data-id="CD004048-fig-0370" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.5</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 5 Anorexia: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0370">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0371"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 6 Anorexia: highly active group." data-id="CD004048-fig-0371" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.6</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 6 Anorexia: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0371">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0372"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 7 Nausea: mildly active group." data-id="CD004048-fig-0372" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.7</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 7 Nausea: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0372">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0373"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 8 Nausea: highly active group." data-id="CD004048-fig-0373" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.8</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 8 Nausea: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0373">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0374"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 9 Vomiting: mildly active group." data-id="CD004048-fig-0374" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.9</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 9 Vomiting: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0374">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0375"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 10 Vomiting: highly active group." data-id="CD004048-fig-0375" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.10</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 10 Vomiting: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0375">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0376"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 11 Diarrhoea: highly active group." data-id="CD004048-fig-0376" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.11</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 11 Diarrhoea: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0376">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0377"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 12 Dry mouth: mildly active group." data-id="CD004048-fig-0377" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.12</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 12 Dry mouth: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0377">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0378"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 13 Dry mouth: highly active group." data-id="CD004048-fig-0378" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.13</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 13 Dry mouth: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0378">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0379"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 14 Constipation: mildly active group." data-id="CD004048-fig-0379" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.14</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 14 Constipation: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0379">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0380"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 15 Constipation: highly active group." data-id="CD004048-fig-0380" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.15</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 15 Constipation: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0380">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0381"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 16 Abdominal pain: highly active group." data-id="CD004048-fig-0381" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.16</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 16 Abdominal pain: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0381">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0382"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 17 Muscle weakness: mildly active group." data-id="CD004048-fig-0382" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.17</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 17 Muscle weakness: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0382">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0383"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 18 Ataxia: highly active group." data-id="CD004048-fig-0383" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.18</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 18 Ataxia: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0383">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0384"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 19 Tremor: mildly active group." data-id="CD004048-fig-0384" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.19</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 19 Tremor: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0384">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0385"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 20 Tremor: highly active group." data-id="CD004048-fig-0385" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.20</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 20 Tremor: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0385">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0386"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 21 Facial twitching; highly active group." data-id="CD004048-fig-0386" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.21</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 21 Facial twitching; highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0386">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0387"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 22 Parkinsonism: highly active group." data-id="CD004048-fig-0387" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.22</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 22 Parkinsonism: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0387">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0388"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 23 Somnolence: mildly active group." data-id="CD004048-fig-0388" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.23</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 23 Somnolence: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0388">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0389"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 24 Somnolence; highly active group." data-id="CD004048-fig-0389" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.24</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 24 Somnolence; highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0389">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0390"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 25 Confusion: mildly active group." data-id="CD004048-fig-0390" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.25</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 25 Confusion: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0390">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0391"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 26 Confusion: highly active group." data-id="CD004048-fig-0391" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.26</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 26 Confusion: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0391">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0392"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 27 Slurred speech: mildly active group." data-id="CD004048-fig-0392" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.27</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 27 Slurred speech: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0392">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0393"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 28 Slurred speech: highly active group." data-id="CD004048-fig-0393" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.28</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 28 Slurred speech: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0393">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0394"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 29 Blurred vision: mildly active group." data-id="CD004048-fig-0394" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.29</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 29 Blurred vision: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0394">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0395"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 30 Dizziness: mildly active group." data-id="CD004048-fig-0395" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.30</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 30 Dizziness: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0395">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0396"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 31 Dizziness: highly active group." data-id="CD004048-fig-0396" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.31</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 31 Dizziness: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0396">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0397"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 32 Seizures: highly active group." data-id="CD004048-fig-0397" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.32</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 32 Seizures: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0397">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0398"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 33 Hypotensive reaction: mildly active group." data-id="CD004048-fig-0398" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.33</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 33 Hypotensive reaction: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0398">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0399"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 34 Hypotensive reaction: highly active group." data-id="CD004048-fig-0399" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.34</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 34 Hypotensive reaction: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0399">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0400"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 35 Pruritus: highly active group." data-id="CD004048-fig-0400" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.35</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 35 Pruritus: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0400">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0401"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 36 Polyuria: mildly active group." data-id="CD004048-fig-0401" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.36</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 36 Polyuria: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0401">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0402"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 37 Severe reaction: mildly active group." data-id="CD004048-fig-0402" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.37</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 37 Severe reaction: mildly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0402">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004048-fig-0403"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/urn:x-wiley:14651858:media:CD004048:CD004048-CMP-022-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_t/tCD004048-CMP-022-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 38 Severe reaction: highly active group." data-id="CD004048-fig-0403" src="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.38</div> <div class="figure-caption"> <p>Comparison 22 Appendix 7: lithium vs chlorpromazine ‐ adverse events, Outcome 38 Severe reaction: highly active group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-fig-0403">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/media/CDSR/CD004048/image_n/nCD004048-CMP-022-38.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lithium compared to placebo for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to placebo for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients and a specialist paediatric psychiatry outpatient clinic<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS/MRS decrease by ≥ 50% at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.13<br/> (1.73 to 2.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1707<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>347 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>531 per 1000<br/> (479 to 583) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>YMRS change from baseline at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) measured as YMRS change from baseline to end of study in the placebo group ranged between −20.1 and −6.71 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) measured as YMRS change from baseline to end of study in the lithium group ranged between −22.8 and −12 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>935<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS &lt; 12 at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.16<br/> (1.73 to 2.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1597<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>301 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>482 per 1000<br/> (427 to 536) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.76<br/> (0.46 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1353<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>427 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>362 per 1000<br/> (255 to 482) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> tremor </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 3.25<br/> (2.10 to 5.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1241<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>48 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000<br/> (96 to 203) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> somnolence </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.28<br/> (1.46 to 3.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1351<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>99 per 1000<br/> (66 to 147) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> weight gain </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.48<br/> (0.56 to 3.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>735<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (11 to 70) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MRS:</b> Mania Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to imprecision: wide confidence interval for most of the studies.<br/> <sup>2</sup>Seven studies of variable size, all of which give imprecise results individually, and six cross line of no difference. Overall result is precise but likely over‐exaggeration of true effect.<br/> <sup>3</sup>Downgraded as all three studies cross line of no difference with wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Lithium compared to placebo for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Lithium compared to valproate for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to valproate for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients and outpatients attending mood disorders clinics<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> valproate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with valproate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>YMRS/SADS‐C decrease ≥ 50% by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.22<br/> (0.87 to 1.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>607<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>438 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>487 per 1000<br/> (404 to 569) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>Change in YMRS (ITT‐LOCF) from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in YMRS (ITT‐LOCF) from baseline to end of study in the valproate group ranged from −23.8 to −7.4 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in YMRS (ITT‐LOCF) from baseline to end of study in the lithium group ranged from −23.55 to −6.1 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>398<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 and no increase in MADRS at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.78<br/> (0.46 to 1.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>257<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>713 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>660 per 1000<br/> (533 to 766) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability</b>: total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.20<br/> (0.86 to 1.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>629<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>330 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>372 per 1000<br/> (298 to 455) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> tremor </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 10.51<br/> (1.96 to 56.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>449<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High<sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1000<br/> (9 to 200) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> somnolence </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.47<br/> (0.29 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>575<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>221 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>118 per 1000<br/> (76 to 177) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> nausea </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.53<br/> (0.97 to 2.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>583<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>158 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>222 per 1000<br/> (154 to 310) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>ITT:</b> intention‐to‐treat; <b>LOCF:</b> last observation carried forward; <b>MADRS:</b> Montgomery‐Åsberg Depression Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>SADS‐C:</b> Schedule for Affective Disorders and Schizophrenia‐change; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to imprecision: two small studies with very wide confidence intervals; overall result is precise which is probably an overestimate of true precision.<br/> <sup>2</sup>Downgarded two levels due to imprecision and inconsistency. Six studies, three missing standard deviation, which could not be imputed. Three studies giving highly variable results. Overall estimate is therefore much more consistent than heterogeneity of studies should suggest.<br/> <sup>3</sup>Downgraded for imprecision. Three studies all with differing, imprecise results.<br/> <sup>4</sup>Downgraded one level due to suspicion of reporting bias. Single study reported this outcome when multiple other larger studies will have had this data available; strongly suggests few participants met remission criteria by end of study.<br/> <sup>5</sup>Both studies have very wide confidence intervals.<br/> <sup>6</sup>Likely publication bias, but not downgraded as the included studies are of high quality. Four large studies examined this question but did not report this common adverse event with lithium.<br/> <sup>7</sup>Downgraded one level due to imprecision. All values fairly imprecise, especially <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a>, may be overestimating true effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Lithium compared to valproate for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Lithium compared to lamotrigine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to lamotrigine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients (GlaxoSmithKline studies did not state if the participants were inpatients or outpatients)<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> lamotrigine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lamotrigine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>YMRS/SADS‐C decrease ≥ 50% by end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous</b>) </p> <p>Change in BPRS from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in BPRS from baseline to end of study in lamotrigine group ranged between −3.6 and −2.9 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in BPRS from baseline to end of study in lithium group ranged between −5.1 and −4.9 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>301<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 and no increase in MADRS at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.80<br/> (0.50 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>303<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>408 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>355 per 1000<br/> (256 to 471) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> tremor </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.28<br/> (0.48 to 3.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>272<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000<br/> (28 to 171) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> somnolence </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.14<br/> (0.34 to 3.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>272<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>3,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/> (16 to 151) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MADRS:</b> Montgomery‐Åsberg Depression Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>SADS‐C:</b> Schedule for Affective Disorders and Schizophrenia‐change; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for imprecision.<br/> <sup>2</sup>Downgraded two levels for inconsistency. Heterogeneity was 82%. Two studies by GlaxoSmithKline have similar methodology and inclusion criteria but had very different dropout rates. The study authors do not provide any insight into the cause of this.<br/> <sup>3</sup>Downgraded one level for imprecision: wide confidence interval.<br/> <sup>4</sup>Downgraded one level for imprecision.<br/> <sup>5</sup><a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> would have been expected to have reported somnolence as it is a common adverse effect, however, as we have no objective measure of reporting bias we decided not to downgrade on the basis of a suspicion only. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Lithium compared to lamotrigine for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Lithium compared to carbamazepine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to carbamazepine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> carbamazepine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with carbamazepine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS/SADS‐C decrease ≥ 50% by end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>YMRS/BPRS change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS/BPRS endpoint score in the carbamazepine group ranged between 9 and 24 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS/BPRS endpoint score in the lithium group ranged between 9.46 and 30.9 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>CGI change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) CGI endpoint score ranged between 4.1 and 5.6 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) CGI endpoint score ranged between 5.3 and 5.7 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 and no increase in MADRS at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.20<br/> (0.02 to 1.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>34<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000<br/> (7 to 409) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event:</b> sedation </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.16<br/> (0.01 to 3.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>27<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>154 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (2 to 398) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CGI:</b> Clinical Global Impression; <b>CI:</b> confidence interval; <b>MADRS:</b> Montgomery‐Åsberg Depression Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>SADS‐C:</b> Schedule for Affective Disorders and Schizophrenia‐change; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for risk of bias, and two levels for imprecision.<br/> <sup>2</sup>Downgraded for risk of bias. <a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> blinding strategy unclear, very poor completion rate to the study and not all outcomes reported. <a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a> selective reporting. Other studies low risk of bias.<br/> <sup>3</sup>Pooled estimate has wide confidence interval, reflective of imprecision of all studies. Sample size is very small, would not meet optimal information size (OIS). Downgraded two levels for this.<br/> <sup>4</sup>Downgraded two levels for risk of bias. Studies included participants aged older than 25 years; methodology poorly reported compared to modern studies.<br/> <sup>5</sup>Downgraded for risk of bias (methodology) and imprecision. Single study with wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Lithium compared to carbamazepine for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Lithium compared to quetiapine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to quetiapine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> quetiapine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with quetiapine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS decrease by ≥ 50% by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.66<br/> (0.28 to 1.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>335<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>644 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>544 per 1000<br/> (336 to 737) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous</b>) </p> <p>YMRS change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS change from baseline to end of study in the quetiapine group ranged from −20.28 to −18.2 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS change from baseline to end of study in the lithium group ranged from −20.76 to −15.9 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>359<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission (categorical)</b> </p> <p>Decrease in YMRS ≤ 12 by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.64<br/> (0.26 to 1.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>359<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>538 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>427 per 1000<br/> (232 to 646) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.38<br/> (0.83 to 2.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>359<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>212 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>271 per 1000<br/> (182 to 380) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for inconsistency. High heterogeneity from two similar studies.<br/> <sup>2</sup>Downgraded one level for imprecision: wide confidence intervals.<br/> <sup>3</sup>Outcome 1 downgraded for publication bias. Only two studies found for this outcome, which makes it likely that there are unpublished data not found by our search.<br/> <sup>4</sup>Downgraded one level for imprecision. Large study with tight confidence interval, small study with wide confidence interval. This is to be expected, but it means the precision is highly dependent upon one study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Lithium compared to quetiapine for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Lithium compared to olanzapine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to olanzapine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> olanzapine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with olanzapine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response (categorical)</b> </p> <p>MSRS/YMRS ≥ 50% decrease in score by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.44<br/> (0.20 to 0.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>180<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>730 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>544 per 1000<br/> (351 to 718) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>CGI severity score at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) CGI severity endpoint score in the olanzapine group ranged between 2.26 and 3.69 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) CGI severity endpoint score in the lithium group ranged between 2.83 and 3.41 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>210<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.00<br/> (0.89 to 4.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>140<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>826 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>905 per 1000<br/> (809 to 955) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.60<br/> (1.13 to 5.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>210<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>198 per 1000<br/> (97 to 362) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse even</b>ts </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CGI:</b> Clinical Global Impression; <b>CI:</b> confidence interval; <b>MSRS:</b> Manic‐State Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for publication bias. Olanzapine is used widely to treat acute mania; why so few studies? The lack of studies precluded the use of funnel plots.<br/> <sup>2</sup><a href="./references#CD004048-bbs2-0004" title="BerkM , IchimL , BrookS . Olanzapine compared to lithium in mania: a double‐blind randomized controlled trial. International Clinical Psychopharmacology1999;14:339‐43. ">Berk 1999</a> rated as high risk of bias for selective reporting. Downgraded one level for risk of bias. Downgraded one level for suspected publication bias as described above.<br/> <sup>3</sup>Downgraded one level for imprecision. Wide confidence interval on single small study. Downgraded one level for suspected publication bias as described above.<br/> <sup>4</sup>All studies have wide confidence intervals; strongly suspect result to be an overestimate of favouring olanzapine. Downgraded one level for imprecision. Downgraded one level for suspected publication bias as described above. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Lithium compared to olanzapine for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Lithium compared to chlorpromazine for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to chlorpromazine for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> chlorpromazine </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with chlorpromazine</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response (categorical)</b> </p> <p>MSRS/YMRS ≥ 50% decrease in score by end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>BPRS score change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) BPRS score change from baseline to end of study in the chlorpromazine group ranged from 1.21 to 2.23 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) BPRS score change from baseline to end of study in the lithium group ranged from 0.99 to 1.16 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>284<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.75<br/> (0.92 to 3.31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>262<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>223 per 1000<br/> (131 to 351) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BPRS:</b> Brief Psychiatric Rating Scale; <b>CI:</b> confidence interval; <b>MSRS:</b> Manic‐State Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for risk of bias and publication bias. We identified only two studies comparing lithium and chlorpromazine that we could pool (a third, <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> did not provide any outcomes that were comparable): these were both conducted &gt; 30 years ago. It is possible that the trend to using atypical antipsychotics means research using chlorpromazine has reduced, but we would have expected more publications. Also note that the methodology used in the 1970s/80s was not as rigorous as today, but these studies do give relatively clear accounts of systematic study procedures.<br/> <sup>2</sup>Downgraded for inconsistency. Heterogeneity 90%. Methodology of studies might well be the explanation but this is hard to investigate with minimal information.<br/> <sup>3</sup>Downgraded for publication bias. Chlorpromazine was a mainstay of psychiatry in mid 20th century. We would have expected more publications on this topic. Part of the issue is the lack of combinable outcomes.<br/> <sup>4</sup>Downgraded for risk of bias as <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> was quasi‐randomised. Removing <a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> does not change the result. <a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a> does not give a detailed enough methodology to feel confident about risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Lithium compared to chlorpromazine for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Lithium compared to haloperidol for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to haloperidol for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients (one study did not specify a setting)<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> haloperidol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with haloperidol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>MSRS/YMRS ≥ 50% decrease in score by end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>change in BPRS (total) from baseline to end of study ‐all data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in BPRS (total) from baseline to end of study in the haloperidol group ranged from 1.24 to 12 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) change in BPRS (total) from baseline to end of study in the lithium group ranged from 0.99 to 1 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.29<br/> (0.03 to 3.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>30<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68 per 1000<br/> (7 to 438) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BPRS:</b> Brief Psychiatric Rating Scale; <b>CI:</b> confidence interval; <b>MSRS:</b> Manic‐State Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded two levels for potential risk of bias. Includes studies from 1980 and 1975 with sparse published methodology. Downgraded for inconsistency. Heterogeneity very high (88%); even with removal of outlier in <a href="./references#CD004048-fig-0142" title="">Analysis 8.1</a> (95%).<br/> <sup>2</sup>Downgraded for imprecision. Single study with wide confidence interval. Downgraded for publication bias. Similar to other categories, haloperidol versus lithium is a question we would have expected to see more literature on. It is not possible to do funnel plots with such a limited number of studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Lithium compared to haloperidol for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Lithium compared to zuclopenthixol for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to zuclopenthixol for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> zuclopenthixol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with zuclopenthixol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>BMRS change ≥ 50% from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.33<br/> (0.30 to 5.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>462 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>533 per 1000<br/> (205 to 835) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>change in BPRS (total) from baseline to end of study ‐all data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.78<br/> (0.17 to 3.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>462 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>401 per 1000<br/> (127 to 749) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BPRS:</b> Brief Psychiatric Rating Scale; <b>BRMS:</b> Bech‐Rafaelsen Mania Scale; <b>CI:</b> confidence interval; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level: single study with high risk of bias for blinding and selective reporting.<br/> <sup>2</sup>Downgraded one level for imprecision. Single small study with wide confidence interval.<br/> <sup>3</sup>Downgraded one level for publication bias. Only a single study found in the literature fitting our inclusion criteria. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Lithium compared to zuclopenthixol for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0010"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Lithium compared to risperidone for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to risperidone for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients and specialist mood disorders clinic (one study did not describe the setting)<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> risperidone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with risperidone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>BMRS change ≥ 50% from baseline to end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>YMRS/MRS change at the end of the study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous): YMRS/MRS change at the end of the study was 0 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 7.28 more<br/> (5.22 to 9.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>241<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12/absence of DSM‐IV mania by end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.30<br/> (0.11 to 14.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>211<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>590 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>652 per 1000<br/> (137 to 956) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.85<br/> (1.02 to 3.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>255<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>181 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000<br/> (184 to 425) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events:</b> drowsiness/ somnolence </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.43<br/> (0.24 to 0.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>219<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>455 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>264 per 1000<br/> (167 to 385) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BRMS:</b> Bech‐Rafaelsen Mania Scale; <b>CI:</b> confidence interval; <b>DSM‐IV:</b> Diagnostic and Statistical Manual of Mental Disorders, fourth edition; <b>OR:</b> odds ratio; <b>MRS:</b> Mania Rating Scale; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for imprecision. All studies have wide confidence intervals.<br/> <sup>2</sup>Downgraded one level for publication bias. Very few studies found for this important clinical question using widely used medications.<br/> <sup>3</sup>Downgraded one level for imprecision. Two studies each with wide confidence interval.<br/> <sup>4</sup>Downgraded one level for high probability of publication bias. This is an important clinical question using widely used medications. Seems probable few studies were long enough to show remission and so this outcome has not been reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Lithium compared to risperidone for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0011"> <div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Lithium compared to aripiprazole for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to aripiprazole for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> aripiprazole </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with aripiprazole</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>BMRS change ≥ 50% from baseline to end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>YMRS change by ≥ 50% at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.96<br/> (0.62 to 1.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>309<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>468 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>457 per 1000<br/> (352 to 570) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.99<br/> (0.63 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>309<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>403 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>400 per 1000<br/> (298 to 513) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.94<br/> (0.60 to 1.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>315<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>529 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>514 per 1000<br/> (403 to 621) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events:</b> tremor </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.45<br/> (0.65 to 3.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>313<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000<br/> (48 to 200) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events:</b> somnolence/sedation </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.56<br/> (0.26 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>313<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000<br/> (33 to 140) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events:</b> clinically relevant (&gt; 7%) weight gain </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.07<br/> (0.18 to 23.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>184<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (2 to 201) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BRMS:</b> Bech‐Rafaelsen Mania Scale; <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for publication bias. Despite a full repeated database search and handsearching of grey literature, we found only <a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> lithium verus aripiprazole. We found no ongoing studies for this category. This strongly suggests that data are missing.<br/> <sup>2</sup>Downgraded one level for imprecision. Single study with wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Lithium compared to aripiprazole for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0012"> <div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Lithium compared to topiramate for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to topiramate for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> topiramate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with topiramate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>YMRS change ≥ 50% from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.28<br/> (1.63 to 3.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>660<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>270 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>458 per 1000<br/> (376 to 542) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>YMRS change by ≥ 50% at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.24<br/> (1.58 to 3.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>660<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>415 per 1000<br/> (333 to 499) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.28<br/> (0.66 to 2.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1352<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000<br/> (50 to 166) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Lithium compared to topiramate for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0013"> <div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">Lithium compared to clonazepam for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to clonazepam for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> clonazepam </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with clonazepam</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS change ≥ 50% from baseline to end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>change in CGI score from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) mean CGI endpoint score in the clonazepam group ranged from 2.71 to 4 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) mean CGI endpoint score in the lithium group ranged from 2.07 to 4.4 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy : remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CGI:</b> Clinical Global Impression; <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for risk of bias; includes a single blinded study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 13.</span> <span class="table-title">Lithium compared to clonazepam for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0014"> <div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">Lithium compared to electroconvulsive therapy (ECT) for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to electroconvulsive therapy</b> (<b>ECT) for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> ECT </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with ECT</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: response (categorical)</b> </p> <p>YMRS change ≥ 50% from baseline to end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response (continuous)</b> </p> <p>MRS mean change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) MRS mean change from baseline to end of study in the ECT group was −18.5 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) MRS mean change from baseline to end of study in the ECT group was −16.4 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission (categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Acceptability:</b> total withdrawa<b>ls</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>ECT:</b> electroconvulsive therapy; <b>MRS:</b> Mania Rating Scale; <b>OR:</b> odds ratio; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for imprecision. Downgraded one level for suspected publication bias. We only found this one study looking at electroconvulsive therapy in mania. It is not possible to do a funnel plot in this situation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 14.</span> <span class="table-title">Lithium compared to electroconvulsive therapy (ECT) for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004048-tbl-0015"> <div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">Lithium compared to all antimanic agents for acute mania</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Lithium compared to all antimanic agents for acute mania</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute mania<br/> <b>Setting:</b> inpatients and specialised outpatient clinics<br/> <b>Intervention:</b> lithium<br/> <b>Comparison:</b> all antimanic agents </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with all antimanic agents</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with lithium</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(categorical)</b> </p> <p>YMRS/MRS/BPRS change by ≥ 50% at end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.36<br/> (1.01 to 1.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3666<br/> (14 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>395 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>476 per 1000<br/> (407 to 545) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Efficacy: response</b> </p> <p><b>(continuous)</b> </p> <p>YMRS/BPRS: change from baseline to end of study</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean efficacy: response (continuous) YMRS/BPRS change from baseline to end of study was 0 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.30 lower<br/> (−1.45 to lower 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2410<br/> (19 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy: remission</b> </p> <p><b>(categorical)</b> </p> <p>YMRS ≤ 12 at end of study</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Acceptability:</b> total withdrawals </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.16<br/> (0.89 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4201<br/> (24 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>308 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>341 per 1000<br/> (284 to 404) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study measured this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BPRS:</b> Brief Psychiatric Rating Scale; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MRS:</b> Mania Rating Scale; <b>OR:</b> odds ratio; <b>RCT:</b> randomised controlled trial; <b>YMRS:</b> Young Mania Rating Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded two levels for inconsistency. The overall result of this meta‐analysis is precise, but the individual results are highly heterogeneous. This is probably explainable by small sample sizes in early studies and missing standard deviations that could not be imputed, however, with such a high I<sup>2</sup> value (99%) the results could not be said to be consistent. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 15.</span> <span class="table-title">Lithium compared to all antimanic agents for acute mania</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004048-tbl-0016"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>12 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>8 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>4 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2 weeks</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0005" title="BowdenCL , BruggerAM , SwannAC , CalabreseJR , JanicakPG , PettyF , et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association1994;271:918‐24. BowdenCL , CalabreseJR , WallinBA , SwannAC , McElroySL , RischSC , et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacology Bulletin1995;31(1):103‐9. ">Bowden 1994</a> </p> <p><a href="./references#CD004048-bbs2-0006" title="BowdenCL , GrunzeH , MullenJ , BrecherM , PaulssonB , JonesM , et al. A randomized, double‐blind, placebo‐controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry2005;66:111‐21. ">Bowden 2005</a> </p> <p><a href="./references#CD004048-bbs2-0007" title="BowdenCL , MosolovS , HranovL , ChenE , HabilH , KongsakonR , et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12‐week trial. International Clinical Psychopharmacology2010;25(2):60‐70. ">Bowden 2010</a> </p> <p><a href="./references#CD004048-bbs2-0021" title="KushnerSF , KhanA , LaneR , OlsonWH . Topiramate monotherapy in the management of acute mania: results of four double‐blind placebo‐controlled trials. Bipolar disorders2008;8(1):15‐27. NCT00035230 [Kushner 2006PDMD‐008] . A study on the safety and efficacy of topiramate in the treatment of patients with bipolar I disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of topiramate in patients with acute manic or mixed episodes of bipolar I disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00035230 (first received 3 May 2002). NCT00037674 [Kushner 2006PDMD‐004] . A study on the safety and efficacy of topiramate in the treatment of patients with Bipolar I Disorder [A randomized, double‐blind, multicenter, placebo‐controlled 12‐week study of the safety and efficacy of two doses of topiramate for the treatment of acute manic or mixed episodes in patients with bipolar i disorder with an optional open‐label extension]. clinicaltrials.gov/ct2/show/NCT00037674 (first received 21 May 2002). ">Kushner 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0013" title="GellerB , LubyJL , JoshiP , WagnerKD , EmslieG , WalkupJT , et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry2012;69(5):515‐28. [10.1001/archgenpsychiatry.2011.1508] NCT00057681 . Study of outcome and safety of lithium, divalproex and risperidone for mania in children and adolescents (TEAM). clinicaltrials.gov/ct2/show/NCT00057681 (first received 7 April 2003). SalpekarJA , JoshiPT , AxelsonDA , ReinblattSP , YenokyanG , SanyalA , et al. Depression and suicidality outcomes in the treatment of early age mania study. Journal of the American Academy of Child and Adolescent Psychiatry2015;54(999–1007):e4. VitielloB , RiddleMA , YenokyanG , AxelsonDA , M , WagnerKD , JoshiP , et al. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:867‐87. ">Geller 2012</a> </p> <p><a href="./references#CD004048-bbs2-0032" title="SmallJG , KlapperMH , KellamsJJ , MillerMJ , MilsteinV , SharpleyPH , et al. Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry1988;45(8):727‐32. ">Small 1988</a> </p> <p><a href="./references#CD004048-bbs2-0033" title="SmallJG , KlapperMH , MilsteinV , KellamsJJ , MillerMJ , MarhenkeJD , et al. Carbamazepine compared with lithium in the treatment of mania. Archives of General Psychiatry1991;48:915‐21. ">Small 1991</a> </p> <p><a href="./references#CD004048-bbs2-0010" title="FindlingRA , RobbA , McNamaraNK , PavuluriMN , KafantarisV , SchefferR , et al. Lithium in the acute treatment of bipolar I disorder: a double‐blind, placebo‐controlled study. Pediatrics2015;136:885‐94. ">Findling 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0014" title="GlaxoSmithKline . A six‐week, multicenter, double‐blind, placebo‐controlled, fixed‐dose evaluation of the safety and efficacy of lamotrigine compared to placebo and lithium in the treatment of an acute manic episode in patients who have bipolar disorder [SCAB2009]. GSK ‐ clinical study register (www.gsk‐studyregister.com)2005. GoldsmithDR , WagstaffAJ , IbbotsonT , PerryCM . Lamotrigine: a review of its use in bipolar disorder. Drugs2003;63(19):2029‐50. ">GlaxoSmithKline 2005</a> </p> <p><a href="./references#CD004048-bbs2-0024" title="LusznatRM , MurphyDP , NunnCMH . Carbamazepine vs lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry1988;153:198‐204. ">Lusznat 1988</a> </p> <p><a href="./references#CD004048-bbs2-0001" title="AstraZeneca . An international, multicenter, double‐blind, randomized, placebo‐controlled, phase IV study of the safety and efficacy of lithium versus placebo as an add on to SEROQUEL XR (quetiapine fumarate) in adult patients with acute mania. AstraZeneca Clinical Trials2009. ">Astra Zeneca 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0002" title="BangaN , GoswamiU , KohliK . A comparison of efficacy and tolerability of lithium monotherapy and valoproate monotherapy in mania. Journal of the Association of Physicians of India: Scientific Abstracts of the 59th Annual conference of the association of physicians of India.2003;51:1158 (Abstract no, 37, pg 10). ">Banga 2003</a> </p> <p><a href="./references#CD004048-bbs2-0004" title="BerkM , IchimL , BrookS . Olanzapine compared to lithium in mania: a double‐blind randomized controlled trial. International Clinical Psychopharmacology1999;14:339‐43. ">Berk 1999</a> </p> <p><a href="./references#CD004048-bbs2-0009" title="ClarkHM , BerkM , BrookS . A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania. Human Psychopharmacology1997;12:325‐8. ">Clark 1996</a> </p> <p><a href="./references#CD004048-bbs2-0011" title="FreemanTW , ClothierJL , PazzagliaP , LesemMD , SwannAC . A double‐blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry1992;149:108‐11. ">Freeman 1992</a> </p> <p><a href="./references#CD004048-bbs2-0016" title="GouliaevG , LichtRW , VestergaardP , MerinderL , LundH , BjerreL . Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatrica Scandinavica1996;93(2):119‐24. ">Gouliaev 1996</a> </p> <p><a href="./references#CD004048-bbs2-0017" title="HirschfeldRM , AllenMH , McEvoyJP , KeckPEJr , RussellJM . Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. Journal of Clinical Psychiatry1999;60:815‐8. ">Hirschfeld 1999</a> </p> <p><a href="./references#CD004048-bbs2-0018" title="IchimL , BerkM , BrookS . Lamotrigine compared with lithium in mania: a double‐blind randomized controlled trial. Annals of Clinical Psychiatry2000;12:5‐10. ">Ichim 2000</a> </p> <p><a href="./references#CD004048-bbs2-0020" title="KowatchRA , SuppesT , CarmodyTJ , BucciJP , HumeJH , KromelisM , et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry2000;39:713‐20. ">Kowatch 2000</a> </p> <p><a href="./references#CD004048-bbs2-0022" title="LererB , MooreN , MeyendorffE , ChoSR , GershonS . Carbamazepine versus lithium in mania: a double‐blind study. Journal of Clinical Psychiatry1987;48:89‐93. [MEDLINE: 3546274] ">Lerer 1987</a> </p> <p><a href="./references#CD004048-bbs2-0023" title="LiH , MaC , WangG , ZhuX , PengM , GuN . Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double‐blind study. Current Medical Research and Opinion2008;24(1):1‐10. NCT00448578 . Efficacy and safety of seroquel and lithium as monotherapy in acute mania treatment in bipolar disorder patients (STAR). clinicaltrials.gov/ct2/show/record/NCT00448578 (first received 19 March 2007). ">Li 2008</a> </p> <p><a href="./references#CD004048-bbs2-0025" title="NCT00485680 . Olanzapine versus comparator in the treatment of bipolar disorder. clinicaltrials.gov/ct2/show/record/NCT00485680 (first received 13 June 2007). NiufanG , TohenM , QiuqingA , FudeY , PopeE , McElroyH , et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double‐blind, randomized, controlled trial. Journal of Affective Disorders2008;105(1‐3):101‐8. ">Niufan 2008</a> </p> <p><a href="./references#CD004048-bbs2-0028" title="SegalJ , BerkM , BrookS . Risperidone compared with both lithium and haloperidol in mania: a double‐blind randomized controlled trial. Clinical Neuropharmacology1998;21:176‐80. ">Segal 1998</a> </p> <p><a href="./references#CD004048-bbs2-0029" title="ShaftiSS , ShahveisiB . Comparison between lithium and valproate in the treatment of acute mania. Journal of Clinical Psychopharmacology2008;28(6):718‐20. ">Shafti 2008</a> </p> <p><a href="./references#CD004048-bbs2-0035" title="TrivediJK , LataA , DalalPK , SinhaPK , SrivastavaSA . Comparative study of side‐effects of lithium, carbamazepine and haloperidol in acute mania. Indian Journal of Psychiatry1996;38(4):248‐9. ">Trivedi 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0015" title="GlaxoSmithKline . A 3 week multicenter, double‐blind, placebo‐controlled evaluation of the safety and efficacy of LAMICTAL (lamotrigine) compared to placebo in the treatment of an acute manic or mixed episode in patients who have bipolar disorder. GSK ‐ clinical study register (www.gsk‐clinicalstudyregister.com)2008. ">GlaxoSmithKline 2008</a> </p> <p><a href="./references#CD004048-bbs2-0019" title="KeckPE , OrsulakPJ , CutlerAJ , SanchezR , TorbeynsA , MarcusRN , et al. The CN138‐135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double‐blind, placebo‐ and lithium‐controlled study. Journal of Affective Disorders2009;112:36‐49. [DOI: 10.1016/j.jad.2008.05.014] ">Keck 2009</a> </p> <p><a href="./references#CD004048-bbs2-0026" title="PlatmanSR . A comparison of lithium carbonate and chlorpromazine in mania. American Journal of Psychiatry1970;127:351‐3. ">Platman 1970</a> </p> <p><a href="./references#CD004048-bbs2-0027" title="PrienRF , CaffeyEMJr , KlettCJ . Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Archives of General Psychiatry1972;26:146‐53. ">Prien 1972</a> </p> <p><a href="./references#CD004048-bbs2-0030" title="ShaftiSS . Olanzapine vs. lithium in management of acute mania. Journal of Affective Disorders2010;122(3):273‐6. ">Shafti 2010</a> </p> <p><a href="./references#CD004048-bbs2-0031" title="ShopsinB , GershonS , ThompsonH , CollinsP . Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry1975;32:34‐42. ">Shopsin 1975</a> </p> <p><a href="./references#CD004048-bbs2-0034" title="SpringG , SchweidD , GrayC , SteinbergJ , HorwitzM . A double‐blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry1970;126:1306‐10. ">Spring 1970</a> </p> <p><a href="./references#CD004048-bbs2-0008" title="ChouinardG , YoungSN , AnnableL . Antimanic effect of clonazepam. Biological Psychiatry1983;18:451‐66. Chouinard , D . Antimanic effects of clonazepam. Psychosomatics1985;26(12):7‐12. ">Chouinard 1983</a> </p> <p><a href="./references#CD004048-bbs2-0012" title="GarfinkelPE , StancerHC , PersadE . A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affective Disorders1980;2:279‐88. [MEDLINE: 6450787] ">Garfinkel 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004048-bbs2-0003" title="BarekatainM , FatemiA , BashardoostN , DaroughehA , SalehiM , AsadollahiGH . Valproate‐risperidone valproate‐lithium combination in acute mania. Journal of Research in Medical Sciences2005;10(5):274‐80. ">Barekatain 2005</a> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004048-tbl-0017"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Risk of bias summary table</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Area of potential bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>Number of studies (N = 35)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High risk</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Unclear risk</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low risk</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blinding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incomplete outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Risk of bias summary table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/full#CD004048-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Lithium vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (categorical): YMRS/MRS decrease by =&gt;50% at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1707</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.13 [1.73, 2.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): YMRS change from baseline at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.85 [‐3.14, ‐2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ response (continuous): CGI change from baseline at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.35, ‐0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Efficacy ‐ remission (categorical): YMRS &lt; 12 at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1597</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.16 [1.73, 2.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Acceptability: withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 All‐cause dropouts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1353</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.46, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Dropouts due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.50, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Dropouts due to lack of efficacy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.29, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse event: depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.33, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse event: mania <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.38, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse event: weight gain (categorical) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>735</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.56, 3.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Adverse event: weight gain (continuous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>599</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.50, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Adverse event: akathisia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>673</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.39, 1.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Adverse event: headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.76, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Adverse event: somnolence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.28 [1.46, 3.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Adverse event: dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>873</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.12 [1.21, 3.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Adverse event: insomnia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.44, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Adverse event: diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1028</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.90, 2.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Adverse event: nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [1.54, 3.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Adverse event: vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1028</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.06 [3.21, 11.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Adverse event: dry mouth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>682</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.58, 2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Adverse event: pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.07, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Adverse event: EPS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>478</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.68, 2.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Adverse event: tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.25 [2.10, 5.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Adverse event: constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1075</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.81, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Adverse event: fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.75, 3.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Adverse event: rash <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.37, 2.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Efficacy ‐ response (continuous): CGI change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐1.00, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Response: YMRS decrease by ≥ 50% end of the trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.12, 0.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Response: remission YMRS &lt; 12 at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.11, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Efficacy ‐ response (continuous): MADRS change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.55 [‐0.85, ‐0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Efficacy ‐ response (continuous): MRS score change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 Manic subscale of MRS ‐ score at end of trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.19 [‐2.78, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.2 MRS 16 item scale from SAD‐C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.67 [‐7.27, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Efficacy ‐ (continuous): GAS score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.17 [‐7.02, 13.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Efficacy ‐ HAMD‐31 score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.12 [‐7.69, 5.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Efficacy ‐ BPRS score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.74 [‐3.70, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 PANSS change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.86 [‐4.33, ‐1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 CGI‐BP change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 Severity of illness score Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.0 [‐2.02, ‐1.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.2 Depression change from baseline at 3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.02, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Use of concomitant medications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.52, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Use of sleep medications over course of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.51, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Use of anticholinergic medications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>520</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.73, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Concomitant use of analgesics/antipyretics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.58, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Acceptability: withdrawal due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.61, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Lithium vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Lithium vs valproate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (categorical): YMRS/SADS‐C decrease ≥ 50% by end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>607</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.87, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (categorical, adults): YMRS/SADS‐C decrease ≥ 50% by end of trial ADULTS only <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>579</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.84, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ response (continuous): change in YMRS (ITT‐LOCF) change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [‐0.36, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Efficacy ‐ response (continuous): CGI‐BP change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.29, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Efficacy ‐ response (continuous): Change in MADRS (ITT‐LOCF) change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.73, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Efficacy ‐ remission (categorical): YMRS ≤ 12 and no increase in MADRS at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.46, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Efficacy ‐ remission (categorical): YMRS ≤ 12 and a reduction of at least 2 points on the CGI‐BP at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.34, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse event: headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.64 [1.52, 4.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Adverse event: somnolence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.29, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Adverse event: tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.51 [1.96, 56.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Acceptability: total withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.86, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Efficacy ‐ response (continuous): MADRS change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.83, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 SADS‐C mania score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.90 [‐28.85, ‐4.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 SADS‐C depression score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.40 [‐9.62, 2.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 GAS score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.30 [‐4.18, 22.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 CGI‐BP end of trial score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.13, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 YMRS insight score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.02, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 BPRS score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.3 [‐11.99, ‐0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Any adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.62, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.15, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Adverse event: diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.59, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Adverse event: nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.97, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Concomitant medication: use of lorazepam <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.28, 5.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Concomitant medication: use of chloral hydrate (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [‐2.76, 5.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Concomitant medication: use of lorazepam (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐5.04, 3.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Concomitant medication: use of anxiolytics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.75, 2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Concomitant medication: use of antidepressants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.17 [0.55, 8.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Lithium vs valproate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Lithium vs lamotrigine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (continuous): change in BPRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Efficacy ‐ Change in BPRS from baseline to end of trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.82 [‐3.78, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): MRS (16 item) change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 MRS 11 item from SAD‐C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.74 [‐5.84, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 MRS Manic Subscale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.38 [‐3.02, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 MRS 16 item from SAD‐C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.74 [‐7.55, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ response (continuous): CGI severity change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>304</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.35 [‐1.24, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Efficacy ‐ response (continuous): change in GAS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.36 [‐0.65, 9.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 All‐cause dropouts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.50, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Dropouts due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>273</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.42, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Dropouts due to lack of efficacy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>273</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.48, 2.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Efficacy ‐ response (continuous): change in Hamilton depression scale (HAMD 31) from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.74 [‐3.72, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Efficacy ‐ response (categorical): ≥ 50% reduction in BPRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.09, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Efficacy ‐ response(categorical): ≥ 50% reduction in MRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.31, 5.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Efficacy ‐ response (categorical): CGI scores of 1 or 2 at the end of the trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.09, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Adverse event: vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.77 [0.75, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Adverse event: all mania <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.16, 2.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Adverse event: diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.83 [0.92, 15.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Adverse event: headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.45, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Adverse event: tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.48, 3.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Adverse event: rash <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.17, 1.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Adverse event: somnolence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.34, 3.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Adverse event: any side effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.47, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Adverse event: any serious event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.26, 3.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Adverse event: constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.18, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Adverse event: accidental injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.43, 4.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Adverse event: pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.07, 1.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Use of concomitant psychotropic medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.07, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Mean total dose of lorazepam (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Lithium vs lamotrigine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Lithium vs carbamazepine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (continuous): YMRS/BPRS change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐0.18, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): CGI change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [‐0.40, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ response (continuous): mean length of treatment in weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [‐12.88, 16.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 All‐cause dropouts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.02, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Dropouts due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 8.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Changes in side effect scores from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.9 [‐0.80, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Response rate ≥ 50% change in YMRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.21, 4.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Score of CGI‐BP of 1 or 2 at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [0.39, 9.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Response: CGI change of 2 or more from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.17 [1.63, 51.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 HDRS 6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐2.21, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 HDRS &gt;11 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.03, 3.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Adverse event: serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.15, 3.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Adverse event: nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.06, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Adverse event: sedation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.01, 3.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Adverse event: rash <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.01, 7.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Adverse event: dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.01, 7.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Adverse event: increased appetite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.4 [0.24, 123.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Adverse event: polyuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.11, 80.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Adverse event: diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.11, 80.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Lithium vs carbamazepine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Lithium vs quetiapine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (categorical): YMRS decrease by ≥ 50% by end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.28, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): YMRS/MADRS change from baseline at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 YMRS change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [‐1.28, 5.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 MADRS change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐0.32, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ remission (categorical): Decrease in YMRS ≤ 12 by end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.26, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Efficacy ‐ response (continuous): MADRS change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐0.32, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse event: dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.23, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse event: diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.34, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse event: weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.14, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Acceptability: withdrawal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 All‐cause dropouts</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.83, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Dropouts due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.61 [0.51, 181.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Dropouts due to lack of efficacy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.36, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 PANSS score change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.20 [‐6.71, 0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in YMRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.28, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 YMRS &gt; or = 50% by day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.21, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 YMRS &lt; or = 12 AND MADRS &lt; or = 8 at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.20, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 YMRS &lt; or = 8 at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.23, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Use of sleep medications over the whole study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.78, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Use of lorazepam over the whole study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.27, 2.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Use of anticholinergics over the whole study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.61, 2.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Lithium vs quetiapine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Lithium vs olanzapine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (categorical): MSRS/YMRS ≥ 50% decrease in score by end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.20, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): change in CGI baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.52, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ response (continuous): CGI severity score at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [‐0.04, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Efficacy ‐ remission (categorical): YMRS ≤ 12 at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [0.89, 4.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Total withdrawal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [1.13, 5.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Withdrawal due to lack of efficacy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.38, 7.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Withdrawal due to adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.96 [0.12, 73.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in BPRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.12 [1.87, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Change in CGI‐BP from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.01, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in MADRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.60, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Concomitant medication: benzodiazepine use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [0.63, 4.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Concomitant medication: mean daily dose of lorazepam <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.06, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Concomitant medication: anticholinergic use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.46, 3.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Adverse event: tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.06, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Lithium vs olanzapine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Lithium vs chlorpromazine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (continuous): BPRS score change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.59 [‐1.75, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): PES change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ response (categorical): ≥ 50% reduction on BPRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [0.25, 63.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Acceptability: total withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Withdrawal (quasi‐randomised study removed)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [0.88, 3.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Total Withdrawals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.92, 3.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Lithium vs chlorpromazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Lithium vs haloperidol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (continuous): change in BPRS (total) from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Sensitivity analysis ‐ removal of Garfinek 1980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [‐1.38, 3.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 All data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.40 [‐6.31, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): CGI change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Acceptability: change in side effect scores from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐2.05, 1.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Total withdrawal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.03, 3.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Concomitant medication: use of orphenadrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Concomitant medication: mean total lorazepam (mg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Lithium vs haloperidol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Lithium vs zuclopenthixol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (categorical): BMRS change ≥ 50% from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.30, 5.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Total withdrawal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.17, 3.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mean dose (mg) of extra clonazepam <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse event rating scale psychic <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse event rating scale neurological <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse event rating scale autonomic <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse event rating scale other <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Lithium vs zuclopenthixol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Lithium vs risperidone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (continuous): YMRS/MRS change at the end of the study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.28 [5.22, 9.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ remission (categorical): YMRS &lt; 12/ absence of DSM‐IV mania by end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.11, 14.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ response (continuous): CGI change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.39, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Drowsiness/ somnolence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.24, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.14 [1.12, 15.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.49 [1.32, 4.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Drowsiness/ somnolence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.27, 3.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Total withdrawal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [1.02, 3.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [1.22, 6.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Withdrawal due to adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.80 [0.72, 10.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 CGI‐BP‐IM response <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.14, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Appetite increase <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.11, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Frequent urination <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.29 [2.12, 13.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.03, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Dry mouth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.42 [1.02, 5.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Abdominal Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.98 [1.91, 8.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Concomitant medication: mean total lorazepam (mg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Concomitant medication: use of orphenadrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Lithium vs risperidone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Lithium vs aripiprazole</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (continuous): YMRS change by ≥ 50% at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.62, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): CGI BP change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.18, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ remission (categorical): YMRS &lt; 12 at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.63, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 PANSS change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [2.16, 2.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Total withdrawal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.60, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 CGI‐BP severity of illness score change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.28, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 MADRS change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.87, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 CGI BP depression change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.08, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐0.89, ‐0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Akathisia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.18, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.50, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.48, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.61, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Somnolence/ sedation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.26, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.65, 3.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 EPSE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.34, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Clinically relevant (&gt; 7%) weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.07 [0.18, 23.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Simpson Angus scale EPS LOCF <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐0.54, ‐0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 BARS score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.18, ‐0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Withdrawal due to lack of efficacy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [1.42, 6.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Withdrawal due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Concomitant use of anxiolytics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.34, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Concomitant use of analgesics/antipyretics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.66, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Concomitant use of anticholinergics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.17, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Lithium vs aripiprazole</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0029"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Lithium vs topiramate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (categorical): YMRS change ≥ 50% from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.28 [1.63, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ remission (categorical): YMRS ≤ 12 at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.24 [1.58, 3.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Treatment emergent depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.42, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 DSM‐IV responders at day 21 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [1.28, 2.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mania exacerbation ≥ YMRS 10% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.31, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Suicidal ideation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.02, 5.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Suicide attempt <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.03, 12.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Lithium vs topiramate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0030"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Lithium vs clonazepam</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (continuous): change in CGI score from baseline to end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐1.46, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): change in CGI score from baseline to end of study [double blind only] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in mania rating from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.70 [‐9.12, 5.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in BPRS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Day 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.4 [‐10.10, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.52 [‐6.68, 3.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Change in IMPS from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [‐0.10, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Motor activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐0.42, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Elevated mood</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐1.96, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Pressure of speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐1.10, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Logorrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐0.98, 2.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Insight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐1.11, 2.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in GAF from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.29 [‐26.28, 5.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Simpson Angus scale change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.83, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Use of rescue medications (haloperidol) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [0.27, 60.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Lithium vs clonazepam</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0030">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0031"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Lithium vs ECT</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (continuous): MRS mean change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): BPRS mean change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Efficacy ‐ response (continuous): CGI mean change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Efficacy ‐ response (continuous): GAS mean change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Efficacy ‐ response (continuous): Hamilton Depression Scale mean change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Lithium vs ECT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0031">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0032"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Lithium vs all antimanic agents</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Efficacy ‐ response (categorical): YMRS/MRS/BPRS change by ≥ 50% at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [1.01, 1.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Efficacy ‐ response (continuous): YMRS/BPRS change from baseline to end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.45, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Acceptability ‐ total withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.79, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Lithium vs all antimanic agents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0032">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0033"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinically significant increases in TSH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.05 [2.06, 124.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any serious adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>723</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.39, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Attempted suicide <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>811</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 8.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Accidental injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.39, 3.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.59, 2.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Anorexia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [0.85, 7.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.19, 5.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Weight loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.26 [0.74, 53.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Agitation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.02, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Back pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.01, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Convulsions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.07 [0.32, 202.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Dyspepsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [0.49, 7.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 AIMS score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.14, ‐0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Emotional lability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 8.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.19, 5.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Psychotic disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.24, 9.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Suicidal ideation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.01, 5.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Simpson Angus scale EPS LOCF <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.07, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Motor dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.03, 3.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Leukopenia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.03, 21.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Aggression/ hostility <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 BARS score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.01, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Gastroenteritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.19 [0.13, 78.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Increased appetite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.31 [0.48, 38.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Hyperprolactinaemia &gt; 20 mcg for men and &gt; 30 mcg in women <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.31, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Change in thyrotropin in mIU/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.1 [2.05, 4.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Arthralgia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.12, 15.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Dysarthria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.14 [0.39, 11.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Twitching <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.52 [0.73, 289.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Exacerbation of cough <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.07 [0.32, 202.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>33.35 [1.79, 620.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Pruritus <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.15, 3.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Appendix 1: lithium vs placebo ‐ single trial data and less common adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0033">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0034"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in weight (in kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐1.65, ‐0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Weight gain greater than 7% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in aspartate aminotransferase IU/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.1 [‐9.97, ‐0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in alanine aminotransferase IU/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.90 [‐8.69, 2.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Change in platelet count (x10^9/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>48.00 [31.20, 64.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.58, 2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.89 [0.84, 263.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in creatinine mcmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.60 [0.57, 6.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Thyroid function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>804</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.11, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Change in TSH in mUI/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.09, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Change in T4 in pmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.9 [‐6.88, 3.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Change in T3 in pmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [‐0.79, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in glucose in mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [‐0.13, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Change in cholesterol in mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.20, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Change in triglycerides in mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.17, 0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Somnolence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>402</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.33, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.89 [0.84, 263.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Appendix 2: lithium vs valproate ‐ single trial data and less common adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0034">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0035"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinically significant increases in TSH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.92 [2.30, 139.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Dry mouth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.08, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Somnolence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.18, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Akathisia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.35 [0.34, 32.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Insomnia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.89 [0.81, 4.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 URTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.28, 3.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.67, 4.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 EPS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.33, 4.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 ECG changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.50, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Asthenia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.17, 2.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.13, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.09, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Cardiac disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.07, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Weight loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.42 [0.67, 17.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Anorexia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.72 [1.33, 86.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Bone marrow depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.08 [0.12, 76.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.91 [0.82, 58.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Raised neutrophils &gt; 10x10<sup>9</sup> /L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.61 [0.51, 181.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Deranged LFTs &gt; 3x normal range <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.07, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.91 [0.82, 58.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 High blood glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.20, 5.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Hyperprolactinaemia &gt; 20mcg for men and &gt; 30mcg in women <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.36, 3.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 GI disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.37, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Nervous system disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.39, 1.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Infections and infestations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.63, 3.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.79 [1.44, 9.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Respiratory, thoracic and mediastinal disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.02, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Skin and subcutaneous tissue disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.28, 3.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Eye disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.03, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Psychiatric disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.74 [0.40, 7.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Metabolism and nutritional disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.25, 9.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 MSK and connective tissue disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.14, 7.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Renal and urinary disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Reproductive system and breast disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Vascular disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.04, 5.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Blood and lymphatic disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.20 [0.25, 110.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Hepatobiliary disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.08 [0.12, 76.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Injury, poisoning and procedural complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.08 [0.12, 76.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Appendix 3: lithium vs quetiapine ‐ single trial data and less common adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0035">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0036"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Convulsions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.14 [0.28, 179.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Insomnia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 EPS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.17, 2.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Dry Mouth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.03, 19.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.15, 3.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.92 [0.30, 28.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Akathisia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 2.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Dyspepsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.38, 5.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Agitation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.02, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Emotional lability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 2.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.92 [0.30, 28.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Psychotic disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.23, 8.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Motor dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.06, 15.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [0.69, 9.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Syncope <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.01, 7.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.01, 3.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Arthralgia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.05, 4.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Back pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 3.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Exacerbation of cough <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.05, 4.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.23 [0.81, 12.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Pruritus <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.25 [0.57, 261.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Non fatal serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.08, 7.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Appendix 4: lithium vs lamotrigine ‐ single trial data and less common adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0036">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0037"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.04, 5.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.31, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [0.59, 5.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.08, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Nasopharyngitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.23, 4.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Somnolence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.05, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.15, 3.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.08, 2.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.08, 2.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Cough <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.13, 7.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Restlessness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.01, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Tachycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.03, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.04, 5.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Increased appetite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Tonsillitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [0.17, 22.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 URTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [0.17, 22.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Dry Mouth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 4.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Gingivitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.24, 106.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Haemorrhoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 4.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Adverse effects possibly related to drug use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.12, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Metabolism and nutrition disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.03, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Nervous system disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.12, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Abnormal hepatic function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.96 [0.12, 73.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 EPSE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.97 [0.17, 22.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Significant high cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.03, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Significant high glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 7.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Weight gain &gt; 7% <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.14 [1.31, 28.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Appendix 5: lithium vs olanzapine ‐ single trial data and less common adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0037">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0038"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 ≥ 50% change in YMRS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 YMRS ≤ 12 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [1.10, 22.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Tremor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.06, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.21, 2.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.14, 3.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Dyspepsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.71 [0.66, 20.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 EPSE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 8.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Proportion of patients requiring seclusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.41 [0.52, 11.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 AIMS score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.11, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 YMRS change from baseline at week 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.42, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Appendix 6: lithium vs risperidone ‐ single trial studies and less common adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0038">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004048-tbl-0039"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Appendix 7: lithium vs chlorpromazine ‐ adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Toxicity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.36, 5.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Intercurrent illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.16, 3.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Side effects total: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.13, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Side effects total: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [0.86, 4.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Anorexia: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.56 [0.21, 96.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Anorexia: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.24 [0.42, 162.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Nausea: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.56 [0.21, 96.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Nausea: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.78 [0.57, 204.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Vomiting: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.56 [0.21, 96.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Vomiting: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.78 [0.27, 122.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Diarrhoea: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.41 [0.14, 85.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Dry mouth: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.03, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Dry mouth: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.05, 6.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Constipation: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Constipation: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.78 [0.27, 122.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Abdominal pain: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.07, 18.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Muscle weakness: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.01, 7.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Ataxia: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.48 [0.35, 34.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Tremor: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.56 [0.21, 96.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Tremor: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.36 [0.86, 63.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Facial twitching; highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.41 [0.14, 85.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Parkinsonism: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.41 [0.14, 85.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Somnolence: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.02, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Somnolence; highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.13, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Confusion: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.69 [0.40, 33.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Confusion: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.48 [0.35, 34.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Slurred speech: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Slurred speech: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.07, 18.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Blurred vision: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.01, 7.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Dizziness: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 3.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Dizziness: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.41 [0.14, 85.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Seizures: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.41 [0.14, 85.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Hypotensive reaction: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Hypotensive reaction: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.01, 9.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Pruritus: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.41 [0.14, 85.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Polyuria: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.69 [0.11, 67.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Severe reaction: mildly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.13, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Severe reaction: highly active group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [0.86, 4.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Appendix 7: lithium vs chlorpromazine ‐ adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004048.pub4/references#CD004048-tbl-0039">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004048.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004048-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004048-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004048-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD004048-note-0007">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD004048-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD004048-note-0006">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD004048-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD004048-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004048-note-0027">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004048\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004048\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004048\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004048\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004048\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1ljSZou6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004048.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004048.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004048.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004048.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004048.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728601245"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004048.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728601248"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004048.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec8720b1df431',t:'MTc0MDcyODYwMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 